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Abstract 
Sister chromatid exchange (SCE) occurs during S-phase of the cell cycle and is the 
physical exchange of genetic information between two sister chromatids. Although it 
has been used for many years as a marker of mutagenesis and genetic instability, the 
exact mechanism of SCE formation remains to be elucidated. However, it is known to 
be an end product of the DSB repair pathway, homologous recombination (HR), and 
defects in various repair proteins have been associated with altered levels of SCE, we 
therefore investigated the DNA damage repair response in uveal melanoma, using these 
cells as a model system for SCE formation. 
Uveal melanoma is a rare but aggressive cancer that arises in the uveal tract of the eye 
. affecting the iris, ciliary body and choroid. It is characterised by non-random 
chromosomal alterations such as monosomy of chromosome 3 that is associated with 
metastasis and a poor prognosis. However, random chromosomal aberrations are rare 
suggesting that these tumours have low genetic instability. In addition these tumours 
have been found to have reduced levels of spontaneous SCE, which is also consistent 
with low genetic instability. In general, cancer is associated with high genetic instability 
and high SCE; this is therefore the only disease state known to date to exhibit this low 
SCE phenotype. 
Here, we have found that uveal melanoma cells have high levels of spontaneous DNA 
damage consistent with a defect in repair. Furthermore, endogenous HR is reduced and 
we postulate that it is caused by a reduction in the expression of the FA protein 
F ANCD2, and that this defect causes the reduced SCE frequency in these cells. 
Consistent with this, complementing uveal melanoma cell lines with F ANCD2 restores 
the spontaneous levels of SCE. 
In addition, we have shown that the high chemo-resistance of uveal melanoma to 
interstrand cross-link inducing agents such as Mitomycin C is due to a defect in 
metabolism rather than a defect in DNA repair. 
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Chapter 1 - Introduction 
1.1 Introduction 
Genomic stability is essential for cell survival. DNA is constantly exposed to 
endogenous and exogenous sources of DNA damage, so the cell employs numerous 
repair processes to deal with this damage and ensure that' faithful replication and 
transcription of the genome continues. Genomic instability is a consequence of 
inefficient DNA repair and is a hallmark of tumourigenesis. It is characterised by 
increased chromosomal aberrations and sister chromatid exchanges (SCEs) in many 
types of cancer. SCE is the physical exchange of genetic information between two sister 
chromatids during replication. Although SCE can be used as a marker of mutagenic 
potential and chromosome stability, the mechanism of SCE formation is largely 
unknown. This chapter will discuss the theories of SCE formation, the cellular DNA 
repair responses to endogenous and exogenous DNA damage and the use of uveal 
melanoma as a model system for studying SCE formation. 
1.2 DNA Damage 
1.2.1 Endogenous Damage 
Within the cell, DNA continually reacts with the surrounding oxygen and water giving 
rise to spontaneous DNA lesions. Without the DNA repair processes, these lesions 
would be lethal to the cell, by causing replication and transcription blockage. Although 
all the primary components of DNA are susceptible to oxidative and hydrolytic 
reactions, the majority of spontaneous lesions arise from the deamination, modification 
and hydrolysis, leading to the loss of the DNA bases; all of which will be discussed 
below. 
The deamination of the bases cytosine, adenine, guanine and 5-methylcytosine to uracil, 
hypoxanthine, xanthine and thymine respectively is the most prevalent endogenous 
DNA lesion (Lindahl, 1993). Deamination of 5-methylcytosine produces thymine and 
results in the formation ofT·G mispairs. Similarly, hypoxanthine can pair with cytosine 
during DNA replication causing A·T - nc transitions (Lindahl, 1979). Cytosine can 
also be deaminated to uracil, a common component of RNA that is easily identified as 
foreign in DNA. Such damage would induce DNA repair pathways such as base 
excision repair (BER), mismatch repair (MMR) and translesion synthesis (TLS), thus 
these pathways are essential to ensure cell survival. 
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In addition to deamination processes, base modifications are a common source of 
endogenous DNA damage. Reactive oxygen species (ROS) such as hydrogen peroxide 
(H202), superoxide (On and hydroxyl radicals (HO) are constantly generated as by-
products of normal cellular metabolism and are a major source of damage to all 
intracellular macromolecules especially nucleic acids, proteins and lipids. ROS attack 
on the sugar residues of DNA can lead to single strand breaks (SSBs) (Mello Filho and 
Meneghini, 1984) and base modifications. Guanine is particularly susceptible to 
modification by ROS, producing 7,8-dihydro-8-oxoguanine (8-oxoG) that causes 
mispairing with adenine (Cadet et al., 2003). During replication persistent SSBs can 
, 
also be converted to double-strand breaks (DSBs) and thus, as well as the SSB repair 
pathways, ROS can also induce homologous recombination (HR) and potentially non-
homologous end-joining (NHEJ), although this is a rare event (Lindahl, 1993). 
ROS can also cause modification of the DNA bases through its attack on unsaturated 
lipids generating lipid hydroperoxides such as malondialdehyde. Malondialdehyde can 
react with DNA, resulting in the formation of bulky adducts to adenine, cytosine and 
guanine, and can lead to the generation of DNA-protein cross-links and interstrand 
cross-links (ICLs) between cytosine and guanine residues on opposite strands of the 
DNA duplex (Nair et al., 1986; Niedemhofer et al., 2003). Although this type of 
endogenous damage is rare, they are highly toxic and may require the coordination of a 
number of DNA repair pathways such as nucleotide excision repair (NER), the Fanconi 
Anaemia (FA) pathway, HR and ILS for efficient repair. 
Finally, hydrolytic reactions can cause loss of the DNA bases that are primarily 
recognised and repaired by BER. The cellular environment arid structural composition 
of DNA make it a common substrate for hydrolytic reactions. A common site for such 
reactions is the N-glycosyl bond between the sugar-phosphate backbone and the DNA 
bases. The hydrolytic cleavage of the N-glycosyl bond leaves the sugar-phosphate 
backbone intact, but results in the loss of the DNA base. Although all bases can be lost, 
it more commonly occurs at purine sites. The loss of the base produces either an apurine 
or apyrimidine abasic (AP) site, the consequences of which have obvious genetic 
implications. 
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Finally, in addition to DNA modifications, endogenous DNA damage can result from 
errors that occur during replication. Replication slippage during the replication of 
repetitive sequences or during recombination causes DNA polymerases to mispair 
nucleotides. In this case the cell employs MMR to remove the affected base and ensure 
continued replication. 
1.2.2 Exogenous Damage 
As well as the constant attack on DNA from endogenous cellular metabolism and 
replication errors, damage can be induced by a wide variety of environmental mutagens, 
to which we are constantly exposed. These exogenous sources of DNA damage can 
cause a number of different lesions that are repaired by specific DNA repair pathways. 
Firstly, similarly to endogenous damage, DNA can be altered through the i~duction of 
oxidative damage induced from exogenous sources. UVB (290-320 nm) and the less 
carcinogenic UV A (320-400 nm) components of ultra-violet (UV) light for example, 
can induce DNA damage by the generation of active oxygen species (Kuluncsics et al., 
1999). Furthermore, it is thought that cytotoxic chemicals such as Benzo[a]pyrene in 
cigarette smoke and Aflatoxin BI, a toxic fungalmetabolite found in foodstuffs such as 
cereal, spices, nuts and dried fruit, can modify DNA (As ami et al., 1997; Shen et al., 
1996). Finally~ ionising radiation (IR) can alter DNA structure through the interaction of 
DNA with hydroxyl radicals. IR occurs naturally within the environment as cosmic rays 
from the solar system and radioactive material within the Earths' crust. Furthermore, 
manmade products such as X-rays and CT scanners emit IR. SSBs, base lesions, sugar 
modifications and AP sites can all be produced from exposure to IR. 
As well as inducing oxidative damage, IR can directly ionise DNA causing DSBs. The 
ability of cells to repair DSBs induced by IR decreases with the density of the ionising 
radiation (Jenner et al., 1993), thus IR can lead to chromosome aberrations, cell death 
and cancer. 
Finally, DNA intra- and interstrand cross-links can be induced from a range of 
environmental mutagens. DNA intra-strand cross-links are highly stable lesions that can 
disrupt both transcription and replication, thus promoting cancer if left unrepaired 
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(Mitchell et aI., 1985). These lesions cause a covalent link between proximal 
pyrimidines, most commonly thymine bases, on the same DNA strand. The most 
common source of such lesions comes from the everyday exposure to UV radiation 
(sunlight) although polycyclic aromatic hydrocarbons (PAHs) found in food can also 
result in these lesions. In addition to intra-strand cross-links, ICLs can also be induced. 
These lesions are the most toxic of all DNA lesions as they produce a covalent link 
between the two strands of the DNA duplex blocking replication and transcription and 
thus the agents that induce such lesions have been used successfully as 
chemotherapeutics to induce cell death. The natural anti-tumour antibiotic mitomycin C 
(MMC) and the platinum-based compound cisplatin are two such agents that have been 
used extensively as chemotherapeutics for many years. MMC generates ICLs between 
cytosine and guanine residues on opposite strands of the DNA duplex, whereas cisplatin 
forms,ICLs between two guanine residues. In addition to these ICLs, these compounds 
also form intra-strand cross-links between guanine residues on the same strand, DNA 
adducts by monofunctional alkylation and DNA-protein cross-links (Fichtinger-
Schepman et al., 1985; Tomasz et aI., 1987). Although ICL-inducing agents are highly 
effective chemotherapeutics, any cytotoxic chemical that can induce DNA damage and 
cause replication inhibition has the potential to be used as a chemotherapeutic agent. 
1.3 DNA Repair Pathways 
1.3.1 Repair of Base Damage 
SSBs can arise from a wide range of endogenous and exogenous sources that cause 
damage to one of the DNA strands either by altering DNA structure or through 
replication errors. If unrepaired, SSBs' can block transcription and replication, and 
persist to be converted into potentially lethal DSBs during replication (see Section 
1.3.2). There are therefore a number of repair pathways that deal with the specific 
lesions that arise from this type of DNA damage. 
1.3.1.A Base Excision Repair (BER) 
BER is probably the most frequently used DNA repair pathway and guards against the 
many types of damage that can alter DNA base structures. This type of damage arises 
mainly from the by-products of many endogenous cellular processes such as 
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deamination, methylation and hydroxylation but can also arise from exogenous. sources 
such as IR and some induced oxidative damage. 
The excision of the damaged base is initiated by a variety of DNA glycosylases, specific 
to the type oflesion. The relevant glycosylase catalyses the hydrolysis of the N-glycosyl 
bond holding the chemically altered base to the deoxyribose-phosphate backbone 
(Cunningham, 1997). The removal of these bases generates AP sites that are then 
recognised specifically by AP endonucleases. These endonucleases produce an incision 
at the AP site through the hydrolysis of the phosphodiester bond 5' to the affected base, 
resulting in the formation of a 5' terminal deoxyribose-phosphate residue that is 
subsequently removed by a DNA-deoxyribophosphodiesterase (dRpase) to form a 
single nucleotide gap. In addition, some DNA glycosylases possess AP lyase activity 
that can cleave DNA 3' to the AP site and require a 3' phosphodiesterase to generate the 
single nucleotide gap (Hazra et al., 1998). 
Subsequent repair of the resulting single nucleotide gap involves DNA synthesis and 
ligation of the DNA backbone. DNA polymerase ~ (Pol~) is the main polymerase in 
mammalian cells to incorporate a newly synthesised base into the nucleotide gap (Sobol 
et al., 1996). Following this, the remaining nick is ligated by either DNA Ligase (Lig) I 
or Ill. This mechanism of action is known as short patch repair and is the most 
dominant BER pathway in mammalian cells. Long-patch repair can also occur, and 
involves the additional proteins PoIS, Pole and PCNA to synthesis several nucleotides at 
the single nucleotide gap. Strand displacement results, and this is removed by the flap 
endonuclease Fenl. The utilisation of either the short-patch or long-patch repair 
pathway is influenced by a number of factors, including the particular DNA glycoslyase 
activity and the type of initial lesion (Fortini et al., 1999). 
1.3.1.B Nucleotide Excision Repair (NER) 
NER deals with the wide variety of helix distorting lesions that can disrupt base pairing 
and inhibit transcription.· Many of these lesions arise from exogenous sources such as 
UV-induced cyclobutane pyrimidine dimers (CPDs) and PAHs found in food but they 
can also arise endogenously from oxidative damage. Furthermore, it is postulated that 
7 
Chapter 1 - Introduction 
NER has a role in the initial stages of ICL repair that involves the excision of th~ cross-
link prior to repair by other repair pathways (see Section 1.3.4). 
NER can be split into two subpathways that differ only in the way in which the lesion is 
initially recognised, Global Genome NER (GG-NER) and Transcription Coupled NER 
(TC-NER). In humans, GG-NER recognises lesions that arise in non-transcribed DNA 
by the GG-NER specific complex XPC-hHR23B that binds to regions of distorted DNA 
and recognises disrupted base pairing (Sugasawa et al., 2001). The XPB and XPD 
helicases of the multi-subunit transcription factor TFIIH subsequently unwind the DNA 
for approximately 30 bp surrounding the damaged site, creating a bubble-like structure 
(Evans et al., 1997). This structure is stabilised by the binding of the single stranded 
binding protein RPA to the undamaged DNA strand (Wang et al., 2000). The two 
endonuc1eases XPG and ERCCIIXPF are recruited to the damaged site by XPA where 
they cleave 3' and 5' of the opened structure respectively, creating a 24 - 32 base 
oligonucleotide containing the damaged bases (de Laat et al., 1998). Once removed, the 
resulting gap is filled by the DNA polymerases POL~ and POLE, stabilised by PCNA. 
Finally, the nick between the newly synthesised and existing DNA strand is joined by 
Lig I (de Laat et al., 1999) or Lig III (Moser et al., 2007). 
TC-NER differs from GG-NER in that it recognises lesions in actively transcribed 
DNA. Therefore any lesion in the transcribed strand that blocks RNA polymerase 11 can 
activate this pathway and thus the XPC-hHR23B complex is not required (van Hoffen et 
aI., 1995). The proteins CSB and CSA displace the stalled polymerase allowing repair to 
take place through the same downstream mechanism as described for GG-NER (Le 
Page et al., 2000). 
1.3.1.C Mismatch Repair (MMR) 
MMR is a highly conserved DNA repair pathway that has an important role in 
maintaining genomic stability hence defects in this repair pathway are a common factor 
in promoting oncogenesis. MMR removes nucleotides that have been mispaired by 
DNA polymerases either as a result of DNA replication slippage of repetitive sequences 
or during recombination. As MMR is highly conserved between species, mammalian 
MMR involves multi-member families of the Escherichia coli (E. coli) prototype factors 
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MutS and MutL (Kolodner and Marsischky, 1999). In humans, mismatch recognition is 
carried out by the MSH2 protein that forms a heterodimer with either MSH6 (hMutSa) 
or MSH3 (hMutSP) depending on whether base to base mispairs (MSH6) or 
insertion/deletion loops (MSH3) are to be repaired (Drummond et al., 1995; Palombo et 
al., 1996). Biochemical studies have shown that mismatched DNA produces ATP. This 
induces a conformational change in the MSH2IMSH6 complex that converts it into a 
sliding clamp that is capable of moving along the DNA backbone (Gradia et al., 1999). 
Whilst ATP binding and hydrolysis is dispensable for mismatch recognition, it may 
facilitate subsequent protein-protein interactions (Blackwell et al., 1998). Upon a 
second ATP dependent step the MutL homolog, MLHl forms heterodimers with both 
PMS 1 (MutLa) and PMS2 (MutLP) and interacts with the MSH complexes allowing 
translocation along the DNA bidrectionally and the subsequent recognition of 
mispairing events (Genschel and Modrich, 2003). 
Once the mispair event has been identified it is excised by the 5' to 3' exonuclease 
Exol, shown in Saccharomyces cerevisiae (S. cerevisiae) to interact with Msh2 (Sancar 
and Hearst, 1993). The resulting single strand gap is stabilised by RP A (Ramilo et al., 
2002) allowing the resynthesis of the excised strand by Polo stabilised by PCNA. In 
human cells it has been found that in addition to resynthesis, PCNA interacts with both 
MutS and MutL homologs (Gu et al., 1998). Furthermore, 'mutations in PCNA in yeast 
increase frameshift mutations in repeated sequences through MMR (Kokoska et al., 
1999), suggesting a role for PCNA in the recognition of the initial mispairing event 
prior to the excision step. 
In addition to replication errors, base mispairing can also arise' as a result of the pairing 
of non-complementary sequences during HR and can lead to translocations and 
deletions, potentially causing cancer. The MMR proteins therefore have a role in the 
suppression of HR, when these mismatches occur, to ensure that HR is an error-free 
process. HR involves the pairing of cOIl1plementary single strands, from two different 
duplexes, resulting in a heteroduplex structure'that can then be resolved to form either a 
SCE or gene conversion event (see Section 1.3.2.B). It is mismatches in this 
heteroduplex intermediate resulting from' non~complementary sequences that can be 
recognised and processed by the MMR proteins. Studies in prokaryotic and lower 
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eukaryotic systems have shown that MutS and MutL homologs are involved in a 
mechanism to reverse strand exchange in the presence of low levels of complementation 
(Surtees et al., 2004). In humans, MLHl complexes are involved in the fidelity control 
of divergent DNA sequences during recombinational processes (Siehler et al., 2009). 
1.3.l.D Translesion Synthesis (TLS) 
TLS is a post-replicative repair pathway that ensures the continuation of DNA synthesis 
in the presence of DNA damage. DNA damage that alters base structure such as CPDs 
and endogenous modifications block the progression of the replication fork, as DNA 
polymerases are unable to replicate past the lesion. To overcome this, the cell utilises 
specialised low fidelity DNA polymerases to bypass the lesion and restart replication. 
Using this system the lesion is not actually repaired, the damage is simply tolerated, 
ensuring the continual replication of the genome. 
The DNA polymerases utilised in TLS belong to the V-family polymerases which, in 
contrast to replicative polymerases, have low processivity with low fidelity. Due to the 
open structure of their active sites, they can bind to altered DNA bases and complete the 
synthesis opposite the affected base. The unspecific nature of these polymerases results 
in less stringent base pairing and thus this process often results in point mutations and 
increased mutagenesis. There are two V-family polymerases in E. coli (poIN and 
polV), two in S. cerevisiae (Po I'll and Revl) and four in mammalian cells (PolT), Polt, 
Poll( and Revl}. In addition, the B-family polymerase Pol~ has been implicated in TLS 
in eukaryotes. The diverse range of TLS polymerases ensures the bypass of the many 
different types of lesions that can disrupt replication. In eukaryotes, it has also been 
postulated that they have a further role in the repair of DNA ICLs (See Section 1.3.4). 
TLS was first observed in E. coli where it was found that a NER mutant produced gaps 
in the nascent strand opposite UV -induced thymine dimers, suggesting that replication 
was able to restart downstream of the lesion (Bridges and Sedgwick, 1974). This 
process was subsequently found to be dependent on the bacterial SOS response 
(Radman, 1975) whereby the expression of both the DinE and UmuDC operon encoding 
the two TLS polymerases PolN and PolY respectively were induced. 
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In eukaryotes, TLS has been extensively studied in the budding yeast S. cerevisiae and 
has been found to be mediated by the RAD genes. Rad6 forms a stable complex with 
Rad18 (Bailly et aI., 1994), that displays ubiquitin conjugation, single-stranded DNA 
(ssDNA) binding, ATPase activities (Bailly et aI., 1997) and physically interacts with 
Pol30 (PCNA) (Hoege et aI., 2002). There are two subpathways of the Rad6-Radl8 
pathway, an error-prone pathway involving the REV genes that encode the non-essential 
DNA polymerases (polll and Revl) to bypass replication blocks (polymerase 
switching), and an error-free process involving the Mms2-Ubc13-Rad5 complex that is 
capable of restarting replication further downstream of the blocking lesion, using 
recombinational repair (strand exchange) to complete the synthesis of the resulting gap 
(template switching) (Broomfield et aI., 2001). The ubiquitination of PCNA has an 
essential role in the control of these two sub-pathways. The TLS polymerases colocalise 
with PCNA during normal replication and following DNA damage that stalls replication 
forks, PCNA is monoubiquitinated by the ubiquitin-conjugating activity of the Rad6-
Rad 18 complex (Hoege et aI., 2002). Additional ubiquitination can then occur through 
the ubiquitin activity of the Mms2-Ubc13-Rad5 complex. It was therefore postulated 
that monoubiquitination of PCNA promotes polymerase switching whereas 
polyubiquitination results in template switching and error-free bypass (Hoegeet al., 
2002). These results have been paralleled in mammalian and human cells (Kannouche 
and Lehmann, 2004; Watanabe et aI., 2004) although the process is less well understood 
and is likely to be more complex. 
1.3.2· Double Strand Break Repair (DSBR) 
DSBs are a common form of DNA damage that can arise from any exogenous or 
endogenous source that is able to break both strands of the DNA duplex. Endogenously, 
metabolic products and ROS can cause a DSB; exogenously they can be induced by IR 
causing clusters of ROS that in turn create a DSB. Furthermore, during replication 
unrepaired SSBs can persist, collapsing the replication fork and generating a DSB. In 
eukaryotes, there are two major pathways for the repair ofDSBs, HR and NHEJ. HR is 
primarily active during late S and 02 phase of the cell cycle when a sister chromatid is 
readily available for re combinational repair, whereas NHEJ predominantly occurs 
throughout 0 I. The exact factors that govern the use of each pathway remain to be 
elucidated, although cell cycle status is thought to have a major influence, controlled by 
11 
Chapter 1 - Introduction 
CtIP phosphorylation. In humans it has been found that mammalian CtIP becomes 
phosphorylated during S-phase and that this phosphorylation is required for the initial 
resectioning of the DSB during HR (Yun and Hiom, 2009). As CtIP is not required for 
NHEJ, it has been proposed that the phosphorylation of CtIP governs the initiation of 
HR during 8/02 phase and thus the use of each DSBR pathway in a cell-cycle 
dependent manner (Yun and Hiom, 2009). 
1.3.2.A Non-Homologous End-Joining (NHEJ) 
NHEJ involves the binding and re-ligation of two broken DNA ends that often results in 
the loss of genetic information hence it is a fast but often error-prone mechanism of 
repair. Within seconds of a DSB being introduced, the KU70/S0 heterodimer migrates 
to the site of damage and binds to the two broken DNA ends (Mari et aI., 2006; Mimori 
and Hardin, 1986). Its high abundance within the cell and its high affinity for DNA 
through its open-ring structure contributes towards this quick response (Walker et aI., 
2001). The binding of the DNA end with this protein complex acts as a scaffold to 
facilitate the binding of the DNi\-dependent protein kinase catalytic subunit (DNA-
PKcs). Once bound, DNA-PKcs forms a synaptic complex that bridges the gap across 
the DSB, bringing the two broken DNA ends together. In its unphosphorylated form, 
DNA-PKcs blocks premature degradation and ligation until the DNA ends have been 
brought together (Calsou et aI., 1999; Weterings et aI., 2003). Autophosphorylation of 
DNA-Pkcs is required to induce a conformational change that allows processing 
enzymes and ligases access to the break site, essential to the downstream NHEJ events 
(Meek et aI., 2007). 
The subsequent steps in NHEJ depend upon the type of DSB. In its simplest form a 
DSB consists of two compatible blunt ends that can be immediately ligated back 
together. More commonly however, the induction of a DSB generates heterogeneous 
incompatible ends producing a 3' or 5' single stranded DNA (ssDNA) overhang at one 
or both of the DNA ends. This overhang must be removed either by resynthesis of the 
DNA strand using the nucleotide sequence of the overhang as a template (gap filling), 
or by resection before ligation can occur. In mammalian cells, a family of DNA 
polymerases j..l, A and terminal deoxynudeotideyltransferase (TdT) are all involved in 
the resynthesis of the DNA strand (Lee et aI., 2004; Mahajan et aI., 1999; Mahajan et 
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al. , 2002), whereas a conformational change in the Artemis protein, phosphorylated by 
DNA-PKcs, allows it to function as a 5' or 3' endonuclease to remove the overhang (Ma 
et al., 2002). Once processed, the resulting compatible ends can be ligated by the DNA 
LIGIVIXRCC4 complex, recruited to the synaptic complex by the KU70/80 
heterodimer (Costantini et al., 2007). LIGIV can ligate double-stranded DNA that have 
compatible overhangs or blunt ends (Grawunder et al., 1997), the efficiency of which is 
increased by XRCC4 that acts to stabilise the interaction between the DNA helix and 
LIGIV (Grawunder et al., 1997; Modesti et al., 1999). 
KU70/80 heterodimer 
DNAPKcs 
a) KU70/80 and DNA-PKCS bind to 
DNA ends 
b) autophosphorylation of DNA-PKcs 
d) resection 
e) Ligation by LigaselVIXRCC4 
Figure 1.1 Model of the NHEJ repair pathway for the repair of DSBs 
a) The KU70/S0 heterodimer binds to the broken DNA ends of the DSB allowing the recruitment 
of DNA-PKcs, forming a synaptic complex across the break site. b) Autophosphorylation of 
DNA-PKcs allows processing enzymes to perform either c) gap filling or d) re ection, before e) 
ligatioo is carried out 00 compatible ends by the DNA LIGIVIXRCC4 complex, adapted from 
Weterings (2008). 
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1.3.2.A.l PARP-l Dependent End-Joining (Alternative NHEJ) 
In addition to NHEJ evidence from both in vivo and in vitro studies suggests an 
alternative end-joining pathway exists to repair DSBs that is independent ofDNA-PKcs 
but dependent on PARP-l (Audebert et al., 2004). Chicken DT40 cells deficient in 
essential NHEJ and HR proteins exhibit sensitivity to IR-induced DSBs but are still 
capable of repairing the DSBs by a more slowly activated pathway (Wang et al., 2001). 
P ARP-l is a major protein of SSBR that catalyses the covalent transfer of successive 
ADP-ribose polymers from NAD to itself and other repair proteins upon binding at the 
break site. Using a yeast two hybrid system it was shown that PARP-l interacts with 
XRCCI at the break site, which then acts as a scaffold protein allowing POL~ and 
LIGIII to resynthesise and ligate the DNA ends accordingly (Caldecott et al., 1996). 
Due to the high affinity ofPARP-l to DSBs as well as SSBs (Weinfeld et al., 1997), it 
is postulated to have a similar role in an alternative end-joining pathway that is 
dependent on microhomology in the sequences at the break site, which are used for the 
resynthesis and ligation of the DNA ends (Audebert et al., 2004). Although the exact 
factors that govern the use of this alternative end-joining pathway remain to be 
elucidated, the CtIP protein has been shown to be required for the repair of DSBs during 
Gl phase of the cell cycle independently of NHEJ and presumably through this 
alternative pathway. In addition, unlike HR, the phosphorylation of CtIP is not required 
for the activation of this PARP-dependent end-joining pathway (Yun and Hiom, 2009) 
suggesting that this pathway is independent of both NHEJ and HR DSBR. 
1.3.2.B Homologous Recombination (HR) 
HR is an error-free conservative process that repairs DSBs through a homology 
mediated mechanism. During late S or 02 phase, a sister chromatid becomes available 
to be used as a homologous template for the faithful repair of a DSB. Like NHEJ, HR 
can repair classic DSBs that produce two free DNA ends as substrates for repair (Fuller 
and Painter, 1988), however this type of DSB is comparatively rare and is primarily 
repaired by NHEJ (Sargent et al., 1997). Another role of HR is therefore postulated to 
be the repair of DSBs that arise during replication. Persistent SSBs that occur during S-
phase are converted to DSBs at collapsed replication forks leaving only one-end of the 
DNA strand free for repair (Amaudeau et al., 2001). 
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1.3.2.B.l Two-Ended Repair 
During mammalian HR, DSBs are initially recognised . and bound by the 
MrellIRad50lNbsl (MRN) protein complex recruiting the ataxia-telangiectasia mutated 
(ATM) checkpoint kinase to the damage site (Paull and Lee, 2005). The MRN complex 
is also thought to have a role in the processing of the free DNA ends to generate 3' 
ssDNA ends due to its exonuclease as well as endonuclease activity (Carney et al., 
1998; Paull and Gellert, 1998). In humans, the CtIP protein has been found to interact 
with BRCAl to promote the resection of ssDNA tail ends at the break site (Yu and 
Chen, 2004). The resected 3' ssDNA overhang is coated with RPA due to its high 
affinity to ssDNA. Strand invasion is initiated by the displacement of RP A by Rad51 
fonning a presynaptic filament on the ssDNA overhang (Baumann and West, 1998) 
(Figure 1.2). In vitro, RP A inhibits the nucleation of Rad51 filaments on ssDNA; the 
process of displacement is therefore promoted by a number of mediator proteins such as 
Rad52 and the Rad51 paralogs, Xrcc2, Xrcc3, Rad51B, C and D. Although the exact 
function of these mediator proteins remains to be elucidated, all are required for Rad51 
nucleoprotein filament fonnation (Y onetani et al., 2005). In humans, BRCA21F ANCD 1 
has also been shown to bind to RAD51 and facilitate nucleoprotein filament fonnation, 
and is essential for efficient HR repair (Chen et al., 1998). Stimulated by Rad54, the 
Rad51 nucleoprotein filament invades an aligned homologous DNA duplex and 
displaces the resident strand to create a heteroduplex structure known as aD-loop 
(Petukhova et al., 1998) (Figure 1.2). DNA polymerases are then recruited to the site 
and synthesis occurs past the original DSB using the sister chromatid as a homologous 
template. 
A Holliday junction will fonn at the site of invasion and it is the direction in which 
branch migration takes place that determines the subsequent steps of the process. If the 
Holliday junction migrates in the direction of replication, the invasion will be reversed 
and the invading ssDNA will re-anneal with the 3' end of the original DSB. This 
synthesis-dependent single strand annealing (SDSSA) is error-free unlike nonnal SSA 
(see Section 1.3.2.B.2), and results in gene conversion (non-crossover event) (Figure 
1.2). Alternatively, the ssDNA end may be repaired by synthesis-dependent NHEJ 
resulting in a tandem duplication at the site of the DSB and hence mutation (Richardson 
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and Jasin, 2000). Finally, the free end of the original duplex may invade the same 
homologous sister chromatid facilitated by Rad52 and RP A known as second end 
capture (Nimonkar et al., 2009; Sugiyama et al., 1998). Subsequent branch migration 
facilitated by Rad54 results in the formation of a double Holliday junction. This 
structure can either be dissolved by topoisomerase IlIa and BLM through convergent 
branch migration forming non-crossover events, or alternatively, it can be resolved by 
resolvases to result in either crossover (SCE) or non crossover (gene conversion) 
products. In humans, the MUS81lEMEl complex has been shown to cleave Holliday 
junctions however this cleavage results in non-ligatable ends (Ciccia et al., 2003). More 
recently, GENt has been identified as a resolvase of Holliday junctions in humans that 
results in ligatable ends (Ip et al., 2008). It is the direction of the resolution that 
determines the end product of HR. If the cleavage of the Holliday junction occurs in the 
same plane no crossovers will result (gene conversion). However, cleavage can also 
occur in opposite planes resulting in crossover between the two sister chromatids, thus a 
SCE is produced (Figure 1.2). 
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Figure 1.2 Models of HR fo r the repair of two-ended DSBs 
a) The initial step of all HR sub-pathways is the 5' to 3' resectioning of the DSB to generate 3' 
ssDNA overhangs. If sequences of homology are revealed, b) SSA takes place annealing the 
complementary ssDNA. c) The strands are displaced and excised by ERCCIIXPF. d) Single 
strand gaps are filled and the strands are ligated back together. Alternatively, e) strand invasion 
can occur initiated by Rad51 which results in either f) synthesis-dependent SSA, where the 
invading strand anneals to the original strand and the gaps are filled resulting in non crossover 
products, or g) second end capture occurs forming a double Holliday junction and allowing 
synthesis to continue. h) The way in which the double Holliday junction is resolved results in 
non-crossover (gene conversion) or crossover products (SCE), adapted from Mimitou and 
Symington (2009). 
1.3.2.B.2 Single Strand Annealing (SSA) 
SSA is a repair mechanism similar to HR in that it utilises homologous sequences to 
facilitate the repair of a two-ended DSB. The 5' to 3' resection at the break site occurs in 
the same way as in HR however if repeated sequences are revealed within the 3' ssDNA 
overhangs, SSA will be initiated by the annealing of RP A coated ssDNA by Rad52 
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(Singleton et aI., 2002). Once annealed, the regions in between the repeats are displaced 
and removed by the flap endonuclease ERCC llXPF (Ahmad et aI., 2008) and the ends 
are ligated together (Figure 1.2). In mammalian cells, SSA is a frequent event between 
repetitive sequences however it is an error-prone process that results in deletions around 
the original break site (Liang et aI., 1998). 
J.3.2.B.3 One-Ended Repair 
During replication, persistent SSBs are converted to DSBs collapsing replication forks, 
a substrate for HR (Arnaudeau et aI., 2001). This type of lesion can be induced 
following camptothecin treatment, however primarily these lesions occur as a result of 
normal endogenous DNA damage during S-phase (Saleh-Gohari et aI., 2005). The 
formation of the DSB at the collapsed fork results in only one end of the DNA strand 
being available for HR (one-ended repair). Upon collapse of the replication fork 5' to 3' 
exonuclease resection of the free DNA end occurs resulting in a 3' ssDNA overhang. 
The resulting single strand gap on the template DNA is filled resulting in an intact sister 
chromatid template (Figure 1.3). In a similar process as described for two-ended repair 
(Section 1.3.2.B.l), strand invasion occurs allowing the leading strand synthesis to 
continue, re-establishing the replication fork. As only a single Holliday junction is left 
behind the replicating fork it can only be resolved in one way to result in an SCE 
(Figure 1.3). 
18 
: :~ 
::~/-
a) Collapsed replication fork 
3' __ --. 
::~ 
3' ---
d) Strand invasion 
5' __ ..... 
3 '~ ,,'--
:~;--.-
b) Gap fill ing ... 
3' ___ ... 
5' 
e) Replication fork is re-started 
Chapter 1 - Introduction 
3' --..... 
5 '~ 
5'~ 
3'---
c) ... and resection 
3'-------5'-------
5' - - -----3'-------
f) Holliday junction resolution 
results in a SCE event 
Figure 1.3 HR at a coUapsed replication fork (one-ended repair) 
a) A SSB is converted to a DSB collapsing the replication fork. b) Gap filling joins the single 
strand gap on the template DNA forming an intact sister chromatid. This is followed by c) 5' to 3' 
resection resulting in a 3' ssDNA overbang. The overhang is coated in Rad51 amongst other 
proteins to facilitate d) strand invasion. e) The displaced template strand is then used for DNA 
synthesis and the replication fork is re-established. f) Fonnation of a single Holliday junction 
behind the replicating fork leads to its re olution in only one direction producing a SCE event. 
Adapted from Helleday (2003). 
1.3.3 Fanconi Anaemia (FA) Pathway 
F A is a rare genetic instability disorder that is usually an autosomal recessive disease 
but in some cases can be X-linked (F ANCB patients). FA causes acute myeloid 
leukaemia, bone marrow failure, congenital abnormalities and a predisposition to 
cancer. Cells from FA patients are characterised by increased chromosomal fragility 
leading to increased chromosomal aberrations and a hypersensitivity to DNA ICL-
inducing agents such as MMC, which is used for its clinical diagnosis. Although a 
genomic instability disorder, unlike BLM and many cancers (see Section 1.4.2), FA 
patient cells exhibit normal levels of spontaneous SCE. They do however display a 
reduced induction of SCE in response to ICL damage (Latt et aI., 1975), consistent with 
an inability to repair this damage and thus their hypersensitivity to ICL-inducing agents. 
To date there have been thirteen complementation groups and their corresponding genes 
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identified; together these genes and more make up the FA pathway. A mutation in any 
one of these genes results in FA, making it an ideal model system in which to study this 
pathway. 
The FA pathway consists of a multi-subunit protein complex known as the FA core 
complex. Its main function is to monoubiquitinate the FA proteins, F ANCD2 and 
FANCI at residues K561 and K523 respectively (Alpi et al., 2008) during normal S-
phase and in response to DNA damage (Garcia-Higuera et al., 2001; Smogorzewska et 
al., 2007). The core complex subunit F ANCL consists of a PHD domain that possesses 
E3 ubiquitin ligase activity (Meetei et al., 2003). Using UBE2T as an E2 ubiquitin 
conjugating enzyme (Machida et al., 2006), the core complex is able to regulate the 
monoubiquitination of F ANCD2 and F ANCI through this essential catalytic subunit. 
This modification of F ANCD2 and F ANCI allows their localisation to chromatin foci 
where they interact with other repair proteins during normal S-phase and following 
DNA damage to promote repair, although their exact function at these foci sites remains 
to be elucidated. 
The FA core complex is composed of the FA proteins FANCA, B, C, E, F, G, L and M 
all of which have been linked to the FA phenotype. FAAP24 and FAAPlOO are also 
members of the FA core complex but have not been associated with the disease (Ciccia 
et al., 2007; Ling et al., 2007). Each member of the complex is essential for the 
monoubiquitination of F ANCD2 as determined by the lack of F ANCD2 
monoubiquitination in each of the FA patient subtypes (Garcia-Higuera et al., 2001). 
FANCA and FANCG form a subcomplex within the core complex, as do FANCB, L 
and FAAPI00, and FANCC, E and F (Medhurst et al., 2006) however the functional 
significance of these remains to be elucidated. 
F ANCM and F AAP24, although a part of the core complex, have a separate function. 
F ANCM and F AAP24 were first identified by Meetei et aI. (2005) and Ciccia et aI. 
(2007) respectively, and are both members of the XPF endonuclease family. FANCM 
contains DNA helicase motifs that have been shown in vitro to be involved in the 
translocation of Holliday junctions and fork reversal (Meetei et al., 2005). F AAP24, in a 
complex with F ANCM, has also been shown to bind to ssDNA and branched DNA 
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structures (Ciccia et al., 2007). As F ANCM and F AAP24 are constantly bound to the 
chromatin during the cell cycle, it is suggested that in response to DNA damage, 
FANCM and FAAP24 recognise and bind to stalled replication forks and recruit the FA 
core complex to the chromatin (Kim et al., 2008). During S phase however, it is the 
reduction in the phosphorylation of F ANCM that allows the recruitment of the core 
complex to the chromatin and thus F ANCD2 monoubiquitination (Kim et al., 2008). 
Conversely, it has been shown that upon hyperphosphorylation of FAN CM by the polo-
like kinase PLKl regulator, the core complex is released from the chromatin (Kee et al., 
2009). 
The final three FA proteins, FANCDl, FANC] and FANCN are not required for the 
monoubiquitination of F ANCD2 and function downstream of this modification. F ANCJ 
also known as BRIPl or BACHl possesses 5' to 3' helicase activity, interacts with 
BRCAl and localises to repair foci with BRCA2 and RPA; its function at these foci is 
currently unknown (Gupta et al., 2007). FANCN also known as PALB2, is a binding 
partner of BRCA2 and is required for the localisation of BRCA2 to chromatin to 
promote HR (Xia et al., 2006). Lastly FANCDl, better known as the tumour suppressor 
BRCA2, facilitates the formation of RAD51 filaments and is essential for HR (Yang et 
al., 2002): FANCD2 functionally interacts with BRCA2IFANCDl, promoting its 
loading into chromatin complexes that are essential to HR (Wang et al., 2004). 
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Figure 1.4 The structure of the FA pathway 
F A CM and F AAP24 are constantly bound to the chromatin and recruit the FA core comp lex to 
the chromatin during S-phase and in response to DNA damage. The three subunits, FA CA and 
G (blue with grey outline), FA CC, E and F (blue with black outline) and FANCB, L and 
FAAPIOO (dark blue) make up the FA core complex. The FA core complex monoubiquitinates 
FANCD2 and FANCI which then localises to DNA repair foci along with the downstream FA 
proteins FANCDlIBRCA2, FANCJ and FANCN to facilitate repair, adapted from Moldovan and 
D' Andrea (2009). 
1.3.3.A Regulation of the FA Pathway 
The A TR checkpoint kinase is the major upstream regulator of the FA pathway and has 
been shown to phosphorylate a number of F A proteins either directly or by its effector 
kinase Chkl to ensure efficient repair during S-phase (pichierri and Rosselli , 2004). 
F ANCA and F ANCG are phosphorylated directly by ATR and this is required for the 
nuclear localisation of the FA core complex (Collins et aI. , 2009; Qiao et aI. , 2004). 
F ANCE however is degraded following phosphorylation by CHKl required for the 
regulation of the ubiquitin ligase activity of the core complex rather than its chromatin 
association (Wang et aI., 2007). Independently of the FA core complex, A TR is also 
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known to phosphorylate FANCD2 and FANCI, and this is essential for FANCD2 
monoubiquitination (Andreassen et al., 2004). Finally, in response to DNA damage, 
ATR phosphorylates the histone family member H2A.X (yH2A.x) and this is required 
for the recruitment ofFANCD2 to chromatin (Bogliolo et al., 2007). 
Whereas F ANCD2 monoubiquitination by the FA core complex is essential for efficient 
repair, the monoubiquitination ofFANCI is not (Ishiai et al., 2008). This suggests that a 
different feature of FANCI is important for efficient repair, postulated to be the ATR-
dependent phosphorylation ofFANCI (Smogorzewska, 2007). A chicken DT40 cell line 
with a point mutation at the monoubiquitination site of F ANCI showed reduced but 
sufficient monoubiquitination of F ANCD2 (Ishiai et al., 2008). When point mutations 
were introduced at phosphorylation sites on FANCI however, no monoubiquitination of 
FANCD2 occurred suggesting that the phosphorylation of F ANCI by ATR is essential 
to the activation of the FA pathway (Ishiai et al., 2008). 
Another mechanism of regulating the FA pathway occurs through the removal of 
ubiquitin from FANCD2 and FANCI by the deubiquitinating enzyme USP1 and its 
activator UAF1 (Nijman et al., 2005). In the absence of DNA damage, USP1 and UAF1 
constantly act to deubiquitinate F ANCD2 and F ANCI however, upon DNA damage, 
USP 1 gene transcription is switched off and the protein is quickly degraded. This allows 
a build up of monoubiquitinated F ANCD2 and F ANCI leading to the formation of foci 
and efficient repair (Nijman et al., 2005). 
1.3.3.B Activation of the FA Pathway 
As FA patient cells are hypersensitive to leL-inducing agents, it was proposed that the 
FA pathway has an important role in the repair of DNA leLs and this was confirmed by 
complementation studies, showing that the hypersensitivity to ICL-inducing agents 
could be corrected by the complementation of the mutated FA proteins in FA patient 
cells (Strathdee et al., 1992). The many interactions of FANCD2 with other repair 
proteins involved in NER, TLS and HR suggests a pivotal role for the FA pathway in 
the coordination of a number of repair pathways to deal with the highly toxic leL lesion 
(Mirchandani and D'Andrea, 2006). (see Section 1.3.4) .. Inactivation of FANCD2 
however, not only sensitises cells to leL-inducing agents but also to oxidative stress 
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(WiIlers et al., 2008) therefore, although it is clear that the FA pathway is involved in 
, 
JCL repair, evidence suggests that this pathway is not linear and that the FA proteins, 
particularly F ANCD2, have a broader role in the response to spontaneous as well as 
induced DNA repair. 
The FA pathway can be activated (as measured by the monoubiquitination ofFANCD2) 
by a wide range of exogenous and endogenous damage (Garcia-Higuera et al., 2001; 
Taniguchi et al., 2002). F ANCD2 monoubiquitination is required for the normal cell 
cycle progression through S-phase and thus forms nuclear foci both spontaneously 
(Taniguchi et al., 2002) and in response to DNA damage induced by a variety of agents 
such as JR, MMC, and replication stress induced by Aphidicolin (APH) and 
Hydroxyurea (HU) (Howlett et al., 2005). Once monoubiquitinated, FANCD2 (and 
FANCI) form discrete nuclear foci and co-localise with the repair proteins BRCAI, 
RAD51 (Garcia-Higuera et al., 2001; Taniguchi et al., 2002) and the DNA polymerase 
processivity factor, PCNA (Howlett et 'al., 2005; Hussain et al., 2004). The co-
localisation of FANCD2 with BRCA1 and RAD51 is S-phase specific and occurs not 
only following the induction of DNA damage from exogenous sources but also 
endogenously through the replicatio~ associated repair by HR (Taniguchi et al., 2002). 
Recently, it has also been shown that F ANCD2 functionally interacts with PCNA 
through a highly conserved putative PCNA interaction motif (PIP-box) (Howlett et al., 
2009). Mutation in the PIP box of F ANCD2 abrogates monoubiquitination both 
spontaneously and in response to DNA damage. AIR phosphorylation of F ANCD2 
however can still occur thus, F ANCD2 is able to localise to chromatin but does not form 
nuclear foci (Howlett et al., 2009). It is therefore postulated that PCNA acts as a 
platform to facilitate the recruitment of monoubiquitinated F ANCD2 to the chromatin at 
stalled replication forks following endogenous or induced replication stress (Howlett et 
al.,2009). 
Although monoubiquitinated F ANCD2 is recruited to stalled replication forks its exact 
function at these sites remains to be elucidated. A role for the FA pathway and thus 
FANCD2 in the restart of collapsed replication forks has been proposed (Wang et al., 
2008). Replication fork restart was measured by radioactive nucleotide incorporation' 
following the induction of damage in Xenopus egg extracts. Using camptothecin to 
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create replication-dependent DSBs and thus collapsed replication forks, it was found 
that fancd2-depleted extracts were deficient in the restart of replication. The replication 
restart of stalled forks induced by APH (an inhibitor of DNA polymerase) however was 
not affected by the depletion of fancd2 (Wang et al., 2008). This suggests that the FA 
pathway has a role in the replication restart of collapsed but not stalled forks, 
irrespective of the presence of a DNA ICL. 
1.3.3.C FANCD2 and Cancer 
The F ANCD2 complementation group accounts for just 2% of all FA patient cells but 
generally causes a more severe phenotype (Timmers et al., 2001). Interestingly, like 
other proteins of the FA pathway such as the well characterised FANCDIIBRCA2 
protein, F ANCD2 defects have also been associated with sporadic and hereditary breast 
cancers in different mammalian systems (Moldovan and D'Andrea, 2009). Firstly, 
Fancd2 knockout mice have been shown to develop ovarian and epithelial breast 
cancers (Houghtaling et al., 2003) whilst in humans, polymorphisms on F ANCD2 have 
been associated with increased sporadic breast cancer risk (Barroso et al., 2006) and 
FANCD2 expression has been found to be absent in 10 - 20% of sporadic and BRCA1-
related breast cancers (van der Groep et al., 2008). Recently it was found that 19/20 
malignant breast carcinomas had negative nuclear immunocytochemical staining of 
FANCD2 whereas cytoplasmic staining was normal (Rudland et al., 2010). One 
possible explanation for this is that F ANCD2 is not being activated in these cells, 
causing a defect in repair that may promote tumour growth. In. addition, a further 
reduction in cytoplasmic F AN~D2 staining was correlated with positive staining for 
metastatic-inducing proteins such as osteopontin and thus was correlated with decreased 
patient survival and metastatic disease (Rudland et al., 2010). Taken together these data 
suggest that deregulation of F ANCD2 transcription and protein expression may be 
important in promoting breast and other human cancers (Ho skins et al., 2008). 
1.3.4 Interstrand Cross-link (ICL) Repair 
ICLs are the most cytotoxic of all DNA lesions covalently linking both strands of the 
" 
DNA duplex, thus preventing unwinding of the DNA and therefore blocking essential 
cellular processes such as replication ~d transcription. Many ICL-inducing agents such 
as MMC and cisplatin are widely used as chemotherapeutic drugs, however ICLs can 
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also arise endogenously from metabolic by-products such as the lipid peroxidation 
product malondialdehyde (Niedernhofer et al., 2003). The ICL repair mechanism has 
been well defined in E. coli and involves the NER complex UvrABC, the recombination 
repair pathway or DNA polymerase II-dependent TLS (Berardini et al., 1999; Cole, 
1973). Similarly in S. cerevisiase, ICL repair requires the NER and HR mechanisms 
(Jachymczyk et al., 1981). The exact repair mechanism in mammalian cells however 
remains to be elucidated. From the evidence in bacteria and yeast, it has been proposed 
that a cascade of repair proteins from several repair pathways; namely NER, HR and 
TLS, and coordinated by the FA pathway, are involved in the repair of this type of 
lesion (Mirchandani and D'Andrea, 2006). 
The initial step of mammalian ICL repair involves a double incision either side of the 
ICL on one strand resulting in the unhooking of the DNA crosslink. The NER 
heterodimer MUS81-EMEl has 3' endonuclease activity and is able to incise DNA at 
ICLs (Hanada et al., 2006). Similarly, the heterodimer ERCC1IXPF has 5' endonuclease 
activity and can incise DNA near to the crosslink both in vitro and in vivo (Fisher et al., 
2008; Kumaresan et al., 2002). Mammalian cells deficient in ERCC1IXPF exhibit 
extreme sensitivity to ICL-inducing agents (De Silva et al., 2000), similarly mouse ES 
cells deficient in either Mus81 or Eme 1 show hypersensitivity to ICL damage (Abraham 
et al., 2003; McPherson et al., 2004). 
The repair of ICLs primarily takes place during replication (Akkari et al., 2000). 
Therefore, the unhooking of the DNA crosslink is postulated to generate a SSB which, 
during replication, can be converted to a DSB leading to replication fork collapse and 
repair by HR. Evidence for the involvement of HR following an ICL-induced DSB in 
mammalian cells was detennined by complementing the ICL hypersensitive irsl and 
irslSF hamster cell lines (Caldecott and Jeggo, 1991) with human HR proteins XRCC2 
and XRCC3 respectively. This corrects the hypersensitivity to ICL-inducing agents in 
these cells (De Silva et al., 2000). Furthennore, NHEJ defective CHO cell lines (Ku80 
knockouts) were still capable of repairing DSBs produced by ICL-inducing agents, 
whereas the HR-deficient irsl andirslSF cell lines were impaired (De Silva et at.; 
2000). 
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The excision of the initial ICL only removes the crosslink from one of the parental 
strands, allowing it to be flipped out (unhooked). The presence of the ICL on the 
opposite parental strand still affects the base structure at this site and therefore must be 
bypassed or repaired. It is postulated that TLS is employed to bypass the affected base 
generating an intact sister chromatid that can be used in the subsequent strand invasion 
step of HR (Figure 1.5). Firstly, Rev3 mutant MEFs are hypersensitive to ICL damage 
(Zander and Bemark, 2004) and in the Xenopus biochemical system· the DNA 
polymerase pol~ is required for the completion of ICL repair (Raschle et al., 2008). 
Furthermore, DT40 chicken cells deficient in Rev3 or Rev7 do not form SCEs in 
response to ICL damage. As SCE is an end product of HR it was postulated that TLS 
and HR act in a sequential manner to repair ICL damage (Niedzwiedz et al., 2004). 
Similarly to the hypersensitivity of ICL-inducing agents in HR deficient cell lines, FA 
patient cells also. show hypersensitivity to ICL-inducing agents. This phenotype 
therefore suggests that the FA pathway has a role in ICL repair; postulated to be the 
coordination of NER, HR and TLS to repair this type of damage (Mirchandani and 
D'Andrea, 2006). Firstly, F ANCM has been implicated in the initial recognition of an 
ICL as it recruits the FA core complex to the site of the cross-linked DNA in chromatin 
. . . 
following ICL damage (Mosedale et al., 2005). FANCJIBRIP1 has also been implicated 
in the initial processing of this lesion due to its ability to bind and unwind DNA strands 
at forked duplexes (Gupta et al., 2005). Recently, ERCC1 has been sho~n to interact 
with FANCD2 and is required for FANCD2 foci formation following ICL damage 
(McCabe et al., 2008). Furthermore, ICL-induced F ANCD2 foci formation is 
significantly reduced in ERCC1IXPF deficient cells suggesting that the initial 
unhooking of the ICL by ERCC1IXPF is essential for the localisation of FANCD2 to 
chromatin (Bhagwat et al., 2009). 
The FA pathway is known to promote HR through the interactions of FANCD2 and the 
HR proteins BRCA2IFANCD1, BRCA1 and RAD51 during S-phase or following 
\ 
exogenous DNA damage (see Section 1.3.3.B). A similar role is therefore postulated to 
promote HR in the repair of an ICL-generated DSB as indicated by studies in DT40 
chicken cell lines where knocking out Fancc impaired HR following ICL damage 
(Niedzwiedz et al., 2004). Furthennore, recently it was found that the newly identified 
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DNA polymerase POLN physically interacts with F ANCD2 and that knocking out 
POLN caused a 50% reduction in HR following MMC-induced damage (Moldovan et 
al. , 2010). 
Finally, interactions between the FA pathway and the TLS polymerases have been 
reported. FA patient cells have reduced point mutations suggesting that TLS pathways 
are suppressed in these cells (Hinz et al., 2006). Furthermore in human cells, REVl 
interacts with the FA core complex and is required in conjunction with PCNA for REV 1 
foci formation following ICL induced damage (Mirchandani et al., 2008). 
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Figure 1.5 Model of mammalian ICL repair 
a) An ICL occurs blocking replication and stalling the replication fork. The NER complexes 
ERCCIIXPF and MUSSI-EMEl un hook the ICL from one of the parental strands at 3' and 5' to 
the ICL b). The resulting SSB is converted to a DSB collapsing the replication fork. c) The FA 
pathway coordinates the HR proteins RAD51 and BRCA2 to bind to the collapsed replication 
fork to promote strand invasion. TLS DNA polymerases bypass the affected base (orange circle) 
on the opposite parental strand generating an intact sister chromatid to be used for d) HR-
mediated strand exchange. e) Holliday junction is formed and TLS polymerases bypass the 
persisting crosslink site allowing synthesis to continue. f) Progression of the fork continues 
resulting in a SCE. Adapted from Thompson (2005). 
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1.3.5 MMC :Metabolism 
MMC is a potent inducer of ICLs and has been used extensively in the study of the FA 
pathway. In the present study, MMC has also been used and so here its metabolism will 
be considered in detail. 
MMC is a natural anti-tumour antibiotic used for many years for cancer chemotherapy. 
It is used to damage the DNA of tumour cells by generating primarily ICLs between 
guanine residues on opposite strands of the DNA duplex (Iyer and Szybalski, 1963). In 
addition to ICLs, MMC also forms intra-strand cross-links between guanine residues on 
the same DNA strand (Bizanek et al., 1992) and monofunctional alkylation of guanine 
residuescausing DNA adducts (Tomasz et al., 1986). These interactions with DNA 
however, can only occur following the reductive activation of MMC by various cellular 
reductases (lyer and Szybalski, 1963). There are a number of flavoreductases in vivo 
that can carry out this reduction including cytochrome P450 reductase (CYP450R) and 
DT-Diaphorase (DTD) (also known as NAD(P)H quinine oxidoreductase I, NQ01). 
Whereas CYP450R reduces MMC to a semi-quinone metabolite and involves a one-
electron transfer (Tomasz and Lipman, 1981), DTD involves a two-electron transfer 
reducing MMC to a hydroquinone (Siegel et al., 1992). Both utilise NADH or NADPH 
as electron donors however, CYP450R reduction of MMC is inhibited in aerobic 
conditions due to the fast re-oxidation of the unstable semi-quinone metabolite whereas 
DTD reduction is not (Siegel et al., 1990). 
Like many chemotherapy drugs, tumours often develop resistance to MMC limiting the 
clinical utility of these agents. The CYP450R and DTD reductases play a major role in 
the anti-cancer activity of MMC, thus the expression of these' enzymes and their 
activation has been the subject of a number of studies investigating chemo-resistance. 
Firstly, using CRO cells expressing the bacterial MMC resistance-associated (MCRA) 
protein, it was found that the resistance to MMC could be reduced significantly by the 
overexpression of DTD and CYP450R (Baumann et al., 2001). Similarly, in human 
bladder tumours, the expression of DTD and CYP450R was positively correlated with 
MMC sensitivity in these tumours (Gan et al., 2001). Taken together, this suggests that 
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chemo-resistance to ICL-inducing agents could be the result of a defect in cellular 
metabolism and not just a result of defects in the DNA repair machinery. 
1.4 Sister Chromatid Exchange (SCE) 
During S-phase, as part of the normal cell cycle, DNA is replicated and chromosomes 
are copied resulting in two closely associated sister chromatids joined together at the 
centromere. Following the normal cycle of mitosis, these sister chromatids then 
segregate resulting in two daughter cells. SCE is the process of the physical exchange of 
chromatid regions resulting from the breaking and rejoining of two sister chromatids. 
SCE usually occur naturally within the cell at a rate that varies between cell types, from 
6 SCE events per cell in human lymphocytes to 10 SCE per cell in human fibroblasts 
(Table 1.1). These spontaneous SCEs are considered to be a product of normal DNA 
replication or endogenous DNA damage. Alternatively, SCE can be induced by a 
variety of DNA damaging agents. DNA ICL-inducing agents such as MMC are potent 
SCE inducers (Nagasawa et aI., 1983) whereas IR and UV both induce SCE but to a 
lesser extent (Wojcik et aI., 2004). It is postulated however, that any agent capable of 
initiating the DNA damage response by collapsing replication forks has the potential to 
cause the induction of a SCE event (Nagasawa et aI., 1983) (Table] .2). 
"Cell Type · ",:': "" " , ' " SCE Frequency Reference 
Peripheral blood lymphocytes 
Fibroblasts 
Amniotic fluid cells 
Human skin fibroblasts 
Embryonic hmg fibroblasts 
6.7 ± 0.145 
9.48 ± 1.74 
8.56 ± 0.28 
9.9 
3.8 
(Miranda et aI., 1997) 
(lung et al., 1986) 
(Goyanes et aI., 1994) 
(Wolffet aI., 1975) 
(Kato and Stich, 1976) 
Table 1.1 Comparison of SCE frequencies in different human cell types taken from the 
literature 
Values shown for spontaneous SCE frequency are the average SCE per cell with standard 
deviations (where available) taken from the reference indicated. 
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!Q.~~ Damaging ~gc~,t ;:~, C~II Typ~ , . ;: Fold " '. " Reference , 
(and '.ConcentratlOnnt:;~ ':~t" ,", " ' Inductlon':- , ' 
Benzo[a]pyrene (0.1 mM) Lymphocytes 2 fold (Lindahl-Kiessling et al. , 1989) 
Camptothecin (lOoM) L ym phocytes 6 fold (Degrassi et aI., 1989) 
Hydroxyurea (0.25 mM) CHO cells 3.4 fold (Ishii and Bender, 1980) 
MMC(100nM) CHO cells 10.4 fold (Perry and Evans, 1975) 
UV light - DV -A (225 Fibroblasts 
11M2), UV-B (150 J/M2) 
1.8 fold (Knees-Matzen et aI., 1991) 
X-rays (4 GY) CHO cells 2 fold (Perry and Evans, 1975) 
Table 1.2 The induction of SeEs by various DNA damaging agents 
A selection of DNA damaging agents found to induce SCE in various cell types taken from the 
reference indicated. The difference shown is the fold difference compared to the spontaneous rate 
in each of the individual references, 
SCEs were first observed by Taylor (1958) using tritium labelled chromosomes and 
autoradiography. Methods for the detection of these SCEs were not further developed 
until the mid 1970's when it was found that a chromatid that has replicated twice in the 
presence of the thymine analogue 5-bromodeoxyuridine (BrdU), has reduced 
fluo'rescence detected by the fluorochrome 33 258 Hoechst (Latt, 1973). Methods based 
on this principle, but without the need for fluorescent rnicroscopy soon followed 
(Korenberg and Freedlender, 1974; Perry and Wolff, 1974) and it is these methods that 
are still widely used today (Figure 1.6). 
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a) b) 
1st S phase 
c) d) e) 
2nd S phase 
Figure 1.6 SCE detection by BrdU incorporation and Hoescht 33 258 staining 
Parental DNA undergoes two rounds of replication in the presence ofBrdU. a) During the fIrst S 
phase BrdU is incorporated into the DNA in place of thymine. The two resulting daughter 
chromatids contain one strand with no incorporation (black) and one with full BrdU labelling 
(grey). b) Sister chromatids can not be distinguished using Hoechst 33 258 staining as both 
chromatids appear dark. c) Following a second round of replication, one daughter chromatid 
contains one strand with BrdU incorporation and one without, and the other daughter chromatid 
contains both strands with BrdU incorporation. d) The sister chfomatids can now be . 
distinguished using Hoechst 33258 staining as the chromatid containing full BrdU incorporation 
in both strands appears light whereas the chromatid with incorporation in only one strand remains 
dark. e) Areas where SeEs have occured can now be distinguished using this method. Adapted 
from Meschini et a1. (1996), images from Hoh, unpublished data (2007). 
The ability to visualise SCEs led to two important concepts. Firstly, it was assumed that 
the process of SCE must involve DNA breakage and hence, that it could be used as a 
measure of DNA damage and repair (Kato, 1973). Secondly, a correlation between the 
ability of agents to induce SCEs and their mutagenic and carcinogenic properties was 
• '- ',. '. ~. • < • 
observed (Latt and Schreck, 1980) and thus SCEs could be used extensively as a genetic 
indicator of potential mutagens. Since then, and despite the widespread use of SCE as a 
mutagenic screen, there is still very little known about the mechanism of SCE. 
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As SCE occurs during S-phase, it was initially postulated that SCE is a recombinational 
process that involves either single (Bender et al., 1974) or double-strand exchange 
(Kato, 1974). Single strand exchange was soon dismissed as a possible mechanism due 
to the fact that SCE is not observed during the first round of replication using BrdU 
labelling (Figure 1.6). Opposing the idea of recombination however, another early 
model for the mechanism of SCE was based on post-replicative repair of cross-linked 
DNA (Shafer, 1977). This model proposes that SCE is the result of the bypass of 
irreparable DNA cross-links that occur during the G 1 phase of the cell cycle, when a 
homologous chromatid is not available for recombinational repair. The model suggests 
that SCE is a two step process whereby the parental strands are first displaced at the site 
of the cross-link and then rejoined downstream of the damage, allowing replication to 
continue. The polarity and alignment of the parental strands forms two duplexes which 
have undergone SCE (Figure 1.7). Although this theory could be used to explain the 
affects of the ICL-inducing agents on SCE, it does not explain the induction of SCE by 
other non-ICL-inducing agents and the earlier postulated involvement of recombination 
(Kato, 1974). 
a) d) 
Gt Phass 
Figure 1.7 Replication bypass model by Shafer (1977) 
a) A single DNA duplex in Gl phase of the cell cycle showing an ICL. b) Bidirectional 
replication begins (S-phase). The advancing nascent strands (grey arrows) cannot replicate 
further than the leL therefore the corresponding complementary region is back-filled with 
Okasaki fragments. c) The advancing nascent strands cause stress at the cross-link site on the 
parental strands causing breaks to occur (thin black arrows). d} Duplexes are displaced and the 
upper left strand aligns with the lower right, and the upper right aligns with the lower left. The 
continued presence of the cross-link maintains structural continuity. Back-filling by Okasaki 
fragments and the final ligation of the presenting gap occurs resulting in the DNA forming two 
continuous double helices and SCE, adapted from Stetka (1979). 
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There were two major models suggested for the idea that SCE is a recombinational 
event involving double strand exchange. The first proposes that DNA topoisomerase 11 
causes transient DSBs during replication, the proximity of which on the sister 
chromatid, results in aberrant rejoining thus resulting in a SCE (Figure 1.8) (Dillehay et 
aI., 1989; Pommier et aI., 1985). DUring replication, DNA topoisomerases I and 11, 
catalyze the unwinding of the double helical structure of DNA by forming cleavable 
complexes with the DNA strands and creating transient DNA strand breaks (Liu et aI., 
1983). DNA topoisomerases also have the ability to ligate these DNA strands following 
replication (Liu et aI., 1983). The biochemical properties of topoisomerase 11 therefore 
support its role in this model of SCE formation. However, the DNA topoisomerase 11 
inhibitors ICRF-193 and Bufalin had a little or no effect respectively, on the SCE 
frequency in both wild type and BER-deficient cells (which display elevated 
spontaneous SCE events). This suggests that topoisomerase 11 is not involved in SCE 
formation although the inhibition of such enzymes during replication cannot be ruled 
out as having an effect on SCE frequency (Dominguez et aI., 2001). 
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a) Topisomerase 11 3' 0 5' 
causes a transient DSB 5' 0 3' 
3' 0 5' 
b)A sister chromatid 5' 0 3' 
aligns 
3' - --0 . - -- 5' 
5' ---- 0- --- 3' 
1 
3' 0------ 5' 
c)Abenant rejoining 5' 0- - -- 3' 
results in a SCE 
3' - --{) 5' 
5' - - - - -0 3' 
Figure 1.8 DNA topoisomerase n subunit exchange model by Pommier et aI. (1985) 
a) During replication, topoisomerase II causes a transient DSB, the subunits of which form 
covalent bonds at the 3' end of the break (blue and orange circles) . b) A sister chromatid aligns 
containing another transient DSB in close proximity to the initial break caused by the action of 
topoisomerase n. c) Aberrant rejoining occurs. The topoisomerase II subunit at the 3' end of the 
break on the parental strand of the original chromatid ligates to the 5' end of the parental strand 
on the sister chromatid, and the subunit at the 3' end on the parental strand of the sister chromatid 
ligates to the 5' end of the parental strand of the original chromatid and vice versa for the 
remaining subunits on the nascent strands. This results in a SCE event, adapted from Dillehay et 
al. (1989). 
The second major recombinational model of SCE formation is that SCE is mediated by 
homologous recombination (HR). The idea that SCE is a result of a DNA repair 
mechanism was first described by Kato (1977) and although no speculation was made 
as to what that mechanism might be, it was suggested that SCE formation may arise 
from various DNA repair pathways dependent on the type of initial lesion (Kato, 1977). 
It is postulated further that a SCE can arise from two initial processes. The first is a SSB 
that allows the free end of the SSB to bind to the complementary sequence of the DNA 
duplex in the sister chromatid (strand invasion) generating a heteroduplex (Holliday 
junction) (Figure 1.9). The second is by the formation of two single-strand 
discontinuities, one in the parental strand and one as the gap in the growing nascent 
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strand, again generating a heteroduplex; a prerequisite for SCE (Kato, 1977). The 
resulting heteroduplexes were postulated to be resolved by an unknown mechanism 
which today is known as HR. 
a) SSB occurs in the b) The free end of the c) A second break occurs d) Replication continues 
parental strand of one of parental strand binds to In the sister chromatid resulting In a SCE event 
the chromatids stalling the complementary and the free end binds 
replication strand in the sister with the complementary 
chromatid (strand strand in the original 
invasion) duplex 
3' 
- :=:£ 3'~ 3' , 5' 5' 5' 
3' , 3' 3'_ 3' 4 
5' 5' 5' 5' 
Figure 1.9 Recombinational modei of SCE formation by Kato (1977) 
a) A SSB occurs in the parental strand of the initial chromatid. b) The resulting free end invades 
the sister chromatid, binding to the complementary strand. c) This causes a second SSB to occur 
in the sister chromatid initiating a second 'strand invasion', binding to the complementary strand 
of the original chromatid. d) A SCE results from the continued replication of the opposite 
chromatids, adapted from Kato (1977). 
A second conflicting theory to the involvement of recombination in SCE formation was 
based on aberrant replication caused by DNA damage (Ishii and Bender, 1980; Painter, 
1980). Although it was agreed that a SCE event was the result of a double strand 
exchange, they postulated that this was due to collapsed replication forks resulting in the 
aberrant breaking and rejoining of the DNA strands. In this model, a SCE results from 
the occurrence of nicks (SSBs) at the replication fork (Ishii and Bender, 1980). These 
nicks can occur spontaneously or result from the presence of DNA damage such as UV 
dimers. It is postulated that a nick occurs in the parental strand near to the damage site 
allowing the free end to incorrectly bind with the newly synthesised daughter strand 
(Figure 1.10). A second nick in the parental strand near the end of the daughter strand 
then occurs resulting in the ligation of this daughter strand with the parental strand 
containing the initial damage (Figure 1.10). For this model, no details were given about 
the process of the breaking and rejoining of the DNA strands, however it was postulated 
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that topoisomerases may be involved (lshii and Bender, 1980), or that the aberrant 
ligation of the DNA strands could be due to a defect in DNA repair (Painter, 1980). 
a) Replication fork 
stalled by DNA 
damage 
~ 
::::!r 
b) Nicks occur in . 
parental strands 
~ 
=!( 
c) Cross-over 
occurs due to 
aberrant rejoining of 
the DNA strands 
-~---~ . 
<l1li-----' 
.......... _--
• 
----- .... 
... -------.. --~ 
e) SCE results from gap filling using the· 
'crossed-over parental strands as a 
template 
d) Replication 
fork restarts 
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.~"-
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Figure 1.10 Replication model of SCE formation by Isbii and Bender (1980) and Painter 
(1980) 
a) DNA damage causes a replication fork (black circle) to stall. b) Two nicks occur in each of the 
parental strands, one near to the damage site and one near the end of the daughter strand in the 
opposite parental strand (sites indicated by arrows). c) The free ends of the strand breaks 
incorrectly rejoin with the newly synthesised daughter strands in the opposite duplex. d) The 
replication fork can restart as the damage has been bypassed. e) Gap filling finishes the SCE 
formation using the crossed-over parental strands as templates for synthesis. Adapted from Ishii 
and Bender (1980). 
1.4.1 DNA Repair Proteins and SCE 
More recently, further evidence implicating DNA repair, particularly HR, in SCE 
formation has been identified by studying the association between defective DNA repair 
proteins and SCE levels in a number of different ·systems (Table 1.3f 
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Rep~ir Protein Cellular Affect on Reference 
pathway '< . System SCE 
HR BLM Humans Increase (Chaganti et aI., 1974) 
Rad54 DT40 cell lines Decrease (Sonoda et aI., 1999) 
Rad51 DT40 cell lines Decrease (Sonoda et al., 1999) 
Rad51b DT40 cell lines Decrease (Sonoda et aI., 1999) 
Rad51c DT40 cell lines Decrease (Sonoda et aI., 1999) 
CHO cells Decrease (Godthelp et al., 2002) 
Rad51d DT40 ceIl1ines Decrease (Sonoda et aI., 1999) 
Xrcc2 CHO cells Decrease (Takata et aI., 2001) 
Xrcc3 CRO cells Decrease (Takata et aI., 2001) 
Brca2 Mouse ES cells Decrease (Tutt et aI., 2001) 
BRCA2 Humans Increase (Kim et al., 2004) 
SSBR Parp1 CHO cells Increase (de Murcia et al., 1997) 
Xrccl CHO cells Increase (Thompson et al., 1982) 
XRCC1 HeLa cells Increase (Fan et al., 2007) 
LigaseIII CHO cells Increase (Puebla-Osorio et aI., 
2006) 
TLS Rad18 DT40 cell lines Increase (Yamashita et aI., 2002) 
Mouse ES cells Increase (Tateishi et aI., 2003) 
Rev1 DT40 cell lines Increase (Simpson and Sale, 
2003) 
Rev3 DT40 cell lines Increase (Okada et aI., 2005) 
Rev7 DT40 cell lines Increase (Okada et aI., 2005) 
FA Fancc DT40 cell lines Increase (Niedzwiedz et aI., 2004) 
pathway Fancd2 DT40 cell lines Increase (Yamamoto et al., 2005) 
FA Humans Normal (Latt et aI., 1975) 
Proteins 
Replisome Timeless MEFs Increase (Urtishak et aI., 2009) 
component 
Table 1.3 Repair proteins involved in altered spontaneous SCE frequencie taken from the 
literature 
Numerous DNA repair proteins have been associated with altered spontaneou SCE levels. Both 
the pathway and system u ed to study the affects are shown as well as the effect observed. The 
relevant reference is al 0 indicated. 
Firstly, in the chicken DT40 cel1lines, HR defective mutants such a Rad5J, Rad54 and 
the Rad51 paralogs, Rad51B, C and D, all show a marked reduction in both spontaneous 
and MMC-induced SCE. Ku70180 knockouts (NHEJ defective mutants) however, 
showed no alteration in SCE frequency further supporting the role of HR rather than 
NHEJ in SCE formation (Sonoda et aI., 1999). In mammalian cells, the same effects 
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have not been observed. Neither isogenic Rad51D mutant CHO or mouse fibroblast cell 
lines show a reduction in spontaneous SCE levels (Smiraldo et aI., 2005). In addition, 
Rad54 knockout mice do not exhibit a reduction in spontaneous SCE, but do show a 
marked reduction in MMC-induced SCE (Dronkert et aI., 2000). Rad51 C however, has 
been shown to be important for SCE formation as CHO cells deficient in Rad51C show 
decreased spontaneous and MMC-induced SCE frequencies (Godthelp et aI., 2002). 
Furthermore, knocking out Brca2 in mouse ES cell lines reduces spontaneous SCE (Tutt 
et aI., 2001). Finally, a deficiency in the replisome component Timeless (Tim), required 
for normal DNA replication, causes an increase in spontaneous SCE in MEF cells. An 
increase in Rad51 and Rad52 foci formation was also observed suggesting that the 
increase in SCE is a result of an increase in the reliance of HR for normal DNA 
synthesis in these cells (Urtishak et aI., 2009). In humans, most evidence has arisen 
from the study of genomic instability disorders (see Section 1.4.2). Bloom syndrome, 
characterised by increased levels of spontaneous SCE, is caused by a mutation in the 
BLM gene that encodes for the BLM helicase involved in HR (Ellis et aI., 1995). 
Furthermore, carriers of the heterozygous BRCA2 germline mutation exhibit an elevated 
. frequency of spontaneous SCE (Kim et aI., 2004). ' 
Knockout mutations in proteins involved in TLS have also been associated with SCE 
levels in chicken DT40 cell lines. Mutants of the E3 ligase Rad18 and the polymerases 
Revl and Pol~ result in increased spontaneous SCE levels (Okada et al., 2005; Simps()fl 
and Sale, 2003; Yamashita et al., 2002). This is consistent with mouse ES cells deficient 
in Rad18 that exhibit a two-fold increase in spontaneous SCE (Tateishi et aI., 2003), 
however Revl mutant mouse ES cells show no change in spontaneous SCE (Jansen et 
aI., 2005). A defect in TLS may lead to increased SCE through the increased capacity of 
HR to repair persistent lesions that would ordinarily be bypassed by TLS. 
The proteins of the FA pathway have also been implicated in varying SCE levels. 
Chicken DT40 cells mutant in the Fancc and Fancd2 genes show elevated SCE levels 
(Niedzwiedz et al., 2004; Yamamoto et al., 2005), whereas isogenic Fancg CHO cell 
lines do not exhibit increased spontaneous SCE (Tebbs et al., 2005). In human FA 
patient cells, SCE levels are normal but these cells are characterised by an decrease in 
MMC-induced SCE (Latt et al., 1975) (see Section 1.4.2.A). 
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Finally, in mammalian cells, proteins involved in SSBR have been associated with 
increased levels of SCE. CHO cell lines deficient in Xrcel exhibit elevated levels of 
SCE (Thompson et al., 1982). This is consistent with XRCCI down regulation in human 
fibroblasts and HeLa cell lines that also show elevated SCE levels (Fan et al., 2007). 
Similarly, Parp-l deficient mice and LigIll knockout mice also show high levels of SCE 
(de Murcia et al., 1997; Puebla-Osorio et al., 2006). The implication of defective 
proteins involved in SSBR can be explained through the repair mechanism of persistent 
SSBs. An irreparable SSB leads to DSB formation and replication fork collapse, and is 
repaired by HR (Arnaudeau et al., 2001), thus resulting in a SCE event (see Section 
1.3.2.B.3). 
The disparity of results from the different study systems suggests that the molecular 
mechanism of SCE formation and the implication of DNA repair may differ between 
lower vertebrate and mammalian cells. In humans, it is even less clear. However, the 
different effect of defective repair proteins on spontaneous and induced SCE suggests 
that there may be more than one mechanism involved in the formation of SCE in higher 
eukaryotes. 
1.4.2 SCE and Disease 
The cellular response to DNA damage employs a number of DNA repair mechanisms 
that work efficiently and conservatively to ensure cellular survival through the control 
of mutations arising within our DNA. Failure to control efficient DNA repair can result 
in various genetic instability disorders and cancer. As SCE is an end product of DNA 
repair and a marker of DNA damage, SCE frequency has been heavily associated with 
these types of diseases and in some cases is used as a diagnostic tool. 
1.4.2.A Fanconi Anaemia (FA) 
FA (as mentioned in Section 1.3.3) is a rare cancer predisposition disorder that at the 
genetic level is associated with chromosome instability, an increase in chromosomal 
breaks and hypersensitivity to DNA ICL-inducing agents such as MMC. Cells from FA 
patients exhibit normal levels of spontaneous SCE but show a marked reduction in the 
number of SCE events induced by MMC. As FA is caused by mutations in the FA genes 
of the FA pathway, the role of which is thought to be to promote HR both endogenously 
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and after ICL damage, it is presumably through this association with HR that the SCE 
frequency in these cells is altered, although the exact causal mechanism is unknown. 
1.4.2.B Bloom Syndrome (BS) 
BS, like FA, is a rare human autosomal recessive disorder which is characterised by 
genetic instability including an elevated baseline mutation rate, an increase in neoplasia 
and a pre-disposition to a wide range of cancers including leukaemia and skin, cancer 
due to sun-sensitive skin. Cells from BS patients are characterised by many cytogenetic 
abnormalities including a ten-fold increase in the spontan,eous SCE frequency, also used 
for its diagnosis (Chaganti et al., 1974). BS is caused by mutations in both copies of the 
ELM gene, cells are therefore defective in the BLM helicase that is a prominent protein 
involved in HR. BLM is a member of the Rec-Q helicase sub~family that possesses 3' to 
5' helicase activity (Ellis et al., 1995). In vitro, BLM, can dissociate D-Ioop 
intermediates and promotes branch migration of Holliday junctions in conjunction with 
topoisomerase IlIa and BLAP75 to yield non-crossover events (gene conversion) 
(Karow et al.. 2000; Wu and Hickson, 2003). Thus, a defect in BLM may result in a 
higher frequency of cross-over events (SCE) as seen in BS patient cells. Finally, BLM 
accumulates at stalled replication forks following DNA damage and can promote fork 
regression aiding repair at stalled forks (Ralf et al., 2006). From this evidence, it is 
postulated that the increase in SCE in BS cells is a hallmark of aberrant HR caused by 
the defect in the BLM protein. 
1.4.2.C Cancer Predisposition 
UNIVERSITY 
OF SHEFFIELD 
LIBRARY 
Genomic instability and dysfunctional genes involved in DNA repair and recombination 
are associated with neoplastic development and cancer (Hoeijmakers, 2001). Although 
SCE cannot be used as a predictive biomarker for this disease (Norppa et al., 2006), it 
can be used as a marker of chromosome stability (Carrano et al., 1978) and thus has 
been found to be elevated in a number of patients with sporadic and hereditary cancers 
(Table 1.4). Firstly, patients with Hodgkins disease have a higher level of spontaneous 
SCE events compared to a control group (Caggana and Kelsey, 1991). Patients with 
sporadic malignant melanoma also have increased levels of SCE compared to their 
relatives and control lymphocytes (Illeni et al., 1991). In the same study, patients with 
familial malignant melanoma also had a similar increase in SCE compared to controls. 
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The peripheral blood lymphocytes of patients with early stage breast cancer have high 
SCE (Aristei et aI., 2009). In addition, varying degrees of elevated SCE frequencies 
have been reported in lymphocytes of patients with various cancers including hereditary 
breast cancer, carcinoma of the cervix uteri and ovarian cancer (Baltaci et aI., 2002; 
Cortes-Gutierrez et aI. , 2000; Roy et aI., 2000). Furthermore, heterozygous carriers of 
germ-line mutations of the BRCA2 breast cancer susceptibility gene demonstrate an 
average 65% increase in spontaneous SCEs compared to wild-type family members 
(Kim et aI., 2004). BRCA2 is an essential protein of HR (Davies et aI. , 2001) and is 
therefore essential for chromosome stability. There is a clear association between mono-
allelic BRCA2 inactivation and increased SCE frequencies however this is not the case 
for all cancers with elevated SCEs. Indeed, it is more likely that different cancers have 
different defects in repair and therefore result in varying levels of SCE. Although SCE 
is a marker of chromosome stability, the exact association between SCE and cancer in 
general remains to be elucidated. 
Patient Type ,,,- ~ ~ -
, '.) SCE Frequency Reference 
Early stage breast cancer 8.2 ± 0.913 (Aristei et aI. , 2009) Control group 6.6 ± 0.6 
Hereditary breast cancer 11.01 (Roy et aI. , 2000) Control group 7.67 
Hodgkins Disease 8.93 ± 1.86 (Caggana and Kelsey, 1991) 
Control group 7.56 ± 1.95 
Cervical cancer 7.8 ± 1.05 (Cortes-Gutierrez et aI. , 2000) Control group 6.98 ±1.13 
Ovarian cancer 18.13 (Baltaci et aI. , 2002) Control group 6.85 
Sporadic malignant melanoma 8.0 ± 0.3 
Patient Relatives 5.4 ± 0.1 (llleni et aI., 1991) 
Control Lymphocytes 4.7 ± 0.2 
Familial malignant melanoma 8.4 ± 0.8 
Patient Relatives 5.4 ± 0.2 (Illeni et aI. , 1991) 
Control Lymphocytes 4.7 ±0.2 
BRCA2T ' - carriers 6.6 (Kim et a1., 2004) BRCA2+1+ carriers (controls) 4.04 
Table 1.4 SCE frequencies in human sporadic and hereditary cancers 
Values shown for SCE frequency are mean SCE per cell with tandard deviations (where 
available). All values are for peripheral blood Iymphocytes from patients with or without disea e 
(controls). 
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1.5 Uveal Melanoma 
Uveal melanoma is the most common form of intraocular tumour in adults with a stable 
annual incidence of approximately 7 cases per million over the last 25 years (Singh and 
Topham, 2003a). The eye is the most common site for non-cutaneous melanoma, 
accounting for approximately 80% of such cases (Scotto et aI., 1976). Ocular 
melanomas mainly arise from the uveal tract of the eye consisting of the iris, ciliary 
body and choroid. Current treatments involve enucleation of the affected eye, plaque 
radiotherapy and transpupillary thermotherapy. Chemotherapy has little effect on this 
tumour due to its high chemo-resistance (Albert et aI., 1992). Despite advances in the 
initial diagnosis and treatment of the primary tumour, the 5 year mortality rate of uveal 
melanoma has not changed since 1973 (Singh and Topham, 2003b) with approximately 
40% of patients developing metastatic melanoma to the liver within 10 years after the 
initial diagnosis and treatment (Virgili et al., 2008). The metastatic potential of these 
cells depends largely on the anatomical positioning of the tumours within the uveal 
tract. Posterior uveal melanoma affecting the ciliary body and choroid of the eye, are 
highly aggressive and frequently specifically metastasise to the liver and thus are 
associated with poor prognosis (Gragoudas et al., 1991). -Conversely, iris melanomas 
have a good prognosis and rarely develop metastatic disease (Shields et al., 2001). 
Metastatic potential and thus prognosis, has been further characterised by cell type. 
Spindle cell uveal. melanoma has the best prognosis whereas tumours containing 
epithelioid cells have the worst; a mixed cell melanoma has an intermediate prognosis 
(McLean et al., 1982). Furthermore, molecular classification using gene profiling 
studies indicated that uveal melanoma associated with high metastatic risk exhibited a 
broad down-regulation of neural crestlmelanocytic genes and an up-regulation of 
epithelial genes (Onken et aI., 2006). Finally, uveal melanoma have been well 
characterised by cytogenetic studies, particularly posterior uveal melanoma where 
recurrent chromosomal abnormalities have been associated with anatomical positioning 
and poor prognosis (Prescher et al., 1992). 
Alterations of chromosomes 1, 3, 6, 8 and 11 have been found to be associated with 
posterior uveal melanoma. More specifically changes in chromosomes 1,3 and 8 have 
been shown to characterise tumours of the' ciliary body whereas alterations of 
chromosome 6 and 11 correlate to choroid melanoma (Sisley et al., 2000). The loss of 
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chromosome 3 and alterations of chromosome 8 (mostly extra copies of 8q) consistently 
occur together, specifically in ciliary body tumours. As these tumours are associated 
with a poor prognosis, this phenotype has been used to identify patients with reduced 
survival (Sisley et al., 1997). Furthermore, monosomy of chromosome 3 seen in over 
50% of uveal melanomas has also been associated with a poor prognosis (Prescher et 
al., 1996). 
As well as the loss or gain of entire chromosomes, small subsets of uveal melanoma 
. tumours show only partial microdeletions on chromosome 3. Deletions of the short arm 
of chromosome 3 are common in other tumours whereas deletions of 3q are an 
infrequent event (Kok et al., 1997). In uveal melanoma however, the entire chromosome 
is subject to such deletions (Prescher et al., 1996). Deletion-mapping studies have 
identified the regions of 3p2S, 3p 11-14 and 3q24-26 as regions that are preferentially 
lost in uveal melanoma (Cross et al., 2006; Parrella et al., 2003; Tschentscher et al., 
2001). This recurrent loss of chromosomal regions in uveal melanoma suggests these 
regions may indicate potential locations for tumour suppressor genes and, as the whole 
of chromosome 3 is subject to deletions, it is likely that multiple tumour suppressor 
genes exist (Prescher et al., 1996). Although potential candidates, including the Von 
Hippel-Lindau gene and FHIT (fragile histidine triad), have been identified on the 3p 
arm, none have been identified to date on the 3q arm, and no definite functional 
association has been found between the loss of these genes and the development of 
uveal melanoma. 
1.5.1 Uveal Melanoma as a Model System for SCE. 
Although uveal melanoma cells exhibit a number of non-random chromosomal 
abnormalities, they do not demonstrate high levels of chromosomal aberrations (Sisley 
et al., 1990), which is a hallmark of many other types of tumours. Taking chromosomal 
aberrations as a marker of genetic instability, this phenotype w?uld suggest that these 
tumours are stable in contrast to other forms of cancer. Furthermore, uveal melanoma 
cells have been found to have a reduced spontaneous SCE frequency in primary samples 
and in established cell lines. This is compared to matched patient blood samples (Table 
, 1.6 and Figure 1.11), other human established cell lines and the cutaneous melanoma 
cell line WM793 (Table 1.5). Interestingly, in general, cancer has been associated with 
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increased levels of spontaneous SCE and indeed, uveal melanoma is the only disease 
state known to show decreased levels of SCE, thus this unique phenotype of uveal 
melanoma makes it an ideal system in which to study SCE formation. 
Cell Line Genotype Average SCE 
~ , SCE Range 
SOM 157 Established uveal melanoma cell line 3.1 1 - 8 
SOM 196 Established uveal melanoma cell line 3.3 1 - 5 
WM793 Established cutaneous melanoma cell line 10.3 3 -23 
MRC5VA Transformed human fibroblast cell line 6.1 2 - 11 
HCT1l6 Transformed human colon carcinoma cell line 12.5 6 - 24 
SW480 Transformed human colorectal carcinoma cell line 6.9 2- 11 
Fibroblasts Primary human fibroblasts 7.4 5 - 13 
Table 1.S SCE frequencies in established uveal melanoma cell lines 
Established uveal melanoma cell lines exhibit a reduced SCE frequency compared to the 
controls. The SCE frequency is shown for two established uveal melanoma cell lines compared to 
a cutaneous melanoma cell line, primary human fibroblasts in culture and other human 
transformed cell lines. The range of SCE is shown as well as the average SCE per cell (Hoh, 
2007, unpublished data), 
'c t· ~ N' :.~ : .: Uveal.Melanoma Tumour ' Matched Patient Blood 
. ase urn er ' - - ., ,., " , 
,- "''': ',.'. . Average SCE ·· SCE Range ' Average SCE , SCE Range 
494 2 2 - 2 4.3 2 - 6 
520 I 3.7 1 - 11 6.3 1 - 11 
521 I 1.9 0 - 7 5.7 2 - 11 
524 ! 3.9 2 - 6 5.3 1 - 10 
526 I 2.9 1 - 7 6.2 3 - 11 
537 I 3.5 2 - 5 5.2 1 - 14 
538 I 2.5 2 - 3 7.4 3 - 15 
543 : 3.1 2 - 8 6.8 2 - 13 
544 • 2.9 1 - 5 6.5 3 - 10 
545 2.0 2 - 2 5.3 4 - 7 
546 I 2.6 1 - 6 6.1 2 - 12 
547 2.5 0 - 4 5.9 2 - 10 
548 2.8 1 - 6 7.0 4 - 16 
551 3.1 1 - 7 6.7 4 - 16 
Table 1.6 SCE frequencies in primary uveal melanoma and matched patient blood samples 
For all cases, the primary tumour samples exhibit a reduced SCE frequency compared to the 
matched patient blood. The SCE frequency is shown for primary uveal melanoma tumour 
samples and the matched patient blood samples isolated from the Ocular Oncology Unit at the 
Royal Hallamshire Hospital, Sheffield. The range of SCE is shown, as well as the average SCE 
per cell . (Hoh, 2007, unpublished data). 
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a 
Figure 1.11 Representative image of the number of spontaneous SCE in a primary uveal 
melanoma tumour and matched patient blood sample 
a) BrdU incorporation and Hoescht 33 258 staining showing the number of spontaneous SCE in 
the matched patient blood of Case Number 520. b) BrdU incorporation and Hoescht 33 258 
staining showing the number of spontaneous SCE in the uveal melanoma tumour sample from 
Case Number 520. Images are representative of all cases showing that spontaneous SCE is 
reduced in uveal melanoma tumour samples compared to matched patient blood. Arrows depict 
regions where exchange has occurred (Hoh, 2007, unpublished data). 
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l.5.l.A Established Uveal Melanoma Cell Lines 
For this study, the established uveal melanoma cell lines SOM 157 and SOM 196 
(Sheffield Ocular Melanoma) were used. Both cell lines were established from male 
patients undergoing enucleation for treatment of primary uveal melanoma at the Ocular 
Oncology Unit at the Royal Hallamshire Hospital, Sheffield. SOM 157 was derived 
from a choroid uveal melanoma that contained epithelioid cells and showed metastatic 
potential. The patient subsequently died from hepatic metastatic disease 14 months after 
treatment. SOM 196 was also derived from a choroid uveal melanoma however this 
tumour contained spindle cells. No metastatic disease developed from this tumour. Both 
tumours showed monosomy of chromosome 3 however, once the cell lines were 
established, chromosome 3 had been gained (Sisley, 1996, unpublished data). In chemo-
invasion assays SOM 196 was found to be highly invasive compared to SOM 157 
(Woodward et aI., 2002) however, it has been shown that numerous invasive sub~ 
populations exist in both cell lines (Cross et aI., 2005). Finally, both cell lines SOM 157 
and SOM 196 exhibit a reduced SCE frequency of 3 and 3.3 SCE per cell respectively 
(Table 1.5) (Hoh, 2007, unpublished data). 
1.5.1.B Short-Term Cultures (Primary Samples) 
Short-term cultures were established from primary posterior UM biopsies from patients 
receiving surgical treatment at the Royal Hallamshire Hospital, Sheffield, UK. Informed 
consent was obtained from all uveal melanoma patients with ethical approval (SSREC 
94/247) and the project followed the tenets of the declaration of Helsinki. A total of 14 
primary uveal melanoma samples were analysed, for which paired blood samples were 
available in all cases. Unsuccessful analysis was also performed on a further 27 cases. 
The clinico-pathology details of the successfully analysed melanomas are presented in 
Appendix 1. 
1.6 Aims of this Study 
Although SCE has been used for many years as a marker of mutagenesis (Latt and 
Schreck, 1980) very little is known regarding the formation of this phenomenon in 
human cells. SCE is a known end-product of HR and it can be induced by a wide variety 
of DNA damaging agents. Furthermore, the frequency of SCE can be affected by 
defective proteins involved in DNA repair. Evidence therefore suggests that SCE occurs 
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as a consequence of DNA repair, although differences in the effect that defective DNA 
repair proteins have on spontaneous and induced SCE levels may suggest that different 
mechanisms exist for both. 
Uveal melanoma is the only disease state known to date that exhibits reduced levels of 
spontaneous SCE. It is therefore an ideal model system in which to study the formation 
of SCE. In order to do this, the following was carried out: 
1) Characterisation of uveal melanoma cell lines for defects in the endogenous 
DNA damage repair response. 
2) . The results of aim 1) were related to the observed reduction in spontaneous SCE 
frequency in uveal melanoma cell lines. 
3) Characterisation of uveal melanoma cell lines for defects in the induced DNA 
damage repair response. 
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2.1 Materials 
2.1.1 General Laboratory Equipment 
Agarose gel electrophoresis system 
Balance 
Benchtop centrifuge - eppendorfs 
Biological safety cabinet 
Colony counter 
DNA Engine Peltier thermal cyeler 
EasyjecT plus electroporation machine 
Electrophoretic transfer cell 
F ACScalibur 
Haemocytometer 
Heat block 
Hoefer SE250 mighty small II system 
Hoefer SE250 miniVE vertical electrophoresis unit 
Ice machine 
Incubator - bacterial culture 
Incubator - shaking 
Incubator - tissue culture 
Irradiator IBL 437C, Source 51.5 TBq, Cs137 
Light microscope 
Mid bench centrifuge - falcon tubes 
N anodrop 2000 system 
OmniPAGE Maxi vertical gel electrophoresis unit 
pH meter 
PhosphorImager system 
Pipette aid 
Pipettes 
Plate reader 
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Geneflow 
Precisa 
Fisher Scientific 
Gelman Sciences 
Stuart Scientific 
BioRad 
Geneflow 
BioRad 
Becton Dickinson 
Hawksley 
Grant Instruments 
Arnersham Biosciences 
Amersham Biosciences 
Scotsman 
Weiss GaUenkamp 
New Brunswick Scientific 
Weiss Gallenkamp 
CIS Bio International 
Olympus 
Sanyo 
Th errn 0 S ci en tifi c 
Geneflow 
BDH Laboratory Supplies 
Molecular Dynamics 
Drummond 
Gilson 
Anthos Labtec 
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) tem (Continued) Company 
.: '" ,~-"", < J~ -'" , 
Power pack 
Savant speed vac concentrator 
Shaking platform 
UGenius gel imaging system 
UV transilluminator 
Vacuum air dryer 
Vortex 
Water baths 
BioRad 
ThermoScientific 
Stovall Life Science 
Geneflow 
BDH Laboratory Supplies 
Fisherband 
Fisons Scientific Equipment 
Grant Instruments 
2.1.2 Glassware, Plastics and Disposables 
0.22 J..lm Millex GP filter unit 
Bacterial culture dish 
Cell scraper 
Centrifuge tubes - 15 ml 
Centrifuge tubes - 30 ml 
Coverglass - 22 x 22 mm 
Cryovials - 1.2 ml 
Culture plates - 12, 24 and 96 well 
Culture plates - 6 well 
Electroporation cuvettes 
Eppendorfs - 0.2 ml, 0.5 ml and 1.5 ml 
Glass bottles 
Microlance needles 
Microscope slides 
Non-steri le FACs tubes 
Plastic pipettes - 5 ml, 10 ml and 25 rul 
Pyrex Glassware 
Refill tips 
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Millipore 
Sterilin 
Sarstedt 
Sarstedt 
Coming 
Scientific Laboratory Supplies 
Nalgene 
Coming 
Griener Bio One 
Geneflow 
Sarstedt 
Fisher Scientific 
Becton Dickinson 
Scientific Laboratory Supplies 
Elkay 
Costar 
Fisher Scientific 
Sarstedt 
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Jtc~ (Contillued)" , ] Company 
" «~ ~ . \ , ,~" , 
RNAse free barrier tips (1 - 200 ~l) 
RNAse free filter 6ps (200 - 1000 ~I) 
Sterile syringes 
Tissue culture dish 
Tissue culture flasks - T25 and T75 
Universal vials 
2.1.2.A Purified Water 
Sorenson, BioScience, Inc. 
Axygen Inc. 
Becton Dickinson 
Griener Bio One 
Nunc 
Sarstedt 
Ultra-pure deionised water (ddH20) was produced via a Purite Prestige Labwater 250 
purification system. Water > 18 MO was obtained from a Purite Neptune Labwater 
system. 
2.1.2.B Sterilisation 
Glassware was washed in RBS detergent and rinsed in cold water followed by ddH20 
before being dried in a hot air oven at 80 QC. Glassware was then either hot air sterilised 
at 180 QC or sterilised by autoc1aving in a MP24 Rodwell autoc1aver supplied by 
Scientific Laboratory Supplies. Solutions requiring sterilisation were also autoc1aved. 
Autoc1aving was carried out at 15 p.s.i and 120 QC for 15min. 
Filter sterilisation was used to sterilise solutions used in tissue culture and this was 
carried out using sterile syringe filters (0.22 ~m pore size) or bottle top filter units (0.2 
)..lm) depending on the volume to be sterilised. 
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2.1.3 Chemicals 
, Item <. Company 
~ii .' 
~ AccuGel acrylamlde (40%) 
Agar 
Ammonium persulphate (APS) 
5-Azacytidine 
~-mercaptoethanol 
Boric Acid 
Bovine serum albumin (BSA) 
Bromodeoxyuridine (BrdU) 
Bromophenol blue 
Deoxynuc1eoside triphosphate set, peR grade 
Diethylpyrocarbonate (DEPC) 
DNA loading dye (5x) 
EDTA 
Ethanol 
Ethidium bromide 
Glacial acetic acid 
Glycerol 
Glycine 
Goat serum donor herd 
Hydrochloric acid (HCI) 
Hyperladder I 
Industrial methylated spirit 
Isoproponal 
Magnesium chloride (MgCh) 
Magnesium sulphate (MgS04) 
Methanol 
Methylene blue 
NP40 alternative 
Paraformaldehyde 
Phenol:chloroform:isoamyl alcohol (25 :24: 1) 
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Fisher Scientific 
BDH laboratory supplies 
Sigma-Aldrich 
Sigma-Aldrich 
Fisher Scientific 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Roche 
Sigma-Aldrich 
Bioline 
Fisher Scientific 
Fisher Scientific 
Sigma-Aldrich 
Fisher Scientific 
Fisher Scientific 
Fisher Scientific 
Sigma-Aldrich 
Fisher Scientific 
Bioline 
Adams 
Fisher Scientific 
Fisher Scientific 
Fisher Scientific 
Fisher Scientific 
Sigma-Aldrich 
Calbiochern 
BDH Laboratory Supplies 
Sigma-Aldrich 
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: It~m (Colltillued) . .'." '.' : .>~ .," Co'mpany . 
<,,:>(~' ~~,(.-'>' 'i • ',¥ .. "< .. ~~,.., " ~ 
Phosphatase inhibitors 
PMSF 
Polybrene 01exadimethrine bromide) 
Potassium chloride (KCl) 
Power SYBR® green PCR master mix (2x) 
Protease inhibitors 
Propidium iodine (PI) 
RNaseA 
SeaKem® LE agarose 
Sodium carbonate (Na2Ca3) 
Sodium chlOlide (NaCl) 
Sodium deoxycholate (DOC) 
Sodium dodecyl sulphate (SDS) 
Sodium hydroxide pellets 
SYBR safe™ DNA gel stain 
TEMED 
Tris-base 
TritonX-lOO 
Tryptone 
Tween 20 
Ultra pure protogel acrylamide (30%) 
Universal developer 
Universal fixer 
Yeast extract 
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Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
BDH Laboratory Supplies 
Applied Biosystems 
Sigma-Aldrich 
Sigma-Aldrich 
Sigma-Aldrich 
Cambrex 
Fisher Scientific 
Fisher Scientific 
Sigma-Aldrich 
BDH Laboratory Supplies 
Fisher Scientific 
Invitrogen 
S igma-Aldrich 
Fisher Scientific 
Sigma-Aldrich 
Fisher Scientific 
Sigma-Aldrich 
National Diagnostics 
Ilford Hypam 
Ilford H yparn 
Oxoid 
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2.1.4 Cytotoxic Agents 
All chemicals were obtained from Sigma-Aldrich 
" ~ • < Standard Doses 
" 
'Cy,totoxic Agent ' Mechanism of Action Diluent (24 h unless 
:~~ h~; ~ ~ '. ~ " <. t _ 
. , . , 
" . 
,- , othenvisc stated) 
Stabilises 
Camptothecin topoisomerase I bound DMSO 10nM (CPT) to DNA preventing 
DNA re-ligation 
Dissolved in 
Forms intra- and DMSO then Up to 2 IlM for 
Cisplatin (CIS) interstrand DNA cross- diluted in continuous 
links (ICLs) growth exposure 
medium 
Hydroxyurea (HU) Inhibits ribonucleotide Growth 0.5 mM 
reductase Medium 
Hydrogen Peroxide 
Causes oxidative stress NIA 100 IlM (H20 2) 
Ionising radiation Causes double strand 10 Gy delivered 2 h 
(IR) breaks N/A prior to 
experimentation 
Methyl Alkylating agent that 
m ethanesu lfonate leads to methylation DMSO 0.5 mM for 30 min 
(MMS) damage 
Alkylating agent that 90 nM for 24 h or Mitomycin C leads to the formation Growth 500 nglml (15 1lM) (MMC) of inter-strand DNA Medium for 1 h 
cross-links (ICLs) 
Thymidine (dT) Suppresses synthesis of Growth 10mM dCTP Medium 
Ultraviolet Leads to the formation 40 J/M 2 delivered 5 
irradiation (DV) of intra-strand DNA N/A h prior to 
(254 mm) cross-links experimentation 
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2.1.5 Selective Agents 
~ Selective agent " '. ,<;:ompany " . : ,'. ' Diluent Standard doses 
,/" .,l; ~~.. ~ ,~ " '.c ' ' , ~ , \. '. . .. 
Ampicillin Sigma-Aldrich Sterile, ddH20 100 llglml 
G418 Melford PBS 300 llglml 
6-Thioguanine Sigma-Aldrich 1 % Sodium carbonate 5 llg/ml 
Puromycin Calbioehem PBS 2 - 3 llglml 
Tetracycline Fisher Scientific PBS 1 llglml 
2.1.6 Antibodies 
':, Primary .''<~ 'l' ~ !'~' :!1r,r·J~~~·~~~l\A<~r~~ ~')(~~(:" ~:-: : .. Dilution Factor, Raised , t I ". -> • !. J'~' • ',' , , , ".' : P~otein t ." , C ..,' ... ", ~ ~ . ~ ~ , l , 
," .. '. .,' ompanv " / '. '.:. . .. , 
" Antibodv In .:.... . 7 , ' • , ' Size \VB IF 
i~;"-' ,~":", , " :~". '·~"'f.l':"'~'·"~: .'i::-... _ '; ... : "'1: 1 ;00. ~ ._"'~< ~ 
ATM Mouse Santa Cruz Biotechnology 370 kDa 1 :1000 
P-ACTIN Rabbit Sigma-Aldrich 37kDa 1:2000 
BrdU Mouse Dako Cytomation - - -
CYP450R Rabbit Abeam 78kDa 1:1000 
DNA-PKcs Rabbit Santa Cruz Biotechnology 460 kDa 1 :1000 
ERCCl Mouse Neomarkers 36 kDa 1 :1000 
155 kDa 
FANCD2 Rabbit Novus Biologieals 1:10,000 
166kDa 
I 
155 kDa 
FANCD2 Mouse Santa Cruz Biotechnology - 1:1000 
166 kDa 
FENl Rabbit Cell Signalling 42kDa 1 :2500 
KU70 Rabbit Genetex Inc. 70kDa 1 :2000 
LIGIII Rabbit Genetex Inc. 100 kDa 1: 1000 
LIGIV Rabbit Abcam 104 kDa 1 :1000 
MLHl Mouse Calbiochem 85 kDa 1 :1000 
MREll Rabbit Calbioehem 85 kDa 1: 1000 
MSH2 Mouse Calbioehem 100 kDa 1 :1000 
NBSl Rabbit Cell Signalling Technology 95 kDa 1 :1000 
NQOl 
I 
Goat Abcam 30 kDa 1 :1000 
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P53 Goat Santa Cruz Biotechnology 53 kDa 1 :1000 
PARP-l Mouse Santa Cruz Biotechnology 100 kDa 1:1000 
RAD50 Rabbit Bethyl Laboratories Inc. 150 kDa 1:1000 
RAD51 Rabbit Santa Cruz Biotechnology 37 kDa 1 :1000 ] :500 
RAD51C Mouse Novus Biologicals 42 kDa 1:1000 
RAD51D Mouse Novus Biologicals 40kDa 1:1000 
RPA-70 Mouse Fisher Scientific 70kDa 1 :1000 
RTEL Rabbit Abcam 152 kDa 1 :1000 
yH2A.X Rabbit Cell Signalling 15 kDa 1 :500 
XRCCl Rabbit Novus Biologicals 90kDa 1 :2000 
XRCC3 Mouse Novus Biologicals 38kDa 1 :1000 
't{, '" , , • < " ' - , ~ "~,, $,' ~ Dilution Factor • -., .. : "':1", ' • 1 r >Or. ~ ... 
:, Secondary Antibodv ' Company 
,. ~ 'It .. A .. , ~ ~ • 
"VB IF '( .. ~ ".," . ~l;::I~~:, ~~. i~, .~ , 
t;\ 
- r goa an l-mouse 
Invitrogen 1 :1000 
IgG FITC conjugate 
Alexa fluo 488 t 
Anti-rabbit IgG, HRP-linked Cell Signalling Technology 1 :2000 
Anti-mouse IgG, HRP-linked Cell Signalling Technology 1:2000 
Anti-goat IgG, HRP-linked Santa Cruz Biotechnology 1:2000 
FITC-conjugated goat anti-mouse Dako Cytomation - -
Zymax Cy3 conjugated goat anti-
Invitrogen 1:500 
rabbit IgG 
I 
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2.1.7 Kits and Company Reagents 
~ Kit' ~'" .. ~. ~~. ":,1'1">'" >v""''''' '~, ~ i"~ ': .' ~ , . , Company ~ ~;''i,~'i"; J~./':~C)";d'{.~ ,~,",<"'if; ,1 "* \ •• \""', ~ .' y<>'; ~+_~'1:"'::"l~t,· .. ~.,,-w: '",,,v1'A'.f':;',,H ~}",,;,,~». lA"'} ~< .. ', t ~, ~ .. ~ ,~. {<-
Cell Proliferation Kit I (MTT) Roche 
CometAssaylM Reagent Kit TrevigenQ9 
CpGenome™ DNA Modification Kit Chemicon\IY International 
EndofreeQ9 Plasmid Purification Maxi Kit Qiagen 
GenElute™ Mammalian Genomic DNA Miniprep Kit Sigma-Aldrich 
GenElute™ Mammalian Total RNA Kit Sigma-Aldrich 
GenElute lM PCR Clean-Up Kit Sigma-Aldrich 
Lipofectamine ' M 2000 Transfection Reagent Invitrogen 
MAX EfficiencyQ9 Stb12 Competent Cells Invitrogen 
One-ShotQ9 TOP1 0 Competent E.coli Invitrogen 
Platinum\IY Taq DNA Polymerase Invitrogen 
RiboQuant I M Multiprobe Template Sets Pharmingen 
RPA IW M Kit Ambion 
Superscript I M Reverse Transcriptase Invitrogen 
T7 MAXlscript 'M Kit Ambion 
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2.1.8 Cell Lines 
':Ccll Lme" ,/~.Genotype , :, - ' Reference 
i"'.,,;i. .... ',M·;" .. ,''';~t~\< </- h:: , ><l,u' , ' , . , , , ' , 
MRC5VA Transformed human fibroblast cell line (J acobs et al. , 1970) 
U20S Transformed human osteocarcinoma cell line 
(Ponten and Saksela, 
1967) 
Transformed human colon carcinoma cell line. 
HCT116 Has mutant MRE11 and is mismatch repair (Brattain et al. , 1981) 
deficient 
Transformed human colorectal carcinoma cell (Mohindra et al., 
SW480 
line 2002) 
Cutaneous melanoma cell line established from 
WM793 the vertical growth phase of a primary melanoma (Hsu, 1999) 
lesion of a 39 year old male, caucasian patient 
Uveal melanoma cell line established from a Ocular Oncology 
SOM 157 
choroid tumour containing epithelioid cells Unit, Sheffield 
Uveal melanoma cell line established from a Ocular Oncology 
SOM 196 
choroid tumour containing spindle cells Unit, Sheffield 
Retro-viral packaging cell line derived from the 
293-GPG transformed human kidney cell line HEK293 (Ory et al., 1996) 
(Graham et al., 1977) 
F ANCD2 deficient immortalised fibroblast cell (Timmers et al., 
PD20 
line, derived from a FA patient 2001) 
PD20-D2 
PD20 immortalised fibroblast cell line retrovirally (Timmers et al., 
complemented with pMMP-F ANCD2 2001) 
2.1.9 Plasmids 
• The pMMP-empty vector and the pMMP-F ANCD2 vector were both kind gifts 
from Dr. Alan D' Andrea at the Dana-Farber Cancer Institute, in Boston, 
Massachusetts (Appendix 2). 
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• The pEF-P450R-IRES-P vector was a kind gift from Dr. Kaye Williams at the 
School of Phannacy and Phannaceutical Sciences, University of Manchester, 
Manchester (Appendix 3). 
2.1.10 Preparation of Standard Solutions 
2.1.10.A 1 x Phosphate Buffered Saline (PBS) 
Ix PBS was produced by dissolving 1 Oxoid PBS tablet in 100 ml of ddH20. This was 
autoclaved and stored at room temperature. 
2.1.10.B Tris-Buffered Saline (TBS) 
10x TBS was made by dissolving 24.2 g of Tris base and 80 g of NaCl in a small 
volume of ddH20. The solution was then adjusted to pH 7.6 using HCI before adding 
sufficient ddH20 to make the total volume 1 1. The 10x stock was autoc1aved and kept 
at room temperature. 
2.1.1O.C 1 M Tris pH 6.8, 7.4 and 8 
121.14 g of tris(hydroxymethyl)aminomethane was dissolved in 700 ml of ddH20. The 
solution was adjusted to the required pH using HCI and sufficient ddH20 was added to 
achieve a total volume of 1 L. The solutions were autoclaved before being stored at 
room temperature. 
2.1.1O.D 1.5 M Tris pH 8.8 
1.5 M Tris was made by dissolving 181.71 g of tris(hydroxymethyl)aminomethane in 
700 ml of ddH20 and the solution ~as adjusted to pH 8.8 using HCt. Sufficient ddH20 
was added to achieve a total volume of 1 L and the solution was autoc1aved before 
being stored at room temperature. 
2.1.10.E Ethidium bromide 
A 100 mg tablet was dissolved in 20 ml of ddH20 to produce a 5 mglml stock of 
ethidium bromide. The stock was foil-wrapped and stored at room temperature. The 
working concentration was 0.5 J.lglml. 
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2.1.10.F 0.5 M EDTA 
186.1 g disodium ethylene diamine tetra-acetate was added to 750 ml of ddH20. The 
pH was adjusted as required by the addition of solid sodium hydroxide pellets. The 
volume was then adjusted to 1 L with ddH20 and the solution was stored at room 
temperature. 
2.1.10.G SOB medium and agar 
SOB medium was made up of 10 mM NaCI, 2.5 mM KCI, 10 mM MgCh, 10 mM 
MgS04, 2% Tryptone and 0.5% Yeast extract in ddH20. This suspension was 
autoclaved and stored at room temperature. Prior to use 100 Jlg/ml of ampicillin was 
added to the medium as the selective marker. For solid culture medium, 1.5% agar was 
added to the above solution prior to autoclaving. 
2.1.11 Tissue Culture Reagents 
2.1.11.A Foetal Calf Serum (FCS) . 
Foetal Calf Serum was purchased from Biosera that had previously been screened for 
virus, endotoxin and mycoplasma, and filter sterilised before use. Aliquots of which 
were stored at -20 °C. 
2.1.11.B DMEM 
All cell lines were cultured 10 Dulbecco's modified Eagle's medium (DMEM) 
purchased from Lonza containing 4.5 glL glucose with glutamine. 500 m1 DMEM was 
- t 
supplemented with 10% FCS. Medium was stored at 4 °C, heating to 37 °C before use. 
2.1.11.C Trypsin and VersenelEDT A 
A sterile 2.5% solution of trypsin was supplied by Invitrogen and stored at 4 °C. The 
working concentration of trypsin was 0.025%. VersenelEDT A was supplied by VWR. 
A stock solution was made by dissolving 0.2 g in 1 L of phosphate buffered saline 
(PBS) and this was stored as 10 ml aliquots at 4 °C. The working concentration of 
Versene/EDTA was 0.02%. 
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2.1.11.D DiMethyl Sulphoxide (DMSO) 
DMSO prevents crystal fonnation within the cells that minimises the disruption of cell 
membranes and general damage to the cells whilst stored at -80°C. DMSO was 
purchased from BDH Laboratory Supplies and used as a 10% supplement of growth 
medium in the cryopreservation of cells. 
2.1.11.E Presept 
Presept was supplied by Johnson and Johnson Medical Ltd and was prepared by 
dissolving 20 tablets in 2 L of tap water. This solution was stored at room temperature. 
2.2 Methods 
2.2.1 Bacterial Studies 
2.2.1.A Transfonnations 
2.2.1.A.l One Shot® TOPIO Chemically Competent Escherichia coli (E. coli) 
2 J.ll (-10 pg) of plasmid DNA was added to one vial of One Shot® TOPI0 chemically 
competent E. coli (Invitrogen) and then incubated on ice for 5 min. The cells were then 
heat shocked at 42°C for 30 s without shaking and transferred back onto ice. 250 J.ll of 
SOB medium (10 mM NaCI, 2.5 mM KC1, 10 mM MgCh, 10 mM MgS04,' 2% 
Tryptone and 0.5% Yeast extract in ddH20) without antibiotics, was added to the 
. - , " ' 
transfonned cells and shaken horizontally at 37°C for 1 h. 50 J.ll and 150 J.llofbacteria 
were inoculated onto selective SOB-agar plates (SOB medium with 1.5% agar and 100 
" ; 
J.lglml ampicillin as selective agent) pre-wanned at 37°C in the presence of a flame 
using a glass spreader, and incubated at 37°C overnight to fonn single colonies. 
2.2.1.A.2 MAX Efficiency® Stb!2 Chemically Competent Cells 
The MAX Efficiency® Stb!2 chemically competent cells (InVitrogen) we~e used for the 
transfonnation of the. pMMP plasmids. These cells, unlike the One Shot® TOP10 
chemically competent E. coli, have a set of genetic markers that allow the stabilisation 
of unstable retroviral sequences. Thus, they were used here to· reduce the risk of 
recombination, a common occurrence in pMMP plasmids. 1 J.l1 (0.1 Ilg) of plasmid 
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DNA was added to 45 Jll of MAX Efficiency® Stbl2 competent cells and incubated on 
ice for 30 m. The cells were then heat shocked at 42°C for 25 s without shaking and 
transferred back onto ice for a further 2 m. 250 lil of SOB medium without selection 
was added to the cells before shaking at 225 rpm at 30°C for 90 m. Using a glass 
spreader, 50 lil and 150 lil of the bacterial suspension was spread onto pre-wanned 
selective SOB-agar plates (100 J..lg/ml ampicillin) in the presence of a flame, and 
incubated at 30°C for 24 h to form single colonies. 
2.2.1.B Bacterial Culture 
To expand the single colonies, individual colonies were picked from the SOB-agar 
plates using a pipette tip in the presence of a flame and placed in a universal vial 
containing 2 ml of selective SOB medium. Bacterial growth was then induced by 
shaking at 37°C in a shaking incubator for 4 - 6 h. From this starter culture, 50 lil was 
added to 50 ml of selective SOB medium in the presence of a flame and further 
incubated in a shaking incubator overnight at 37°C. 
2.2.2 DNA Studies 
2.2.2.A Plasmid Purification using the Endofree® Plasmid Purification Maxi Kit 
The Endofree® plasmid purification maxi kit (Qiagen) was used to purify plasmid DNA 
for use in subsequent transfections and was carried out according to the manufacturers' 
instructions. The kit uses a modified alkaline lysis procedure (Birnboim and Doly, 
1979) followed by the binding of the plasmid DNA to the Qiagen Anion-Exchange 
Resin. The plasmid DNA was then washed in a medium-salt wash solution to remove 
cellular impurities such as RNA and protein and eluted into a high salt buffer. The salt 
was then removed and the DNA, concentrated by the subsequent isopropanol 
precipitation. 
2.2.2.B DNA extraction usmg the GenElute™ Mammalian Genomic DNA 
Miniprep Kit 
The GenElute™ mammalian genomic DNA miniprep kit (Sigma-Aldrich) was used to 
extract pure genomic DNA from at least Ix 107 cultured cells. The kit is based on silica 
binding and was carried out in accordance with the manufacturers' instructions. The 
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cells were first lysed in a chaotropic salt-containing solution to denature 
macromolecules. In the presence of ethanol, the DNA binds to a silica membrane when 
the lysate is spun through the membrane by centrifugation. The DNA was then washed 
to remove contaminants and eluted in 200 J..lI ofTE solution (10 mM Tris-HCI, 5 mM 
EDTA, pH 9.0). 
2.2.2.C Quantification 
Spectrophotometric analysis was carried out to quantify the resulting DNA from 2.2.2.A 
and 2.2.2B. This was done using the Nanodrop 2000 system from Thermoscientific. 
Absorbance was measured at 260 run and 280 run to check for contaminants, where an 
absorbance of 1.0 at 260 run corresponded to 50 J..lglml of dsDNA. 
2.2.3 Methylation Studies 
Methylation of cytosines located 5' to guanosine (CpG sites) is known to have a 
profound effect on the expression of many eukaryotic genes (Bird, 1992). Although CG-
rich regions called CpG islands are largely unmethylated, aberrant methylation of these 
areas is a frequent event and has been associated with transcriptional inactivation of 
many tumour suppressor genes in human cancer (Baylin et aI., 2001; Robertson, 2002). 
Here, genomic DNA was first subjected to sodium bisulphite modification using the 
CpGenome™ DNA modification kit, followed by PCR amplification and·. DNA 
sequencing, to determine the methylation status of the F ANCD2 promoter in uveal 
melanoma cell lines compared to other human control cell lines .. 
2.2.3.A Bisulfite Modification using the CpGenome™ DNA Modification Kit 
The CpGenome™ DNA modification kit from Chemicon® International was used for 
the sodium bisulphite modification of 1 J..lg of genomic DNA and carried out in 
accordance with the manufacturers' instructions. In a sodium bisulphite reaction, all 
unmethylated cytosines are deaminated and sulfonated, converting them to uracHs 
leaving methylated cytosines (5-methy1cytosines) unchanged (Figure 2.1). The sequence 
of the treated DNA therefore differs from the untreated sequence depending on whether 
the CpG sites were originally methylated or unmethylated. 
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Unmethylated DNA 
GGG GCG GAC CGC GAG 
1 III 
GGG GUG GAU UGU GAG 
Methylated DNA 
1 
Figure 2.1 Sodium bisulphite modification of DNA 
All unmethylated cytosines (C) are deaminated to uracils (U) whereas 5-methylcytosines (CM) 
remain unchanged. 
Using the CpGenome™ DNA modification kit for sodium bisulphite treatment, the 
DNA was first denatured to its single-stranded fonn to expose the bases using an 
alkaline pH at 50°C. A sodium salt ofbisulfite ion (HS03-) was then added, this causes 
unmethylated cytosines to be sulfonated and hydrolytically deaminated to produce a 
sulforiat~ C intennediate (Figure 2.2). The DNA was then bound to a micro-particulate 
carrier in the presence of another salt, and then desalted by the addition of 70% ethanol. 
Alkaline desulfonation and desalting in 90% ethanol completes the conversion to uracil 
and the DNA was finally eluted in TE buffer. 
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o NH SO; 
Cytosine 
sulphonate 
H20~ .. 
Hydrolytic 
deamination 
NH/ . 
Desulphonation ~ 
HSO. HN ~ 
( 3) l I 
OH-
o NH S03· 
Uracil 
sulphonate 
Figure 2.2 The chemical process of deaminating cytosine to uracil by sodium bisulphite 
modification 
Cytosines are first sulfonated to cytosine suphonate and then hydrolytic ally deaminated to 
produce the sulphonate intermediate, uracil sulphonate. Alkaline desulphonation and desalting in 
90% ethanol completes the conversion of cytosine to uracil. 
2.2.3.B The Polymerase Chain Reaction (PCR) 
peR is an in vitro method for enzymatically synthesising defined sequences of DNA 
(Saiki et al., 1985). The reaction uses two pre-designed oligonuc1eotides known as 
primers that hybridise to, and flank either end of, a target sequence. The system consists 
of a number of phases of differing temperatures carried out in a thermocycler, which 
allows the exponential· amplification of the DNA target sequence. The first step is a 
denaturation phase that separates the double helix structure of DNA. This is followed by 
primer annealing, where the primers bind to the separated strands of the DNA, flanking 
the target sequence. Finally, an extension phase is used to lengthen the primers 
according to the template DNA sequence using the thermo-stable enzyme Taq DNA 
polymerase. 
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2.2.3.C Primer Design 
Primers were ordered from Invitrogen and designed to amplify a 1000 bp region of the 
human FANCD2 promoter (GenBank accession number NG_0073 1 1). Three sets of 
overlapping primer pairs were designed for the amplification of the sodium bisulphite 
modified DNA. Following modification, DNA becomes fragmented and very unstable 
therefore three primer pairs were used to generate three shorter amplicons, spanning the 
whole 1000 bp promoter region. These primers were designed specifically for sodium 
bisulphite modified DNA. To do this, it was assumed that all cytosines not at CpG sites 
were converted to uracils by the modification process. The primer sequences were 
therefore designed so that thymines replaced all cytosines thus, during PCR 
amplification, uracil bases in the modified DNA would be recognised by the thymine 
bases in the primer sequences. CpG sites that may have been originally methylated 
before modification were avoided. The primers were designed as follows: 
l(l?!i~l~'J~ri~!9~i;~'lI"l"~l'(~\;~~:e~~~k;J: ~tl'f~~:~~~-~'l"""'.~~, ;·l;~-~· ~-';'i< '.' > ~.~ > AA," ~"~~., , + 'l'Pri!rier;'S"e~s ~~':;iji:J~;::t:~'~hj)ririicr:siguenc~"¥(5' ; to 3'>, ' ' . ,',";, : .. :. :: ( Size of Amplicoil ', 
i-~~il1;~ .. ~$t%&\!~la:}!lt;~~«:,:~:,-.{~"I~~~t:,.i&·;~::;,,:'~~cQuk~'~"~.': .. '",,t;4~/' '", v";".':' '\: <"" .'" . ~ 
Primer Set 1 Forward - TTTTATTTTAGGAAGGGAAATG 666 bp Reverse - AGGATTA TTT AGAGGT AGATGTTGGA 
Primer Set 2 Forward - TGATTTTT A TTTGTTTA TGAGGGAG 327 bp Reverse - AGGA TT ATTT AGAGGTAGATGTTGGA 
Primer Set 3 Forward - TGGGTAGGATTATTTAGAGGTAGATG 408 bp Reverse - TTTTTTGTGGTTT AATTTTTAAGTT 
2.2.3.D PCR set up using Platinum® Taq DNA Polymerase 
High background and low product yield can often result from the assembly of a PCR 
reaction at room temperature, due to the formation of unspecific primer annealing and 
primer dimer formation created by the premature activity of the Taq DNA polymerase. 
This is a particular problem with sodium bisulphite modified DNA due to its instability 
following the modification process. Using a polymerase antibody that blocks 
polymerase activity at ambient temperatures is therefore essential. Platinum® Taq DNA 
polymerase from Invitrogen is recombinant Taq DNA polymerase coupled with a 
proprietary antibody that blocks polymerase activity at ambient temperatures. The 
activity of the polymerase is restored after the initial denaturation step in PCR at 95 cC, 
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therefore allowing more convenient PCR set up at room temperature. Each PCR 
reaction was set up as follows: 
r: ,t ~{-t:4~A~t"-~\-:.<J,;:iI'S:""" ''':';- ·"', .... t ~ A "-?, ~ "~' ' ~ I i ~,< • 
,Component ,,':.':,', ,:';:: . '\ < ,0 :,', .' Volume " Final Concentration 1 
~~<~~." :;:' .. ~.: ":~" .. >J<~' f:~''1:J.'. ~ ~_>. ~ :;'::~ ,j;'1" '~ " ~: ~ ~ _ ~ _~ 
10x PCR Buffer 5 ~l Ix 
10 mM dNTP Mix 1 ~l 0.2 mM each 
50 mM MgCh ].5 ~l 1.5 mM 
10 ~tM Forward Primer 1 ~l 0.2~M 
I 0 ~M Reverse Primer I ~l 0.2~M 
Template DNA 2 ~l 100 - 200 ng 
Platinum® Taq DNA polymerase 0.2 ~l 1.0 unit* 
Autoclaved, ddH20 To 50 III N/A 
* Where 1 Unit of Platinum Taq polymerase incorporates 10 nmol of 
deoxyribonucleotide into acid-precipitable material in 30minat 74 °C. 
2.2.3.E PCR Conditions 
The PCR reactions were thermocycled in a DNA Engine Peltier thermal cycler from 
BioRad using the following conditions: 
Denaturation 95 °C 4min 
Denaturation 95 °C 30 s 
Annealing 54 °C 90 s 5 cycles 
Extension 72 °C 2 min 
Denaturation 95 °C 30 s 
Annealing 54 °C 90 s 25 cycles 
Extension 72 °C 90 s 
Extension 72 °C 4min 
Due to the poor quality of sodium bisulphite modified DNA, a second round of peR 
amplification was needed in order to yield enough target DNA for sequencing. Here, the 
second reaction was assembled as the first, but using 2 III of the first round peR product 
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as template DNA. The second reaction was then thermocycled again using the same 
conditions as the first round. 
2.2.3.F Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate the target PCR product from non-
specific amplicons for subsequent purification and sequencing. 1 % agarose gels were 
made by adding 2 g SeaKem® LE agarose in 200 mllx TAE buffer (400 mM Tris base, 
10 mM EDTA pH 8 and 1.1% Glacial Acetic Acid, pH 7.6 - .7.8 in ddH20) before 
heating the suspension in a microwave to dissolve the agarose. The solution was then 
left at room temperature to cool before adding 0.5 J.lg/ml ethidium bromide to visualise 
the DNA. The cooled agarose was poured into a mould containing a comb to produce 
wells and was left at room temperature to set. The comb was then removed and the gel 
immersed in Ix TAE in the gel tank. 20 J.lI of the PCR product was mixed with 5x DNA 
loading dye (Bioline) and loaded onto the gel alongside 5 J.lI of Hyperladder 1 DNA size 
ladder (Bioline). The gel was run at 80 V for I h to separate the bands of DNA. The 
gel· was then visualised and documented using the UGenius gel imaging system 
(Geneflow). 
2.2.3.G PCR product purification using the GenElute™ PCR Clean-Up Kit 
The GenElute™ PCR clean-up kit· (Sigma-Aldrich) was used to purify the peR 
amplification products from the other components in the reaction such as excess 
primers, nuc1eotides, DNA polymerase, oils and salts. It is based on silica binding and 
was used following the manufacturers' instructions. Briefly, the DNA was bound onto a 
~ 
silica membrane by centrifugation and contaminants removed by an ethanol based wash 
solution. Finally, the bound DNA was eluted into TE buffer and quantified as in 2.2.2.C. 
2.2.3.H Sequencing 
Sequenc,ing was carried out on 100 ng/J.lI samples by the Genetics Core Facility in the 
University of Sheffield Medical School. The same primers used for the amplification of 
the target sequence were used for sequencing at a concentration of I J.lM. Sequencing . 
was carried out using an ABI 3730 capillary sequencer and data analysed using 
Sequencher™4.1. , , 
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2.2.3.1 Genome-wide demethylation using 5-azacytidine treatment' 
5-azacytidine is an analogue of cytidine and thus becomes incorporated into the DNA at 
these sites. Due to its altered structure, methyl groups can no longer be covalently 
, 
bound at these sites by DNA methyltransferase. Thus, 5-azacytidine treatment causes 
genome-wide de~ethylation ofcytosi~e bases. To study the affects of genome-wide 
demethylation in uveal melanoma cell lines, cells were treated for 5 consecutive days 
> ( " -
with 5-azacytidine. Cells were seeded into T75 sterile flasks and then left under normal 
. , 
incubation co~ditions to adhere. The next day, 2.5 mM 5-azacytidine was added to the 
cells and the cells returned to normal incubation conditions. This was repeated for 5 
consecutive days after which time toxicity assays and western blot analysis was carried 
~)Ut as in 2.2.4.E and 2.2.7, respectively. 
, , 2.2.4 Tissue Culture Studies 
All work was carried out in containment 2 laboratory cabinets t~ maintain sterility and 
cabinets were cleaned ~ith methanol before ~d after use. Cultured cells were grown in 
DMEM supplemented with 10% FCS (referred to as growth medium throughout), 
unless otherwise stated, and were incubated at 37°C in a humid environment containing 
5-10% CO2.,, 
2.2.4.A' Maintenance, Storage and Passage of Cell Lines 
Cells were grown in a monolayer on the surface of; T75 flask until seen:to be 70 -' 80% 
confluent under a light microscope: Passage of the' cells involved r~moving the growth 
medium and washing twice with PBS. 1 ml TrypsiniVerserie mix was then added and 
the cells placed in an incubator at 37°C until the cells were seen to be free from' the 
flask side. The cells were then fully res~spended in' 9 'ml ;O\vth medium by pipetting. , 
. . . 
The appropriate volume of cells for the dilution required (usually 1 in 3 to" achieve 
confluence in 2 days) was placed i~to a new '~terile T75 flask ~d' fresh groWth m~dium 
I 
added to a total volume of 10 ml. 
" , 2.2.4.B Cryopreservation 
Aliquots of each cell line were kept for long term storage at -80°C. Cells were passaged 
as in 2.2.4.A except that the fully resuspended cells in 10 ml growth medium were 
placed in 15 ml falcon tubes and centrifuged at 2000 rpm for 3 m. The growth medium 
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was poured off and the pellet resuspended in 3 ml 10% DMSO in growth medium. 
Approximately 1 ml was aliquoted into two 1.2 ml cryovials and then placed at .80 °C. , 
2.2.4.C Thawing of Cells 
Cells were thawed quickly in a 37 °C waterbath to minimise the toxic effects of DMSO 
, ' 
and placed in a 15 m1 falcon tube and centrifuged at 2000 rpm for 3 m. The medium 
was poured off and the pellet was resuspended in 5 ml PBS and centrifuged again. The 
pellet was then resuspended in 10 ml medium, placed in a T25 flask and incubated as 
normal at 37 °C. 
2.2.4.D Counting Cells 
Cells were counted using a Neubauer haemocytometer (Hawksley & Sons Ltd). Once 
cells were resuspended as in 2.2.4.A, 7 JlI was placed under the cover slip of a 
haemocytometer and the average of 4 squares (5x 5 squares) was calculated. This value 
was then multiplied by 10,000 to give the number of cells/m!. 
2.2.4.E Toxicity Assays 
Toxicity assays were used to determine the cytotoxic response to various cytotoxic 
agents, of uveal melanoma cell lines compared to control cell lines. Cells that were less 
than 80% confluent were trypsinised and quantified as in 2.2.4.A and 2.2.4.D. 500 -
5000 cells were then plated in 10 ml growth medium on 100 mm plates. Cells were then 
placed under normal incubation conditions for 4 h to allow cells to adhere. After this 
time the cytotoxic agents were added to the medium in a range of 8 increasing' doses. 
All treatments were continuous except for MMS that was removed after 30minand H202 
that was removed after 2 h, and replaced with 10 ml fresh growth medium. Plates were 
then further incubated at 37 °C with 5% C02 for 15 days. After this time, the growth 
medium was removed from the plates and the viable colonies fixed and stained with 
methylene blue (4 g in 500 ml methanol) for 30 m. The stain was then removed using 
cold tap water and the plates left to dry before the colonies were counted using a colony 
counter. The survival fraction was calculated for each cell line by dividing the number 
of colonies' at each dose by the ~umber of colonies -counted at dose zero. Only colonies 
with more than 50 cells were counted. 
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2.2.4.F Colorimetric Assay using the Cell Proliferation Kit I (MTT) 
The colorimetric (MTT) assay kit from Roche was used as an alternative to the toxicity 
assays to study the viability of primary uveal melanoma tumour samples in the presence 
ofMMC and to determine the proliferation rate of uveal melanoma cell lines compared 
to other established human cancer control cell lines. This kit allows the reliable 
quantification of viable cells as only metabolically active cells are able to cleave the 
yellow tetrazolium salt, MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium 
bromide) to purple formazan crystals (Figure 2.3). The resulting crystals are then 
solubilised and the absorbance quantified using spectrophotometry. The absorbance 
directly correlates to the total metabolic activity in the sample and thus the number of 
Viable cells within that same sample. 
o 
Figure 2.3 Metabolism of yellow MTT to a purple formazan salt by viable cells 
Only viable cells can cleave the yellow tetrazolium salt, MTT to purple formazan salt and thus 
the absorbance can be quantified using spectrophotometry at OD 570 mm. This is directly 
proportional to the number of viable cells within a given sample. 
2.2.4.F.l The proliferation of primary uveal melanoma tumour samples in the 
presence of MMC 
Cells were counted and plated in duplicate at a density of 500 cells/well of a 96-well 
plate for the primary uveal melanoma cells, and 250 cells/well for the established cell 
lines. The cells were then placed under nonnal incubation conditions for 4 h to allow 
cells to adhere. After this time, the cells were treated with increasing doses ofMMC (0 
- 50 J.1M) and then left at 37 °C, under normal incubation conditions for 10 days. After 
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10 days, Ix MTT labelling reagent from the kit was added to each well at a dilution of 1 
in 10. The cells were then placed back at 37°C for 3 h, checking every 3Ominfor the 
presence of purple formazan crystals. Once the crystals had formed, 100 ).11 of the Ix 
solubilisation solution from the kit was added and incubated overnight at 37°C. The 
absorbance of each well was then measured at OD 570 run on a plate reader and the 
relative absorbance (proliferation rate) calculated for each cell line by dividing the OD 
at each dose by the OD at dose zero. 
2.2.4.F.2 M1T Proliferation Assay 
Cells were counted and plated at a density of 250 cells/well of a 96-well plate in 
triplicate for each cell line. Cells were incubated under normal conditions for 4 h, 2 
days, 4 days and 7 days; after which time a 1 in 10 dilution of the MTT labelling reagent 
from the kit was added to each well and incubated for a further 3 h until purple crystals 
had formed. Following this, 100 ).11 of Ix solubilisation solution from the kit was added 
and the plates were further incubated overnight at 37°C. The OD of each well was then 
meas,ured at 570 run on a plate reader and the relative absorbance (proliferation rate) 
calculated as in 2.2.4.F.l. 
2.2.4.G Fluctuation Assay 
The fluctuation assay was used to determine the spontaneous mutation rate of the house-
keeping gene HPRT in uveal melanoma cell lines. Within the cell, the nucleoside dOTP 
is catalysed from GMP (guanosine monophosphate) for use in DNA synthesis. There 
are two ways in which GMP can be formed either by de novo synthesis or by a 
functional HPRT gene. During de novo synthesis, GMP is catalysed from PRPP 
(phosphoribosyl pyrophosphate) using 10 different enzymatic steps. By using the HPRT 
enzyme however, OMP is formed from guanine and PRPP. The addition of the 
antimetabolite drug 6-Thioguanine (6-TG) to cells with a functional HPRT gene 
therefore causes cell death as it is incorporated into the DNA instead of guanine. 
Continual growth in 6-TO allows for the selection of cells with a HPRT gene that has 
mutated, as the 6-TO is no longer incorporated into the DNA allowing cells to survive 
(Figure 2.4). The rate at which this mutation occurs can then be calculated using the 
fluctuation test ofLuria and Delbruck (Luria and Delbruck, 1943). 
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Guanine 
----- GMP -11- dGTP --- DNA + survival 
HGPRT 
6-Thioguanine 
----- GMP -11- dGTP - Apoptosis 
Mutant 
6-Thioguanine HGPRT_I GMP -11_ dGTP _ DNA + Survival 
I de novo / 
synthesis 
Figure 2.4 The HPRT mechanism of guanine metabolism for DNA synthesis 
6-TG is incorporated into DNA by a functional HPRT gene instead of guanine causing cell death. 
A mutated HPRT gene results in survival as the drug can no longer become incorporated into the 
DNA through this mechanism. Guanine can now be incorporated by de novo synthesis and thus 
cells survive in the presence of 6-TG. 
Cells were plated at a density of 1000 cells in 36 wells of 6-well plates and incubated 
under nonnal incubation conditions until 80 - 90% co~fluent.'After this time, the cells 
were trypsinised, counted and replated 10 times at Ix IOs cells/lOO mm plate. I mg/ml 
of 6-TO was dissolved in I % sodium carbonate and then 5 p.g/ml of this solution was 
added to the plates. The cells were then incubated for at least 15 days under nonnal 
incubation conditions before the colonies were stained and counted using methylene 
blue (4 g in 500 ml methanol) and a colony counter. The mutation rate was calculated 
using the Luria Delbruck method as follows: 
Rate of mutation = In Po 
N" of cell generations 
Where Po = the proportion of plates with no colonies 
and the N" of cell generations = (the final N" of cells - the initial N° of cells) 
In2 
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2.2.4.H Retroviral Complementation 
Retroviruses are used widely as an efficient method of complementing mammalian cells 
with new genetic material in vitro (Mulligan, 1993). Although retroviruses containing 
amphotropic envelope proteins have the ability to infect mammalian cells, human cells 
are relatively resistant to this infection (Emi et al., 1991). It was therefore found that by 
incorporating the vesicular stomatitis virus G' (VSV -G) protein into amphotropic 
retrovirus vector particles, it was possible to create a retroviral pseudotype that 
possessed a wide host range, enhancing the efficiency of infection and hence 
complementation in human cells (Emi et al., 1991). The human 293GPG packaging cell 
line (Ory et al., 1996) can be used to create these retroviral pseudotypes as it continually 
expresses essential retroviral packaging proteins whilst providing large amounts of 
VSV-G by its inducible expression by tetracycline. Unlike other packaging cell1ines 
that often lose their packaging efficiency through culture, 293GPG can be cultured in 
medium supplemented with 1 ~glml tetracycline, 2 ~glml puromycin and 300 ~glml 
G418 to maintain the expression of these essential packaging proteins. Here, the 
pMMP-empty or pMMP-F ANCD2 retroviral vector were first transfected into the 
293GPG packaging cell line to produce the retroviral pseudotype, which could then be 
used to infect uveal melanoma cells to produce stable uveal melanoma cell lines 
complemented with F ANCD2 (Figure 2.5). . 
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Figure 2.5 Method of retroviral complementation 
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The packaging cell line 293-GPG was first transfected with the retroviral vectors, pMMP-empty 
and pMMP-F A CD2, to produce the viral pseudotypes that were then collected from the 
medium 96, 120, 144 and 168 h post transfection. The collected pseudotypes were then used to 
infect the uveal melanoma cell line, SOM 196b in the presence of polybrene to produce the 
complemented cell lines 196b-pMMP and \96b-D2. 
2.2.4. H 1 TransJection using LipoJectamine ™ 2000 
Lipofectamine™ 2000 from Invitrogen was used to transfect the 293GPG packaging 
cell line with pMMP-empty and pMMP-FANCD2 retroviral vectors. Lipofectamine™ 
2000 is a cationic lipid formulation commonly used for the delivery of plasmid DNA 
into eukaryotic cells. Cells were seeded in T25 flasks in 10 ml growth medium with 
selection so that they would be 90% confluent after 24 h. In a 1.5 ml sterile eppendorf 
tube, 5 Ilg of retroviral plasmid DNA was diluted in a total volume of 750 III of serum 
free DMEM and left at room temperature for 15 m. In a second eppendorf tube, 10 III of 
Lipofectamine™ 2000 was mixed with 750 III serum free DMEM and then added to the 
first, mixed by inversion and left for another 15minat room temperature. During this 
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time, the cells were washed twice with sterile PBS to remove any traces of serum and 
then covered with 1.5 ml serum free DMEM. Finally, the DNA-lipofectamine™ 2000 
mix was added evenly to the cells and incubated at 37 °C with 5% C02 for 6 h. After 
this time, the transfection mix was replaced with 5 ml growth medium without selection 
and placed at 37 °C. The growth medium was removed daily and replaced with fresh 
growth medium. After 96 h, 120 h, 144 h and 168 h post transfection, the pseudotype 
virus that had been expressed into the medium was collected using filter tips, filter 
sterilised and stored at -80 °C. 
2.2.4.H2 Viral infection o/the uveal melanoma cell line 
Cells were seeded into T25 flasks in 10 ml growth medium so that they were 80 - 90% 
confluent after 24 h. The next day, the medium was removed and 2 ml of the virus 
collected after 96 h was added to the cells in the presence of 24 J.lg/ml polybrene 
(hexadimethrine bromide). Polybrene increases the efficiency of infection by 
neutralising the charge repulsion between the retrovirus and sialic acid on the cell 
surface. The cells were placed back at 37 °C and the following day the viral.containing 
medium was replaced with fresh growth medium. The cells were allowed 24 h to 
< • 
recover before the addition of the virus taken at 120 h. This procedure was repeated 
until all viral medium had been used. After the final viral containing medium had been 
washed off, cells were incubated in non-selective growth medium for 48 h. 3 J.lg/ml 
puromycin was then added to the medium to select for cells that had been successfully. 
infected. Selection was maintained by continual growth in growth medium 
supplemented with 3 J.lg/ml puromycin. 
2.2.5 Single cell gel electrophoresis assay using the Trevigeit® CometAssayTM 
Reagent Kit 
- .' . 
Alkaline single cell gel electrophoresis allows the evaluation of DNA damage in single 
, . 
cells based on the technique of microelectrophoresis (Ostling and Johanson, 1984; 
Singh et aI., 1988). The assay is based on the principle that damaged, denatured DNA 
fragments have the ability to migrate out of the cell when an electric field is introduced 
., 
whereas intact, supercoiled DNA migrates slower and therefore remains within the 
• ? • . TM .. 
nucleus under the same conditions. Here, the CometAssay was used to evaluate the 
, . 
presence of DNA ICLs. Cells were first treated with MM~ to allow the formation of 
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DNA ICLs. Following this, the cells were treated with IR to induce DSBs and to 
fragment the DNA. The induced ICLs hold the damaged DNA fragments together, 
causing them to move slower than non-crosslinked controls, and prevent them from 
migrating out of the cell under electrophoresis. Analysis was carried out using the 
average Tail Moment (TM) defined as the product of the amount of DNA in the tail and 
the mean distance of migration in the tail (Olive et aI., 1990). From this, the MMC-
induced percentage decrease in TM was calculated where the quantity of ICLs is 
proportional to the MMC-induced decrease in TM (Pichierri et aI., 2002). 
Cells were counted and plated at Ix 106 cells/lOO mm plate for each condition and 
incubated under normal conditions for 24 h. After this time, the cells were treated with 
I Jlglml MMC and returned to normal incubation conditions for 1 h. The cells were then 
scraped into 5 ml PBS using a cell scraper and centrifuged at 2000 rpm for 5 min at 4 
cC. The cells were then washed in PBS by centrifugation and resuspended in 3 ml PBS, 
and counted as in 2.2.4.D. 2x 10s cells were transferred to a 1.5 ml eppendorf tube and 
treated with 10 GY IR. 25 JlI of each cell sample was transferred to a 0.5 ml eppendorf 
tube and mixed with 250 JlI of comet LMAgarose from the kit, which had· previously 
been melted at 80°C for 10 min then kept molten at 37°C for at least 20 min before 
use. 75 J.lI of the agarose-cell mix was immediately transferred onto a CometSlide™ 
using the side of the pipette tip to ensure even coverage onto the sample area, and the 
slides incubated at 4 °C for 20 min until set. The slides were immersed in prechilled 
Lysis solution from the kit (approx. 5 ml per slide) and incubated at 4 °C for 1 hand 
~ " 
then transferred to an alkaline solution pH >13 (0.6 g NaOH pellets, 200 mM EDTA in 
50 ml ddH20) for 1 h at room temperature in the dark; The slides, were placed in a 
horizontal electrophoresis tank (Geneflow) equidistant from the electrodes, to which the 
alkaline electrophoresis buffer was carefully added (300 mM NaOH, 1 mM EDTA) 
~ 
until the slides were covered. The current was set to 20 V (1 Voltlcm) and the current 
set to 300 mA by the addition or removal of buffer. Electrophoresis was then carried out 
for 30 min at the controlled temperature of 4 °C to reduce background damage and 
increase sample adherence. Following electrophoresis, the slides were carefully washed 
twice in ddH20 for 5 min then immersed in 70% ethanol for 5 m. The slides were then 
left to dry at room temperature in the dark for approximately 20 min before adding 50 
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J.11 of Ix SYBR Safe™ DNA gel stain (1 J.11 of 10,000x SYBR Safe™ diluted in 10 ml 
TE buffer) onto each sample for 10 min and leaving at room temperature in the dark 
until dry. Samples were visualised using a Nikon TE200 inverted microscope and 
images recorded using a Hamamatsu C4742-95 digital camera. Analysis of the average 
TM from at least 100 cells was carried out using the TriTek CometScore™ Freeware 
v1.5 software package. The MMC-induced percentage decrease in TM was then 
calculated using the formula set out below to determine the quantity of ICLs formed in 
each cell line (Pichierri et al., 2002). 
% decrease in TM = 1 _ [TM of IR and MMC treated sample - TM of untreated samPle] X 100 
, TM of IR treated sample - TM of untreated sample 
2.2.6 RNA Studies 
All RNA experimental work was carried out using filter tips, sterile eppendorf tubes and 
sterile ddH20 that had been autoc1aved so that it was known to be nuclease-free to stop 
the degradation of the RNA. 
2.2.6.A RNA extraction using the GenElute™ Mammalian Total RNA Kit 
The GenElute™ mammalian total RNA kit from Sigma-Aldrich was used to isolate total 
RNA from a flask containing Ix 107 cells and was carried out according to the 
manufacturers' instructions. Briefly, cells were lysed in a buffer containing guanidine 
thiocyanate to ensure thorough denaturation of macromolecules and inactivation of 
RNases. Ethanol was then added to bind the RNA to a silica membrane during 
centrifugation. Contaminants were removed by washing and the RNA eluted in TE 
buffer. Quantification was carried out using the nanodrop system (2.2.2.C) measuring 
absorbance at 260 run and 280 run where an absorbance of 1.0 at 260 run corresponds to 
40 J.1g1ml of RNA. 
, , 
2.2.6.B cDNA Synthesis using Superscript™ II Reverse Transcriptase 
For generating cDNA copies from total RNA·· extracts, Superscnpt™ II Reverse· 
Transcriptase (lnvitrogen) was used to reverse transcribe the RNA and was carried out 
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according to the manufacturers' instructions. Briefly, 1 f!l Oligo (dT)12-18 primer, 1 f!l 
dNTP Mix (10 mM each), and 1 f!g total RNA were added to a nuclease-free 
microcentrifuge tube and made up to a volume of 12 f!l with sterile ddH20 then heated 
to 65 QC for 5 min and quickly chilled on ice. To this, 4 f!l 5x First-strand buffer and 2 
f!l 0.1 M DTT from the kit was added. The contents were mixed gently then incubated 
at 42 QC for 2 min followed by the addition of 1 f!l Superscript™ II RT. The reaction 
was incubated at 42 QC for 50 min before being inactivated by incubating at 70 QC for 
15 m. 
2.2.6.C Real Time PCR 
Real time PCR is a technique used to quantify sequence specific PCR products as they 
accumulate in 'real time' (Heid et aI. , 1996; Winer et aI., 1999). Here, this technique 
was coupled with reverse transcription (2.2 .6.B) to determine the amount of F ANCD2 
mRNA in uveal melanoma cell lines. Using a fluorescent dye (SYBR Green I) that 
emits light and becomes excited when bound to newly synthesised DNA in the PCR 
reaction, the accumulation and quantification of the cDNA in the initial PCR reaction 
can be determined. 
2.2.6.C.J Primer Design 
Forward and reverse primers were ordered from Invitrogen and were designed to 
amplify the longer F ANCD2 isoform a transcript sequence (GenBank accession number 
NM_033084). f3-ACTIN primers were also used to amplify the f3-ACTIN cDNA 
(GenBank accession number NM_00l101) of each sample as a reference gene. The 
primer sequences were designed using the primer design software at 
www.genscript.com and excluded intronic regions to ensure genomic DNA was not 
amplified. The primers were designed as follows: 
FANCD2 
fJ-ACTIN 
Forward - CAT GGC TGT TCG AGA CTT CA 
Reverse - GAC ACA AGG CTG crr CAT CA 
Forward - ACA CCC CAG CCA TGT ACG TAG CC 
Reverse - AAG AGC CTC AGG GCA ACG GAA CC 
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2.2.6.C2 Real Time peR Reaction Set Up 
Reactions were set up in triplicate for each cell line in a 384-well plate. For the number 
of reactions to be carried out, a master mix was made by mixing 5 III of 2x Power 
SYBR® Green PCR master mix with 0.3 III (per reaction) 10 IlM primers (forward and 
reverse) made up to a volume of 6 III per reaction. This was aliquoted into the 
appropriate wells, to which 4 III of cDNA was added. The plate was then covered with a 
clear plastic foil and centrifuged at 1000 rpm for 5 min to spin down any residual 
reaction mix. The plates were placed in the Applied Biosystems 7900HT fast real time 
PCR system and the samples were subjected to the following PCR conditions: 
Stage 1 50 QC 2min 
Stage 2 95 QC 10 min 
Stage 3 95 QC 15 s 
60 QC 1 min } 40 cycles 
Images and data were documented using the SDS Enterprise Database software 
(Applied Biosystems). 
2.2.6. C 3 Testing primer efficiency 
Primer efficiency was determined using a standard curve and calculating the Coefficient 
of determination (R2). Increasing dilutions ofWM793 control cDNA (from 1: 1 to 1: 50) 
were added in triplicate as in Section 2.2.6.C.2. Following the Real Time PCR 
procedure, CT values for FANCD2 and ~-ACTIN were plotted against cDNA 
concentration to produce a regression line of efficiency (Figure 2.6). To determine how 
accurately this regression line approximated the real data points the coefficient of 
determination (R2) was calculated for each set of primers. If primers are 100% efficient 
R2 would equal 1. Here, both primers had a R2 value of approximately 0.7 and thus are 
70% efficient. As both primers had the same efficiency we were able to use the 
Comparative CT (T~ t.CT) method to compare the mRNA levels of FANCD2 to ~­
ACTIN in each cell line and then between uveal melanoma and the control cell lines 
(see Section 2.2.6.CA). 
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Figure 2.6 Standard regression' lines showing the Rl values and thus the primer efficiency 
for the F ANCD2 and P-ACTIN primer sets used in the Real Time PCR experiments 
CT values for the increasing concentrations of cDNA from the control cell line, WM793. 
Regression lines were produced for FANCD2 and ~-ACTIN primers and the R2 values 
" ,determined to evaluate the, efficiency of the primers. A R2 value of 1 equals 100% primer 
efficiency. 
2.2. 6. CA Quantification 
The real-time relative quantification of nucleic acids was determined using the 
Comparative CT (2'&\CT) method (Livak and Schmittgen, 2001). Firstly, the average 
difference in cycling threshold of the gene of interest, in this case F ANCD2, and the 
reference gene (fJ-ACTIN) was determined (~CT) for each cell, line. The difference in 
these ~CT values between cell lines was then calculated (~~CT) and the fold change in 
gene expression determined using the 2'&\CT equation. 
2.2.6.D Ribonuclease (RNase) Protection Assay' 
The ribonuclease (RNase) protection assay is a sensitive proced~e that allows the 
detection and quantification of multiple target mRNA sequences in a total RNA sample 
(Friedberg et at, 1990). The technique involves the synthesis of a radioisotopically 
labelled RNA probe that' is complementary to part of the t~get" ~NA seq~ences 
followed by hybridisation to the sample RNA. After hybridisation, the mixture is treated 
with RNase to degrade unhybridised probe. RNase only degrades single-stranded RNA, 
thus the probe bound to the target mRNA sequences protects them from degradation. 
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These protected fragments can then be separated on a denaturing TBE-urea 
polyacrylamide gel and visualised by autoradiography (Figure 2.7). Here, the RNase 
protection assay was carried out using the RPA IU™ and T7 MAXlscript® kits from 
Ambion with RiboQuant™ Multi-probe custom template sets (PharMingen) to detect 
and quantify 18 DNA repair genes in uveal melanoma and other human control cell 
lines. As the probes were labelled with a radioisotope for visualisation, all procedures 
were carried out in a separate laboratory set up for radioactive work. All procedures 
were carried out behind a perspex screen in the designated areas using a series 900 
mini-monitor geiger counter to measure the level of radiation (beta particles) whilst 
conducting the experiment and to screen for contamination before and after the 
procedures had been completed. Laboratory coat and gloves were worn at all times. 
Total RNA 
I 
Hybridisation , 
/\/\/\/ 
/\/\/\/ 
RNase 
Digestion 
l 
/\/\/\/ 
/\/\/\/ 
labelled probe 
Gel analysis 
~ 
Figure 2.7 RNase protection assay procedure 
Undigested ProbeIYeast RNA control 
Digested ProbeIYeast RNA. control 
-
-
Protected probeJtarget mRNA. 
fragments of differing intensities 
, 
The probe was synthesised by in vitro transcription using the T7 MAXIscript® kit, the 
hybridisation, digestion and precipitation were carried out using the RP ATM III kit and the 
fragments separated on a denaturing TBE-urea polyacrylamide gel. The digested and undigested 
probes were made using the yeast RNA control provided in the kit. The intensity of the protected 
fragments was directly proportional to the quantity of mRNA in the original sample. 
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2.2.6.D.l Multi-probe template set design 
Multi-probe custom template sets were designed to detect the rnRNA sequences of 18 
different DNA repair genes and then purchased from PharMingen. In order to detect 
multiple mRNA sequences, all target sequences must differ in size sufficient for 
separation on a denaturing TBE-urea polyacrylamide gel (Hobbs et al., 1993). Thus 
repair genes were chosen depending not only on their previous published association 
with altered levels of SCE but also by the difference in fragment size between the genes 
of a template set to allow the detection and analysis of the target sequences. Two multi-
probe template sets were made, each containing the housekeeping genes L32 and 
GAPDH as internal controls. The two multi-probe template sets and the corresponding 
protected fragment size in nucleotide length (nt) of each target sequence are shown 
below: 
:' Probe r,'~ . ;" Protected ' Probe 2 Protected 
y;,*~"V' <'< '~'}<1',,:. ":~"~ .A" ." ",\ " i.17:~·:~< ~";.':~; ).ragmc~t ~iz~ (nt) : . ", Fragment ,size (nt) : 
,.~l'.E:f;C)"~ t11~">4:' :, ~i ",,. ~ )''',,' ;, ( ~ " " 
ATM 404 RAD50 362 
NBS1 362 RAD54 323 
XRCC4 295 RAD52 297 
L1G4 256 MREll 258 
XRCC2 227 RAD51 185 
XRCC3 202 RAD51B 160 
FANCG 181 RAD51C 148 
KU86 161 RAD51D 127 
DNA-PK 144 L32 113 
KU70 127 GAPDH 96 
L32 113 
GAPDH 96 
2.2.6.D.2 Probe Synthesis using the T7 MAXIscript®Kit 
Radiolabelled probe synthesis was carried out by in vitro transcription using the T7 
MAXlscript® kit from Ambion. Briefly, the multi-probe template sets contain a double-
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stranded 19 - 23 base T7 promoter, upstream of the sequence to be transcribed. Under 
reaction conditions and in the presence of normal rNTPs and a radio labelled rNTP, the 
T7 phage RNA polymerase binds to this promoter and using the 3' to 5' strand as a 
template, synthesises a complementary 5' to 3' strand at the end of the DNA template. 
All reagents were RNase-free and kept on ice. The transcription reaction was set up for 
each multi-probe template set as follows: 
,;~~~"f»~~>}'ir •• ";1"'/>"\:~," "'et.' y,,' , » , 
, Componcnt ~'· , ,. : " , . Volume 
!~~~~:~~.~~,~l~~:_\:~·':i:l\,~ ~:,,>< "~~ . ' ; 
RiboQuant multi-probe template set (5 ng/f.tl) 1 f.tl 
10x Transcription buffer 2 ~ll 
10 mM A TP 1 f.tl 
10 mM CTP 1 f.tl 
10 mM GTP 1 f.tl 
[a32P]UTP* 5 f.tl 
T7 RNA polymerase (15 U/f.tl) 2 f.tl 
Nuclease-free dH20 To 20 f.t\ 
* radioisotopically labelled UTP ( Phosphorus) 
T7 RNA polymerase was added last, immediately before the reaction was incubated for 
1 hat 37 QC. Following this incubation, 1 f.tl TURBO DNase 1 (from the kit) was added 
to the reaction to remove the template DNA and incubated for a further 30 min at 37 cC. 
The reaction mix was resuspended in 80 f.tl nuclease-free ddH20 and then extracted with 
100 f.tl phenol:chloroform:isoamyl alcohol (25:24: 1) by mixing and removing the upper 
aqueous layer to a fresh RNase-free 1.5 ml eppendorf tube. 10 f.tl 5M sodium acetate 
(provided in the kit) and 275 f.tl 100% ethanol were added to precipitate the probe 
transcripts from the reaction mix. The samples were then incubated at -20 cC for 30 min 
followed by centrifugation at maximum speed at room temperature for 30 m. The 
supernatant was removed and the pellet resuspended in 50 f.tl nuclease-free ddH20. The 
probe was then stored at -20 cC until required. 
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2.2.6.D.3 RNA Preparation and Hybridisation using the Ambion RPA ]]]TM Kit 
Total RNA was extracted from cells and measured as in 2.2.6.A. 10 Ilg total RNA was 
added to a RNase-free 0.5 ml eppendorf tube for each cell line and dried to completion 
using a Savant Speedvac concentrator with no heat (approximately 10 min for a 10 III 
sample). Two tubes containing 2 III (10 Ilg) yeast RNA were also included as controls. 
Once dry, the samples were re suspended in 8 III RPA III hybridisation solution 
(provided in the kit) by vortexing and ~en 2 III diluted probe from 2.2.6.D.2 was added 
to each sample and controls. The samples were then placed in a thermal cycler, heated 
to 95°C for 3 min and then incubated overnight at 56 QC. 
2.2.6.DA RNase Digestion and Precipitation of Probe/Target mRNA Protected 
Fragments 
The RNase AlRNase Tl mix (provided in the kit) was diluted 1 in 1000 in RNase 
digestion III buffer (from the kit) and 100 III of this solution was then added to the 
hybridised samples. One yeast RNA control was treated with RNase A in the same way 
as the samples and thus acted as a control for effective RNase treatment and to ensure 
that the probe was not protected in the absence of a complementary sequence. There 
should be no signal in this lane upon gel migration (Figure 2.6). The other yeast RNA 
control was not subjected to RNase treatment and thus only RNase digestion III buffer 
was added. This serves as a control for probe integrity to ensure no degradation or 
secondary structures exist. The full length probe was seen in this lane upon gel 
migration (Figure 2.6). 
Following the addition of RNase, the samples were vortexed and incubated at 30°C for 
45 min to allow the digestion of unhybridised RNA and probe. 150 J.lI 
InactivationlPrecipitation III solution (from the kit) was added to each sample, vortexed 
and incubated at -20°C for 30 m. The samples were then centrifuged at room 
temperature for 30 min and the supematant removed. The samples were centrifuged 
again at room temperature for 15 min and the remaining supematant removed by 
pipetting. The pellets were then air dried for 10 min at room temperature. The pellets 
were re suspended in 8 III Gel loading buffer II (provided in the kit), and incubated at 95 
°C for 3 min and place immediately on ice until loaded onto the gel. 
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2.2.6.D.5 Separation of Protected Fragments using a Denaturing TBE-Urea 
Acrylamide Gel 
Electrophoresis was carried out using the OmniP AGE Maxi (20 x 20 cm) vertical gel 
electrophoresis unit from Geneflow. To stop RNA contaminants, the kit was washed in 
0.05% DEPC-treated ddH20 (500 ~l DEPC in 1 L of ddH20 and left at room 
temperature for 2 h before autoc1aving) prior to use and all reagents were made up with 
0.05% DEPC-treated ddH20 in RNAse-free bottles and tubes, using RNase-free filter 
tips. DEPC-treated ddH20 was made by adding 500 f...ll DEPC to 1 L ddH20 , leaving at 
room temperature for 2 h before autoclaving. The gel apparatus was set up according to 
the manufacturers' instructions using the glass plates (one set with spacers attached) 
aligned to the edge on the silicone seal to stop leakage. A 5% acrylamide/8 M urea gel 
was cast to separate the protected probe/target mRNA fragments for a 16 x 17.5 cm x 
0.75 mm gel as below: 
·Resolving Gel Components 
~;L::~/ T~, ,'~ :" ~~.,A I' ~~.~ ".' ", 
Urea 
40% (w/v) 19:1 Acrylamide: Bis-
acrylamide stock solution 
10 x TBE 
10% ammonium persulfate (APS) 
TEMED 
0.05% DEPC treated ddH20 
14.4 g 
3.8 ml 
3ml 
240 III 
32 III 
to 30 m1 
Before the addition of the 10% APS and TEMED, the gel solution was stirred at room 
temperature until the urea was completely dissolved. As it is the interaction between the 
10% APS and TEMED that catalyses the polymerisation of the gel, following the 
addition of TEMED, the gel was poured immediately. A comb was then placed in the 
gel to create the loading wells and the gel was allowed to set at room temperature. Once 
set, the comb was removed, and the cast gel and glass plates were placed inside the 
vertical electrophoresis tank and covered with approximately 2 L 1x TBE running 
buffer (from a lOx stock of 0.9 M Tris base, 0.9 M Boric acid and 20 mM 0.5 M EDTA, 
made up to 1 L with 0.05% DEPC-treated ddH20). Prior to sample loading, urea was 
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rinsed from the wells of the gel by pipetting up and down with Ix TBE running buffer. 
The total volume of each sample (S JlI) and probe controls were loaded into the wells. 
Electrophoresis was then carried out at 250 V for approximately 4 h or until the loading 
dye had run offthe end of the gel. 
2.2.6.D.6 Quantification 
Following electrophoresis, the gel was removed from the tank and placed on to a piece 
of thick blotting paper. The gel was then covered in Cling film and placed in a vacuum 
pump air dryer (Fisherband) for 40 min at 70°C until dry. The gel was then placed in a 
light proof cassette and exposed onto a storage phosphor screen for 1 h. The screen was 
then scanned using a PhosphorImager (FUn Film FLA3000) and the intensities of the 
bands analysed using the ImageGauge V 4.21 and ImageReader VI.SE software. 
2.2.7 \Vestern Blot Analysis 
2.2.7.A Protein Extraction and Quantification 
2.2.7.A.l Han;est by Trypsinisation 
Cells grown in a monolayer on T75 flasks until 70% confluent or at least Ix 106 cells 
were present at the point of extraction. Cells were trypsinised using the protocol in 
2.2.4.A and centrifuged at 2000 rpm at 4 °C for 5 m. The pellets were then washed in 3 
ml cold PBS and centrifuged again at 2000 rpm at 4 °C for 5 m. This time the pellets 
were re suspended in 500 JlI of cold PBS, transferred to 1.5 ml eppendorf tubes and 
centrifuged again at 2000 rpm at 4 °C for 5 m. The PBS was then removed and the 
pellets lysed in 100 - 200 JlI of Ix RIPA buffer (0.75 M NaCI, 5% NP40, 2.5% DOC, 
0.5% SDS and 0.25 M Tris pH S in ddH20) supplemented with Ix protease inhibitors 
and 1 mM PMSF. The extracts were incubated on ice for 30 min before being passed 
through a 25 G needle 5 times. The lysate was then spun at maximum speed (14,000 
rpm) for 10 min at 4 °C to pellet the cell debris and the supematant removed and stored 
at -20°C. 
91 
Chapter 2 - Materials and Methods 
2.2.7.A.2 Harvest by Scraping into 2x RIPA Buffer to Maintain Phosphate 
Moieties 
Cells were seeded onto 100 mm plates so that at least I x 106 cells were present at the 
point of extraction and then incubated under nonnal conditions for 4 - 24 h before being 
treated as required. During the extraction procedure, the cells and reagents were kept 
cold on ice. Plates were washed 3 times in ice-cold PBS and residual PBS removed by 
pipetting. To the plates 100 J.ll 2x RIPA buffer supplemented with 2x protease 
inhibitors, 2 mM PMSF and 2x phosphatase inhibitors (Sigma-Aldrich) was added and 
the cells detached from the plates using a cell scraper. The cells were then transferred to 
a 1.5 ml eppendorf tube and the extraction procedure followed as in 2.2.7 .A.I. 
2.2.7.A.3 Quantification 
A range of standard solutions (1 J.lg/ml to 20 J.lg/ml) were made from a 10 mg/ml stock 
of BSA and used to generate a standard curve. For each protein extract, 2 J.lI was added 
to 800 J.ll ddH20 before the addition of 200 J.ll of BioRad Protein Assay Dye Reagent 
Concentrate. The solutions were mixed by vortexing and incubated at room temperature 
for 5 m. 200 J.lI of each solution was then transferred to a 96-well plate and the OD 
measured at 595 nm using a plate reader. The protein concentration was calculated by 
comparing the sample OD to the standard curve generated. 
2.2.7.B Western Blot Procedure 
2.2.7.B.} Assembly of Casting Equipment 
Tris-glycine SDS-polyacrylamide gels were cast using the vertical Hoefer SE250 
mighty small II system. The SE245 dual gel caster was assembled according to the 
manufacturers' instructions. Glass plates and spacers were washed with 70% ethanol 
prior to assembly and aligned to the edge of the caster to prevent leakage. 
2.2.7.B.2 Casting of the Tris-GlYcine SDS-Polyacrylamide Gels 
The resolving gel was poured first. This gel allows the separati0rl of proteins according 
to electrophoretic mobility. An 8, 10 or 12% gel was prepared as below depending on 
the size of the proteins to be analysed. It is the interaction of TEMED and APS that 
facilitates the polymerisation of acrylamide to produce a gel. Once poured, the gel was 
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immediately overlaid with approximately 1 ml H20 to create an even surface. This was 
then left to set at room temperature. Once set the water overlay was removed and the 
stacking gel poured. 
~ResolviiiiGel C(,mponcnts " 8 % 10 % 12 % 
~i,~-rl~'~y,;,::\~""~ ,.~~~,h'.\·", {.,4i~\.'~L"'.:'''·h· ~, • 
ddH20 2.3 ml 1.9 ml 1.6 ml 
30% (w/v) acrylamide: 0.8% (w/v) 
Bis-Acryl-amide stock solution 1.3 ml 1.7 ml 2.0 m! 
(37.5:1) 
1.5 M Tris (PH 8.8) 1.3 ml 1.3 ml 1.3 ml 
10% SDS 50 ~l 50 ~1 50 ~l 
10% ammonium persulfate (APS) 50 ~l 50 ~l 50 ~1 
TEMED 6 ~1 4 ~1 4 ~l 
The stacking gel has a lower pH and acrylamide concentration than the resolving gel, 
which causes protein samples to compress at the interface between the gels. This 
produces better resolution and sharper protein bands. Once poured, a comb was 
immediately inserted into the gel to create wells. The composition of the stacking gel 
per gel cast is shown below: 
~ Stacking Gel Components . . 
.. ~ -.," ~ '-
, . 
.~. . . .. . . .. 
ddH20 1.4 ml 
30% (w/v) acrylamide: 0.8% (w/v) 
Bis-Acryl-amide stock solution 330 J..ll 
(37.5: 1) 
1.5 M Tris (PH 6.8) 
10% SDS 
10% ammonium persulfate (APS) 
TEMED 
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2.2.7.B.3 Electrophoresis 
Once set, glass plates and spacers containing the gels were removed from the caster and 
washed with tap water before being assembled in the SE250 miniVE vertical 
electrophoresis unit. Ix SDS-PAGE running buffer was made from a 10x stock (250 
mM Tris Base, 1.9 M Glycine dissolved in ddH20 before the addition of 1 % SDS) and 
then added to the chamber ensuring the gel was fully submerged and that the buffer was 
present in both sides of the chamber. Samples consisting of20 - 30 Jig of protein in Ix 
protein loading dye from a 5x stock (250 mM Tris pH 6.8, 10% SDS, 50% glycerol, 250 
mM DIT and 0.02% bromophenol blue in ddH20) were first incubated at 100 °C for 10 
min to denature the proteins before loading into the wells along with 5 Jil of 
ColorBurst™ Electrophoresis Marker (Sigma-Aldrich). The gel was then subjected to 
an electrical current of 180 V at room temperature for approximately 1 h for all proteins 
except for larger proteins such as ATM and DNA-PK, which were run at 4 °C for 
approximately 4 h. 
2.2.7.B.4 Semi-Dry Transfer 
Following electrophoresis, the gel was removed from the glass plates and the stacking 
gel discarded. Ix Towbin transfer buffer was made from a 10x stock (250mM Tris Base 
and 1.9 M Glycine in ddH20) by adding 1 ml of 10% SDS to 100 ml of 10x Towbin 
transfer buffer and 700 ml of water before adding 200 ml of methanol. The remaining 
resolving gel was submerged in this buffer to remove any contaminating buffer salts 
from the electrophoresis. Two pieces ofblotling paper were cut to the size of the gel,' 
moistened in transfer buffer and placed onto the BioRad Trans-Blot SO Semi-dry 
Electrophoretic Transfer Cell. A piece of Protran nitrocellulose transfer membrane cut 
to the size of the gel and soaked in transfer buffer was then placed on top of this. The 
gel was then placed on top of the membrane ensuring that the surface was even, 
followed by the addition of two more pieces of moistened blotting paper. Transfer was 
then carried out at 10 V for 40 m. For larger proteins (>200 kDa), a 2x Towbin transfer 
buffer was used that contained twice the amount of 10x stock and 2 ml 10% SDS, and 
the transfer time was extended to 1.5 h. 
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" 2.2.7.B.5 Blocking the Membrane 
To prevent non-specific binding of the antibodies and reduce background signal, 
following transfer, the membranes were incubated in 5% non-fat milk in PBS-T (0.1 % 
Tween-20 in PBS) for 1 h at room temperature on a shaking platform. 
2.2. 7.B. 6 Antibody Incubation 
Following blocking, membranes were incubated with the appropriate primary antibody 
diluted in 5% non-fat milk in PBS-T to the correct dilution overnight at 4 °C on a 
shaking platform. After this time, the membranes were subjected to 3, 10 min washes 
with PBS-T (0.1 % Tween-20 in PBS). After the washes, the membranes were incubated 
with the appropriate secondary antibody diluted in 5% non-fat milk in PBS-T for 1 hat 
room temperature on a shaking platform. Following this, the membranes were washed 3 
times in PBS-T for 10 m. 
2.2. 7.B. 7 EeL Detection 
Proteins bound to the nitrocellulose membrane were visualised using Amersham ECLTM 
. . . 
western blotting detection reagents. The ECL reagents are supplied as 2 solutions that 
were mixed in equal volumes according to the manufacturers' instructions before being 
added to the membranes for 1 min at room temperature. This incubation allows an 
oxidation reaction between the horseradish peroxidise conjugate to the secondary 
antibodies, and the luminol in the ECL reagents to take place, which leads to 
chemiluminescence. Excess ECL was removed and the membranes wrapped in Cling 
film avoiding any bubbles and placed in a light proof cassette. Under the safety red 
light, the membranes were incubated with Fujifilm Super RX medical x-ray film for 
between 20 s and 1 h in order for the light emitted from the chemiluminescence reaction 
to be recorded onto the light sensitive autoradiography film. To visualise this transfer, 
the film was placed in developing solution for 30 - 60 s, briefly washed in tap water, 
then placed in fixing solution for 2 min before finally washing once more with water. 
2.2.8 Immunofluorescence 
Immunofluores~ence was used to visualise the nuclear distribution of specific proteins 
spontaneously and following treatment with MMC. All cells were visualised using a 
Nikon TE200 inverted microscope and images were recorded and analysed using a 
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Hamamatsu C4742-95 digital camera and the image analysis software Velocity version 
3.61. 
2.2.8.A -Sample Preparation 
2.2.B.A.l Spontaneous Foci Formation 
Coverslips were first sterilised by washing with 70% methanol then' placed into 
individual wells on a 6-well plate. Cells were then trypsinised and quantified as in 
2.2.4.A and 2.2.4.D, and Ix 10s cells in 3 ml growth medium was added to each 
coverslip. Cells were incubated under normal conditions for 24 h after which time the 
growth medium was removed from the cells and the cells washed for 5 min in PBS 
followed by fixing. 
2.2.B.A.2 Induced Foci Formation Following MMC Treatment 
The DNA damage response in uveal melanoma cells compared to control cell lines 
following the induction of ICLs was determined by studying the induced foci formation 
at various time points after treatment with MMC. Cells were prepared in 6 well plates as 
described in 2.2.8.A.l. Each 6 well plate was used for one time point, ranging from 0 h ,;, 
48 h. The following day 500 nglml MMC (15 JlM) was added to the growth medium in 
each well and then returned to normal incubation conditions for 1 h, after which time 
the medium was removed and replaced with fresh growth medium. The cells for the 0 h 
time point were washed immediately with PBS for 5 min and then fixed. After fixing, 
cells were stored at 4 °C in either PBStx (0.15% BSA dissolved in PBS supplemented 
with 0.1 % Triton X-lOO), Washing buffer (0.1 % NP-40 in PBS) or 1 % goat serum in 
TBS for RAD51, FANCD2 or 'YH2A.X foci formation respectively, until the final time 
point cells had been fixed. Each subsequent time point was fixed after the appropriate 
time using the described method. 
2.2.8.B RAD51 Foci Formation 
Cells were prepared as in either 2.2.8.A.l or 2.2.8.A.2 and then fixed using 3% PFA (3g 
paraformaldehyde dissolved in 100 m! PBS by heating to 80 °C overnight on a stirring 
heat block) for 20 min at room temperature, after this time the PF A was removed and 
the cells washed 4 times in PBStx (0.15% BSA dissolved in PBS supplemented with 
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0.1 % Triton X-lOO) for 15 m. Cells were incubated with the primary RAD51 antibody 
diluted 1 in 500 in 3% BSA in PBS and left overnight at 4°C in a humidified chamber. 
The following day cells were washed 4 times in PBStx for 15 min at room temperature 
then incubated with the CY3 goat anti-rabbit secondary antibody at 1 in 500, diluted in 
3% BSA in PBS for 1 h at room temperature in a dark humidified chamber. To stop 
fading of the fluorescently tagged secondary antibody, subsequent steps were carried 
out away from direct sunlight and the plates wrapped in foil. After incubation, the cells 
were washed two times in PBStx for 15 min followed by one wash for 5 min in PBS. 
Cells were mounted onto slides using mounting medium containing DAPI 
(Vectorshield) and stored in the dark at 4 °C until analysis. To quantify RAD51 foci 
formation, cells with greater than 10 foci/cell were scored as positive and at least 50 
cells were counted! condition on 3 separate occasions. 
2.2.S.C FANCD2 Foci Formation 
Cells were prepared as in either 2.2.S.A.l or 2.2.S.A.2 and then fixed in 2% PF A in PBS 
(dissolved by heating to SO °C overnight on a stirring heat block) for 20 min at room 
temperature. The PFA was then removed and the cells permeabilised in 0.3% Triton X-
100 in PBS for 10 min at room temperature. Following this, the cells were incubated in 
blocking buffer (10% goat serum in PBS) for 1 h at room temperature and then 
incubated with the primary FANCD2 antibody diluted to 1 in 1000 in 3% goat serum in 
washing buffer (0.1 % NP40 in PBS) overnight in a humidified chamber at 4°C. After 
this time, the cells were washed 3 times in washing buffer for 10 min on a shaking 
platform and subsequently incubated with the secondary Alexa fluor 4SS~ goat anti~ 
mouse IgG (H+L) antibody diluted 1 in 1000 in 3% goat serum in washing buffer, for 1 
hr at room temperature in the dark. The cells were subsequently washed 3 times in 
washing buffer for 10 min in low light and then mounted onto labelled microscope 
slides using mounting medium containing DAP!. The cells werevi'sualised and the 
number of foci/cell quantified where cells with greater than 10 foci/cell were scored as 
positive. At least 50 cells were counted for each condition on 3 separate occasions. 
2.2.S.D yH2A.X Foci Formation 
Cells were prepared as in either 2.2.8.A.1 or 2.2.8.B.l and then fixed in 3% PFA in PBS 
(dissolved by heating to SO °C overnight on a stirring heat block) for 10 min at room 
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temperature. The cells were then penneabilised in 0.2% TritonX-100 in PBS for 5 min 
followed by washing 3 times in TBS for 10 min before the cells were incubated with 
blocking buffer (10% goat serum in TBS) for 1 h at room temperature. Following this 
incubation, the cells were washed twice in TBS for 10 min and subsequently incubated 
~th 'the primary yH2A.X antibody diluted to 1 in 500 in 3% goat serutn in TBS 
, , 
overnight in a humidified chamber at 4°C. The cells were then washed 4 times in TBS 
for 10 min and incubated with the CY3 goat anti-rabbit secondary antibody at 1 in 500, 
diluted in 3% goat serum in TBS for 1 h in a dark humidified chamber at room 
temperature. Following this, the cells were washed 3 times in TBS for 5 min ~n low light 
and then mounted onto labelled microscope slides with mounting medium containing 
DArI. The cells were visualised and the number of foci/cell quantified where cells with 
it"eater th~ 10 foci/cell were scored as positive. At least 50 cells were counted for e~ch 
, 
condition on 3 separate occasions. 
2.2.9 Fluorescence-Activated Cell Sorting (FACS) Analysis 
F ACS analysis or flow cytometry' is a technique that allows· the simultaneous 
measurement of· various cellular parameters, such as' cell size and granularity. 
Fluorescently labelled cells are passed in a constant stream of fluid through a beam of 
light and the amount of fluorescence emitted as well as the amount of light scattered 
from the beam is measured. 
2.2.9.A Propidium Iodine (PI) Staining 
Cells were counted and plated at a concentration of Ix 106 cells on 100,mm plates in 10 
ml growth medium. For each cell line, one plate was used for no treatment and one for 
MMC treatment. The cells were left for 4 h to allow them to adhere before 100 nM ' 
MMC was added to the appropriate plate. After 24 h cells were trypsinised and washed 
twice in PBS by centrifugation at 2000 rpm for 3 min at 4°C. The cells were then 
pelleted by centrifugation at 1000 rpm for 3 min at 4°C. To fix the cells, 1 ml ice cold 
70% ethanol was added drop-wise whilst vortexing the pellet to ensure full resuspension 
and the cells placed at -20°C. The following day, the pellets were washed twice with 
~BS by centrifugation at 2000 rpm for 3 min at 4,oC and then resuspended in 100 1lg/1l1 
RNase A (diluted in ddH20) and left on ice for 20 m. Following this, 500 III of 50 Ilg/ml 
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PI (diluted in PBS) was added and the cells left in low light at 4 °C overnight. Analysis 
was perfonned the following day using F ACS. 
2.2.9.B BrdU Staining 
BrdU is an analogue of thymine that competes with this base for uptake during DNA 
synthesis. As only actively synthesising cells at, the time of BrdU addition will be 
positive for it, using an antibody specific to BrdU and co-staining with PI, the cell cycle 
status of a cell population can be detennined. 
Cells were counted and plated at a concentration of Ix 106 cells on 100 mm plates in 10 
ml growth medium. For each cell line, one plate was used for each of the time points 0 
h, 4 h, 8 h, and 12 h. The following day 10 JlI of 10 mM stock of BrdU was added to 
each of the plates for 20 min then washed off with fresh growth medium. The 0 h time 
point plate was immediately trypsinised and then washed twice in PBS by centrifugation 
at 2000 rpm for 3 min at 4°C. The cells were then pelleted by centrifugation at 1000 
, . - ' 
rpm for 3 min at 4°C. To fix the cells, 1 ml ice cold 70% ethanol was added drop-wise 
whilst vortexing the pellet to ensure full resuspension and the cells placed at -20°C. 
The subsequent plates for each time point were harvested and fixed as described and 
stored at -20°C until 24 h after the final time point plate had been fixed. After fixing, the 
alcohol was spun off by centrifugation at 2000 rpm at 4 °C for 5' min' followed by 
washing twice in PBS by centrifugation. The subsequent pellet was resuspended in 2 M 
HCL and incubated for 30 min at room temperature. After this incubation, the acid was 
spun off by centrifugation at 2000 rpm at 4 °C for 5 min and the pellet washed 3 times 
in PBS followed by 1 wash in PBS-T (0.1% BSA, 0.2% Tween-20 in PBS pH 7.4) by 
centrifugation. The pellet was then resuspended in 10 JlI Dako Cytomation mouse anti-
BrdU antibody diluted in PBS in equal volumes and incubated for 30 min at room 
temperature in the dark. Following this, the pellet was washed twice in PBS-T and then 
incubated with 50 JlI Dako Cytomation FITC-conjugated goat anti-mouse F(ab')2 
fragments antibody diluted to I in 10 in PBS for 20 min in the dark. The pellet was 
washed once in PBS and resuspended in 500 JlI of 50 Jlg/ml PI and 100 Jlg/JlI RNase A 
for 30 min in the dark at room temperature followed by immediate analysis using 
FACS. 
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3.1 Introduction 
Uveal melanoma affects the uveal tract of the eye and is the most common form of 
ocular melanoma in adults (Singh and Topham, 2003a). Previously, it has been found 
that uveal melanoma exhibit a reduced spontaneous SCE frequency compared to 
matched patient blood samples and other human cancer cell lines (Table 1.5 and 1.6) 
; 
(Hoh, 2007, unpublished data). This is in contrast to many other types of sporadic 
tumours that have increased chromosomal aberrations and are associated with increased 
levels of spontaneous SCE, indicative of genetic instability. Uveal melanoma is 
therefore an ideal model system in which to study SCE formation. 
SCE is the process of the physical exchange of chromatid regions resulting from the 
breaking and rejoining of two sister chromatids. SCE is a known end-product of HR and 
it can be induced by a wide variety of DNA damaging agents. Furthermore, the 
frequency of SCE can be affected by defective proteins involved in DNA repair (Table 
1.3).' Although very little is known about the mechanism of SCE formation, evidence 
therefore suggests that a SCE is formed as a consequence of DNA repair. For this 
- . .' . . 
reason, we characterised the DNA repair pathways in the uveal melanoma cell lines 
SOM 157d and SOM 196b (referred to as 157d and 196b respectively from here in) to 
understand the mechanism of SCE formation and investigate the underlying cause of the 
reduced spontaneous SCE phenotype. 
. _. 
As well as in disease states, spontaneous SCE frequency can vary between cell types 
- , . . 
(Table 1.1). It is possible then that the low SCE frequency in uveal melanoma is a 
consequence of cell type rather than a result of molecular defects. Ideally, to control for 
this, normal melanocytes from an unaffected uveal tract of a uveal melanoma patient 
would be investigated alongside the uveal melanoma cell lines and primary tumour 
samples. However, due to ethical issues this material is unavailable. Instead, we have 
used the cutaneous melanoma cell l~ne, WM793 (Hsu, 1999). This cell line was 
established from the vertical growth phase of a primary cutaneous melanoma lesion of a 
39 year old male caucasian patient and thus, although it does not originate from the 
uveal tract, it shares the same progenitor cell as uveal melanoma cells and thus is 
considered the best available control for the investigation of uveal melanoma cell lines. 
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In addition, we used a panel of standard cell lines used routinely in our laboratory to 
investigate DNA damage repair. 
3.2 Differences in proliferation rate are not responsible for the reduced 
spontaneous SCE frequency in uveal melanoma 
SCE is a recombinational event that occurs during S-phase of the cell cycle and thus is . 
c~nsidered to be a result of normal DNA replication or repair of endogenous DNA 
damage. Altered spontaneous SCE frequency may therefore reflect changes in 
proliferation and cell cycle progression through S-phase. To investigate the association 
between SCE and S-phase in uveal melanoma, MTT proliferation assays (Figure 3.1) 
and cell cycle progression using BrdU incorporation and PI staining were carried out 
(Figure 3.2). 
The proliferation rate of the uveal melanoma cell lines 157d and 196b were compared to 
the melanoma control cell line WM793 and the MRC5V A cell line over a 7 day period. 
There was no difference in the proliferation of both uveal melanoma cell lines compared 
to WM793 (Figure 3.1 a). Furthermore, there was no difference in the percentage of . 
cells in S-phase as indicated by PI staining between these cell lines (Figure 3.1 b). 
Interestingly; both the uveal melanoma cell lines and WM793 proliferated at a 
significantly lower rate than the MRC5V A transformed fibroblast cell line (p = 0.04, P 
= 0.008 and p = 0.02 for 157d, 196b and WM793 respectively) (Figure 3.1 a). As the 
WM793 cell line has high SCE, uveal melanoma cell lines have low SCE and the 
MRC5V A cell line has an intermediate SCE frequency (Table 1.5), there appears to be 
no correlation between proliferation and spontaneous SCE. 
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Figure 3.1 Proliferation rates are similar in uveal melanoma and control ceU lines and thus 
are not responsible for the reduced SCE phenotype 
a) Proliferation rates for the uveal melanoma cell lines 157d and 196b, and the WM793 and 
MRC5V A control cell lines shown by an MTT assay. Cells were allowed to grow for either 4 h 
(0 days), 2, 4 or 7 days after which time the number of viable cells was estimated from MTT 
reduction and measured using spectrophotometry (OD 570 run) . The fold change in absorbance 
was calculated relative to the absorbance measured on day O. b) The % of cells in S-phase as 
indicated by PI staining in 157d, 196b and WM793. In each case, data represent the average of at 
least three separate experiments and error bars represent standard deviations. Statistical 
significance was calculated using the Student's T-test where p < 0.05 is indicated by +. 
Significance between samples is indicated by brackets and no significance is indicated by eNS'. 
To further confirm that uveal melanoma cell lines undergo normal cell cycle 
progression, BrdU staining was carried out (Figure 3.2). BrdU is incorporated into DNA 
during DNA synthesis thus, by staining with an antibody specific to BrdU and co-
staining with PI, the cell cycle status, the percentage of cells actively replicating in the 
cell population and the speed at which the cells move through the cell cycle can all be 
determined using F ACS. There was no difference in the cell cycle progression of both 
uveal melanoma cell lines compared to WM793 over a period of 12 h (Figure 3.2). The 
reduced level of spontaneous SCE is therefore not a consequence of aberrant cell cycle 
progression or a lack of proliferation in uveal melanoma cell lines. 
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Cell cycle % labelled cells at ° h post BrdU Cell cycle % labelled cells at 8 h post BrdU 
phase '\fI/Ml93 157d 196b phase '\fI/Ml93 157d 196b 
Gl 44.7 26 21 .6 G1 22.4 46.4 34 
S 37 50.1 41 .1 S 23.9 11 .8 6.1 
G2 18.2 23.9 37.3 G2 32.1 26 29.1 
Cell cycle % labelled cells at 4 h post BrdU Cell cycle % labelled cells at 12 h post BrdU 
phase WM793 157d 196b phase WM793 157d 196b 
Gl 26.2 23 10.5 G1 56.6 63.6 69.6 
S 34.2 35.1 33.2 S 11 .3 10.5 1.3 
G2 39.6 41 .8 56.3 G2 32.1 26 29.1 
Figure 3.2 Cell cycle progression is similar in uveal melanoma and control cell lines and is 
not responsible for the reduced SCE phenotype 
a) BrdU and PI staining in 157d, 196b and WM793 analysed using FACS. Cells were pulsed with 
BrdU for 20 minutes and then released for 0, 4, 8 or 12 h. BrdU positive cells were gated into G 1, 
Sand G2 phases, the quantification of which can be seen in b). 
3,3 Uveal melanoma cell lines have increased levels of endogenous DNA 
damage, indicative of a defect in DNA repair 
Once proliferation had been ruled out as a cause for reduced SCE frequency, we next 
investigated endogenous DNA damage. Differences in the levels of endogenous DNA 
damage in uveal melanoma cell lines may suggest defects in the response and repair of 
this damage. An early target of the DNA damage signalling pathway is histone H2A.x. 
Both ATR and ATM are able to directly phosphorylate histone H2A.X to form yH2AX 
105 
Chapter 3 - Results 
in response to DNA damage and replication stress (Rogakou et al., 1998; Ward and 
Chen, 2001). The formation of yH2A.X foci can therefore be used as a marker of 
endogenous as well as induced DNA damage. yH2A.X foci formation was visualised 
using fluorescent microscopy where DAPI was used to stain the nuclei of the cells 
(Figure 3.3). 
There was a significant increase in the percentage of cells with greater than 10 yH2A.X 
foci/cell in both the uveal melanoma cell lines 157d and 196b compared to the 
cutaneous melanoma control cell line WM793 (p = 0.005 and p = 0.003, respectively) 
and other control cell lines (Figure 3.3). This suggests that uveal melanoma cell lines 
have an increased level of spontaneous DNA damage. 
Given that proliferation rates and growth conditions are similar in all cell lines, we 
assume that the amount of endogenous DNA damage occurring in all cell lines is 
similar. Thus, increased yH2A.X foci formation is likely to represent decreased or 
aberrant repair of endogenous damage in uveal melanoma. Uveal melanoma have 
decreased SCE levels and increased levels of endogenous DNA damage. This data is 
therefore consistent with the idea that spontaneous SCE results from the repair of 
endogenous DNA damage. 
Interestingly, the increased level of yH2A.X foci formation does not appear to affect cell 
cycle progression or proliferation (Figure 3.1 and 3.2) and furthermore, apoptosis levels 
are normal as shown by Annexin V staining (Appendix 4, Hoh, 2007, unpublished 
data). Together this data suggests that cell survival is not affected by increased yH2A.X 
foci formation. 
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Figure 3.3 Uveal melanoma cell lines have increased levels of endogenous yH2A.X foci 
formation compared to WM793, MRCSV A and U20S control cell lines 
a) Endogenous yH2A.X foci formation visualised by fluorescent microscopy in the uveal 
melanoma cell lines, 157d and 196b, and in the WM793 , MRC5V A and U20S control cell lines. 
Cells were plated and left for 24 h before being fixed and stained. On each occasion, at least 50 
cells were analysed and the % of cells with > 10 yH2A.X foci/cell was calculated . Data represents 
at least three separate experiments and error bars represent standard deviations . Statistical 
significance was calculated using the Student' s T -test where p < 0.01 is indicated by **. Brackets 
indicate significance calculated between samples. b) Representative images of endogenous 
yH2A.X foci formation (red) in all cell lines studied, nuclei stained with DAPl (blue). 
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3.4 Endogenous levels of HR are reduced in uveal melanoma cell lines 
As SCE is a known end-product of HR, we investigated the levels of endogenous HR in 
uveal melanoma cell lines using RAD51 foci formation as a marker of activation. 
RAD51 forms nucleoprotein filaments on the 3' ssDNA overhang following the 
resection of a DSB to initiate strand invasion. RAD5l therefore accumulates at these 
sites forming discrete nuclear foci that can be visualised using fluorescent microscopy 
(Haaf et al., 1995). Cells were stained with an antibody specific to the human RAD5l 
protein and a CY3 goat anti-rabbit secondary antibody. The nuclei of the cells were 
stained using DAP! to determine where the cells were located (Figure 3.4). 
Endogenous RAD51 foci formation was significantly reduced in uveal melanoma cell 
lines compared to WM793 (p = 0.002 and p = 0.02, for 157d and 196b respectively) 
(Figure 3.4). This is consistent with both the increased levels of endogenous yH2A.X 
foci formation and the decreased levels of spontaneous SCE. We therefore postulate that 
the reduced SCE phenotype in uveal melanoma is due to a defect in endogenous HR 
repaIr. 
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Figure 3.4 Endogenous RAD51 foci formation is reduced in uveal melanoma cell lines 
compared to control cell lines. 
a) Endogenous RAD51 foci formation visualised by fluorescent microscopy in the uveal 
melanoma cell lines 157d and 196b, and in the WM793, MRC5V A and U20S control cell lines. 
Cells were plated and left for 24 h before being fixed and stained. On each occasion, at least 50 
cells were analysed and the % of cells with> 10 RAD5l foci /cell was calculated. Data shown is 
representative of at least two separate experiments and error bars represent the standard 
deviations. Statistical significance was calculated using the Student's T-test where p < 0.05 is 
indicated by * and p < 0.01 is indicated by **. Significance between samples is indicated by 
brackets. b) Representative images of endogenous RAD5l foci formation (red) in all cell lines 
studied, nuclei stained with DAPI (blue). 
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3.5 TLS and MMR are not upregulated in uveal melanoma cell lines 
No change was observed in the cell survival of uveal melanoma cell lines as assayed by 
apoptosis levels (Appendix 4, Hoh, 2007, unpublished data) thus it is possible that to 
overcome reduced endogenous HR repair, an alternative error-prone repair pathway 
such as NHEJ, TLS or MMR may be upregulated in uveal melanoma. The role ofNHEJ 
in uveal melanoma is part of a separate study in our laboratory and will not be discussed 
here. 
The ubiquitination ofPCNA is essential to TLS and is postulated to be the determining 
factor in polymerase switching (Hoege et aI., 2002). Here, the level of PCNA 
ubiquitination was used to determine the level of spontaneous TLS in uveal melanoma 
cell lines. There was no difference in spontaneous PCNA ubiquitination in 157d and 
196b cell lines compared to WM793 and MRC5VA control cell lines (Figure 3.5 a). 
Furthermore, UV is known to induce TLS, and thus it. was used here as a positive 
control. Again there was no difference in PCNA ubiquitination between the uveal 
melanoma cell lines and control cell lines suggesting that TLS activation is normal in 
uveal melanoma cell lines (Figure 3.5). 
Cells that utilise error-prone pathways are associated with high mutation rates due to the 
increased potential for errors· occurring during DNA·· repair. To· investigate the 
spontaneous mutation rates in uveal melanoma cell lines, fluctuation assays were carried 
out (Figure 3.5 b). This technique is used to determine the spontaneous mutation rate of 
the house-keeping gene HPRT and it is the rate at which this mutation occurs that is 
calculated using the fluctuation test of Luria and Delbruck (Luria and Delbruck, 1943). 
There was no difference in the· spontaneous mutation rate of the uveal melanoma cell 
lines 157d and 196b compared to WM793 and MRC5VA (Figure 3.5 b). The MMR 
deficient cell line, HCTl16, is shown as a positive control and has a much higher 
mutation rate than any of the cell lines studied here. We therefore concluded that 
although uveal melanoma cell lines exhibit a reduction in error-free HR, error-prone 
repair is not upregulated to overcome this defect. 
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~-ACTIN ~~""·~~B 
WM793 157d 196b HCT116 MRCSVA 
b) 
WM793 6.6 x 10-9 
157d 1.0 x 1Q-8 
196b 4.0 x 10-8 
HCT116- 1.5 x 10-5 
MRCSVA 2.8 x 1Q-8 
Figure 3.5 Error-prone pathways are not upregulated in uveal melanoma 
a) PCNA ubiquitination shown by western blot analysis in the uveal melanoma cell lines l57d 
and 196b, and in the WM793 and MRC5V A control cell line . Cells were either left untreated or 
treated with 40 JIM2 UV with 5 h recovery before extracts were made. Images are representative 
of at least three separate experiments and ~-ACTlN was u ed a a loading control where 30 !!g of 
protein was added. b) Spontaneous mutation rates in the uveal melanoma cell lines 157d and 
196b compared to the WM793 and MRC5VA control cell lines and the publi hed data for the 
HCTl16 cell line (Bhattacharyya et aI., 1994) indicated by ... u ing a fluctuation assay. Data 
represents the average mutation rates from two separate experiments calculated using the Luria 
Delbruck method (Luria and Delbruck, 1943). 
3.6 Uveal melanoma cell lines have reduced FANCD2 gene and protein 
expression 
Western blot analysis was carried out on a range of potential candidate DNA repair 
proteins that may be associated with the observed defect in endogenous repair and 
decreased level of spontaneous SCE in uveal melanoma cell lines (Figure 3.6). Proteins 
were selected for the screen based on their previous association with altered levels of 
SCE in different mammalian systems (Table 1. 3). Only differences that were common 
to both uveal melanoma cell lines were classed as being altered and therefore subject to 
further study. In addition, the human cancer cell line HCT116 showed a reduction in 
III 
Chapter 3 - Results 
protein expression of ATM, MLHl, MRE11 and P53, all of which have been previously 
reported (Brattain et al., 1981). P53 expression was also altered in WM793, however as 
MRC5V A and SW 480 exhibited similar levels to that observed for both uveal 
melanoma cell lines, we postulated that this was not associated with the defect in repair 
or low SCE frequency. 
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Figure 3.6 FANCD2 and LIGIV protein expres ion i reduced in uveal melanoma cell lines 
a) Western blot screen showing the expre sion of a wide range of DNA repair protein in the 
uveal melanoma cell lines 157d and 196b compared to the WM793, HCTl16, MRC5VA and 
SW480 control cell lines. b) F ANCD2 and LIGlV prot in expression in uveal melanoma cell 
lines compared to controls. Images are representative of at least three separate experiments. ~­
ACTIN is shown as a loading control where 30 Ilg of protein was loaded. 
112 
Chapter 3 - Results 
, 
From this screen, it is clear that uveal melanoma cell lines have reduced protein 
expression of the FA protein, FANCD2 (Figure 3.6 b). FANCD2 is an essential protein 
of the FA pathway and is postulated to promote HR during S-phase and in response to 
DNA damage (Howlett et al., 2005; Taniguchi et al., 2002). The reduced expression of 
F ANCD2 seen here is therefore consistent with the reduced levels of RAD51 foci 
formation (Figure 3.4). 
To confirm the reduction in F ANCD2 protein expression, endogenous F ANCD2 foci 
formation was investigated. The uveal melanoma cell lines 157d and 196b had a 
significantly lower percentage of cells with greater than 10 F ANCD2 foci/cell compared 
to the WM793 cell line (p = 0.008 and p = 0.002, for 157d and 196b respectively) 
(Figure 3.7 c), which is consistent with the reduced protein expression. Furthermore, to 
determine if the reduced F ANCD2 protein expression seen in the uveal melanoma cell 
lines was a cell line specific phenomenon, western blot analysis of FANCD2 protein 
expression was also carried out in primary uveal melanoma tumour samples. Each of the 
9 samples tested had been shown previously to have reduced levels of spontaneous SCE 
(Table 1.6) and in all cases there was a reduced expression of F ANCD2 compared to 
WM793, MRC5VA and HCT116 control cell lines (Figure 3.7 a). 
Finally, to identify whether this reduced F ANCD2 protein expression in uveal 
melanoma was due to a reduction in gene expression or a post-transcriptional 
modification, Real Time PCR was carried out to determine the amount of FANCD2 
mRNA in the uveal melanoma cell line, 157d compared to the WM793 melanoma 
control. As this technique detects the amplification of PCR products in 'real time', by 
comparing the accumulation of FANCD2 to a housekeeping gene (in this case p-
ACTIN), the differences in the amount ofmRNA and thus gene expression between two 
cell Hnes can be identified. Consistent with reduced protein expression, the uveal 
melanoma cell line, 157d showed a three-fold reduction in the level of FANCD2 gene 
expression compared to the WM793 melanoma control (Figure 3.7 b). 
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Figure 3.7 Confirmation of the reduced levels of FANCD2 gene and protein expression in 
uveal melanoma 
a) Western blot analysis for F ANCD2 protein expression in 9 primary uveal melanoma tumour 
samples using WM793, HCTl16 and MRC5VA as control cel11ines. ~-ACTIN is shown as a 
loading control where 30 Ilg of protein was loaded. b) Fold change in FANCD2 mRNA measured 
by Real-Time PCR in 157d and WM793 cell lines. The fold change in gene expression was 
calculated using the 2"':,.6CT equation (Livak and Schmittgen, 2001) and represents two separate 
experiments. c) Endogenous F ANCD2 foci formation visualised by flu ore cent microscopy in the 
uveal melanoma cell lines 157d and 196b, and in the WM793 and MRC5VA control cell lines. 
Cells were plated for 24 h before being fL'(ed and stained with an antibody specific to human 
F ANCD2 protein and a goat anti-mouse FITC antibody. On each occa ion at least 50 cells were 
analysed and the % of cells with > 10 F ANCD2 foci/cell was calculated. Data shown is 
representative of at least three separate experiments and error bars represent standard deviations. 
Statistical significance was calculated using the Student's T -test where p < 0.01 is indicated by 
** and brackets indicate significance between samples. d) Representative images of endogenous 
F ANCD2 foci formation (green) for each of the cell lines studied, nuclei tained with DAPI 
(blue). 
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3.6.1 FANCD2 protein expression is altered following genome-wide 
demethylation 
Epigenetic events are important in understanding human cancer as it has been shown 
that aberrant methylation of the promoter regions of many tumour suppressor genes 
have been associated with transcriptional inactivation and thus tumour development 
(Baylin et al., 2001; Robertson, 2002). Gene promoters contain CG-rich regions called 
CpG islands which, under normal circumstances, are largely unmethylated, however 
aberrant methylation in these regions is known to have a profound effect on the 
expression of many eukaryotic genes (Bird, 1992). It was therefore of interest to study 
whether aberrant methylation was causing the reduced gene expression of F ANCD2 in 
uveal melanoma cell lines. To do this, cells were treated for 5 days with the DNA 
methyltransferase inhibitor, 5-azacytidine. 5-azacytidine is an analogue of cytidine and 
thus becomes incorporated into DNA at these sites. Due to its altered structure, DNA 
methyltransferase can no longer bind to this base and thus methyl groups cannot be 
covalently bound. Inhibition of this enzyme therefore causes genome-wide 
demethylation of the most common methylation site, 5-methylcytosine bases. Following 
treatffient, protein extracts were made and F ANCD2 protein expression was studied 
using western blot analysis. 
Treating uveal melanoma cell lines with 5-azacytidine caused a further decrease in 
FANCD2 protein expression (Figure 3.8 a) suggesting that methylation influences 
FANCD2 gene expression. In the WM793 melanoma control cell line, FANCD2 protein 
expression also decreased with the addition of 5-azacytidine whereas in the HCTl16 
cell line there was no effect and in the MRC5V A ce111ine, F ANCD2 protein expression 
was increased (Figure 3.8 b). 
In addition to F ANCD2 protein expression, spontaneous SCE was also investigated 
following' genome-wide demethylation usmg BrdU incorporation. Changes in 
methylation induced by demethylating agents such as 5-azacytidine have been 
previously shown to affect SCE formation (Perticone et al., 1987), and thus differential 
, . 
methylation patterns could be responsible for the decreased level of spontaneous SCE in 
uveal melanoma. Here, the differences between spontaneous SCE frequency were 
compared between non-treated and 5-azacytidine treated cells. There was no difference 
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in the SCE frequency in any of the cell lines studied (Figure 3.8 b). Differences in 
global methylation therefore do not affect the SCE frequency in WM793, 157d and 
196b cell lines and is unlikely to be the cause of the reduced SCE frequency in uveal 
melanoma cell lines. 
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Figure 3.8 FANCD2 protein expression is reduced further ill uveal melanoma cell lines 
following genome-wide demethylation 
a) Western blot analysis for FANCD2 protein expression in the uveal melanoma celllines 157d 
and 196b, and in the WM793, HCTl16 and MRC5VA control celllines following 5-azacytidine 
treatment. Cells were either left untreated or treated with 2.5 mM 5-azacytidine for 5 days before 
protein extracts were made. Images are representative of at least three separate experiments and 
~-ACTIN is shown as a loading control where 30 Ilg of protein was loaded. b) The average 
spontaneous SCE/cell in WM793, 157d and 196b that were either left untreated or treated with 
2.5 mM 5-azacytidine for 5 days, as determined using BrdU incorporation (Figure ] .6). Data 
represents the average from at least three experiments and the error bars represent the standard 
deviations. Statistical significance between non-treated and treated samples (as indicated by 
brackets) was calculated using the Student's T-test; no significance was obtained. 
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3.6.2 FANCD2 transcription may be altered by aberrant methylation at a 
putative E2F transcriptional binding site within the FANCD2 promoter 
To further investigate the methylation status of the F ANCD2 promoter, sodium 
bisulphite modification of genomic DNA and direct sequencing was used. Here, a 1 kb 
region immediately upstream from the mRNA start site of the F ANCD2 gene was 
analysed (Figure 3.9 a). This region contained one CpG island from 852 bp to 1074 bp 
(highlighted blue) and three putative E2F transcriptional binding sites (highlighted red) 
(Ho skins et al., 2008), two of which were located inside the CpG island and one found 
approximately 580 bp further upstream of the CpG island. Three sets of methylated 
primers were designed to amplify the whole of the 1 kb promoter region using the 
reference sequence from GenBank (accession number NG _ 007311). 
The FANCD2 promoter did not show any regions ofhypennethylation in any of the cell 
lines studied, however we did see an alteration in methylation in one of the putative E2F 
transcriptional binding sites previously identified (Hoskins et al., 2008). Here, it was 
found that the methylation status of the putative E2F transcriptional binding site 580 bp 
upstream of the CpG island was altered in uveal melanoma cell lines compared to 
MRC5VA and S\V480 control cell lines (Figure 3.9 b). The modified DNA sequence 
indicates that the cytosine at the binding site is unmethylated in the uveal melanoma cell 
lines whereas for MRC5V A and SW 480 cell lines this base is methylated. WM793 also 
showed an unmethylated transcriptional binding site similar to the uveal melanoma cell 
lines. 
118 
a) 
Chapter 3 - Results 
Prime r set 1 Forward 
CTGCAATGAAGTATGTGAGGAAGTTGCCTCCACCCTAGGAAGGGAAATGATAATTACAATTCCTTA 
CATGTCTAACAGCAGTGTTACAGATTGCAAAGCGCTTTGGTGCTTAGCATCTCAGCTAACCATTGG 
AACAGTAATTTGGTAGAATGCAGATTATCACACTCACTTGACTGGATGTTACAAATACTAAAAGCTA 
* 
TAAAGCACCAGGCACTCTTCCCAACGAAAGGGTGGGATGGGATAGTTCATAGGTAAACCCACCGA 
AAAGGATTAACAGCACCGTTTTTGTTTTTTGTTTTTAACACTCAATACGT I p rimer set 2 Forward 
CCTAGATCCTGTGCTAAGGGATTTACAGACATCATCTAATTTGATTCCCACCTGTCTATGAGGGAG 
GTACTGTTATTATCCCCATTTCACAGAGGACAAAAGTGAAACACAGAGGTAACGGGTAAGGTCACC 
TTGCCAGTGGGGGCGAGACGTGAACCTAGGCAAACTGACACAACGCCTGCACTTTCTTGTCCAAG 
GTCACGGCGGTGTGAGGTAGGCTGGGGAAGGGAGGGCGCTGACCTGTCAGATACTTGTTCCTGG 
GTGAGCTTCTTGTCGCTCTCCAGCAGGATGGACACGTAGTGGCGGATCATGTCTACGAAGAGTGA 
• Primer set 1 & 2 Reve rse b 
TAACG~TGGGTAGGACCACCCAGAGGCAGATGTTGGA TCAAGCAACAGTTCTGGCCCTGCCATC 
Prime r set 3 Forward • 
TTCACTGAAAGCTGGCTCCCAGCCGGTGATGGGCGAGCTTCTCTTCACCGGGGCGCAGTTGCTTC 
TCTCTGACGTCGCCTCTGGGCCTTCTCTCGCCCCTATGCCCGGCTAGCACAGAACTCTGCTGCAG 
b) 
Unmodified ref. seq 
Modified ref. seq 
WM793 
1S7d 
196b 
MRCSVA 
SW480 
Predicted E2F binding site 
I I 
CCCACCGAGGGTT GG CG CTAACCTARR GG 
TTTATT GAGGGTT GG TGATT AR TTT AAA GG 
TTTATT GAGGGTT OO TGATT AA TTT AAA OG 
TTT TT GAGGGTT OO TG TT AA TTT AAA GG 
TTTATT GRGGGTT GG TGATT AA TTT AAR GG 
TTT TCGAGGGTT GG CGATT AA ITT AAA GO 
TTTATCOAOGG TT OO CGATT AA TTT AAA GG 
Figure 3.9 A putative E2F transcriptional binding site in the F ANCD2 promoter is altered 
in uveal melanoma cell lines 
a) The methylation status of a 1 kb F ANCD2 promoter region in the uveal melanoma cell lines 
157d and 196b, and in the WM793 , MRC5VA and SW480 control cell lines. The sequence 
shown was obtained using GenBank (Accession number NG_007311) and indicated are the 
primer sets used, the three putative E2F transcriptional binding sites (red) (Hoskins et aI. , 2008) 
and the CpG island (blue). Region in b) is indicated by *. b) Genomic D A modified using 
sodium bisulphite. The sequence shown is a 30 bp region containing the putative E2F 
transcriptional binding site at 580 bp upstream of the CpG island. Sequences of the uveal 
melanoma cell lines 157d and 196b were compared to the control cell lines and the modified and 
unmodified reference sequence from GenBank. 
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3.7 Uveal melanoma cell lines have reduced LlGIV protein expression ' 
In Figure 3.6, we also demonstrated a reduced protein expression of LIGIY. As 
mentioned before, the role of NHEJ in uveal melanoma and spontaneous SCE is the 
subject of a different study however the finding that LIGIV is decreased suggests that 
the error-prone pathway NHEJ is not upregulated when HR is decreased. 
To confirm this result, and to screen for other potential candidate genes that may be 
altered in uveal melanoma cell lines, a RNase protection assay was used to study the 
cellular mRNA levels in a panel of uveal melanoma and control cell lines (Figure 3.10). 
This is a sensitive method used to detect and quantify multiple mRNA transcripts from a 
single RNA sample. A RNA probe complementary to multiple gene sequences of 
interest was first synthesised and then hybridised to the target RNA sample. The binding 
of the probe to the target RNA produces a double-stranded molecule of the gene of 
interest and thus, it· is not degraded following RNase treatment. The remaining 
probe/target fragments were then denatured on a TBE-urea polyacrylamide gel. The 
probe was radioactively labelled for visualisation where the intensity of the probe/target 
fragments is directly proportional to the quantity ofmRNA to the gene of interest in the 
original sample. 
Of the 18 DNA repair genes analysed, uveal melanoma cell lines had lower mRNA 
levels of LIGIV and NBSl compared to WM793, although other control cell lines also 
had less mRNA. This confirmed the reduced LIGIV protein result in uveal melanoma 
cell lines at the mRNA level (Figure 3.10) and although NBSl mRNA levels were 
reduced here, this was not seen at the protein level (Figure 3.6 and Figure 3.10) 
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Cell Une ATM I:WI-f'K Cell Une F.ANCG KUOO 
L32 G.APDH L32 GAAJH L.32 GAPOH L32 GAPOH 
WM7ro 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 WM7ro 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 
157d 0.7±0.1 0.8±0.1 1.1±0.3 1.2±0.6 157d 1.0±0.1 1,HO.3 1.1 ±0.1 1.3±0.4 
196b 1.0±0.3 0.8±0.0 1.0±0.0 0.9±0.3 196b 1.0±0.1 0.9±0.2 1.0±0.0 1.0±0.3 
HCT116 05±02 0.7±0.1 0.9±0.1 1.3±0.5 HCT116 0.7±0.1 1.2±0.4 0.7±0.1 1,2±0.4 
WRCBVA 0.7±0.3 0.8±0.3 0.8±0.2 1.3±0.7 WRCBVA 12±02 1.6± 0.4 1.1 ±0.1 1.3± 0.4 
SWif.>IJ 1.1 +0.7 1.2±0.5 1.0±0.2 1.3± 0.4 SWif.>IJ 1.4±0.4 1.6±0.0 1,2±0.0 1.4± 0.5 
Cell Une LIGASE IV NBS1 Cell Une KU70 XRCC2 
L32 GAAJH L32 GAPOH L32 GAPOH L32 GAPOH 
WM793 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 
157d i-0.6:1:V.l · -v.7±(J.1- 1--'0.6:1: 0:1- '- 0.7:1:0.1-
WM793 1.0±0.0 1.0±0.0 1.0±0.0 1.0± 0.0 
157d 1.0±0.3 1.2±0.6 0.8±0.1 0.9± 0.2 
196b 0.8±01 _O.L±0.1 0.HO,2 0.6±0.~_ 
HCT116 0.5 ± 02 0.8±0.0 0.5±0.2 0.8± 0.0 
196b 0.8±0.1 0.8± 0.3 0.8±0.2 0.7± 0.3 
HCTl16 0.7±0.1 1.H 0.4 0.5±0.1 0.9± 0,2 
WRC5VA 0.6±0.1 0.7±0.3 0.5±0.2 0.7±0.3 WRC5VA O,B ±0,3 1.4±0.7 0,7±0,1 0.9± 0.4 
SW480 0.8 ± 0.4 0.9±0.2 0.B±0.4 0.9± 0.2 SW480 1.0 ±0.1 1.1 ±0.4 1.HO.3 1.2±0.0 
calUne XRCC3 XRCC4 Cell Une WREll RAD50 
L32 G.APDH L32 GAAJH L32 GAPDH L32 GAPa-i 
WM793 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 WM7ro 1.0±0.0 1.0 ±0.0 1.0±0.0 1.0±0.0 
157d 0.9±0.1 1.0±0.2 O.B±O.l 0.9± 0.2 157d 1.1±0.3 1.0±0.5 1.4±0.7 1.3±1.0 
196b 1.0±02 0.9±0.2 1.0±0.2 1.0±0.1 196b 1.1±02 0,B±0.5 1,2±0.2 0.9±0.6 
HCT116 0.6:1:0.1 1.0±0.2 0.8± 0.2 1.3±0.2 HCTl16 0.B±02 0.6±0.3 0.9±0.1 0.6±0.3 
WRC5VA 0.9±0.1 1.1 ±0.4 0.7±0.2 1.0±0.4 WRC5VA l.4±OA 2.0± 1.2 1.1 ±OA 1.7±1 .1 
SW480 1.3±0.4 1.5±0.0 1.HO.6 1.3±0.2 SW480 1.0 ± O2 1.3±0.5 O.7±0.2 0.9±O.4 
calUne RAD51 RAD51B Cell Une RAD51C RAD51D 
L32 GAPDH L32 GAPQ-i L32 GAPDH L32 GAPa-i 
WM793 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 WM793 1.0±0.O 1.0±0.0 1.0±0.0 1.0±0.O 
157d 0.9±02 0.8± 0.4 1.2±0.2 1.1 ±0.4 157d 1.0±0.3 1.4± 0.9 1.0±0.2 0.9 ±0.4 
196b O.HO.l 0.5±0.3 1.0±0.1 0.7±0.3 196b 1.0±0.1 0,7±0.4 1.HO.l 0.8±0.3 
HCT116 0.9±0.1 0.6± 0.3 1.1 ±0.1 0.6±0.3 HCTl16 1.3±0.3 O.B± 0,1 lA±O.l 0.9±0.2 
WRC5VA 1.2±0.3 1.7± 1.0 1.3±0.4 0.7±0.2 WRC5VA 1.2±0.3 1.7±1 .0 1.2±0,3 1.7±O.8 
SW480 1.0±0.1 1.2±0.4 1.1 ±O.O 1.8±1.2 SW480 1.3±0.0 1.6±0.3 1.3±0.1 1.6 ±0.4 
Cell Une RAD52 RAai4 
L32 GAPDH L32 GAPQ-i 
WM7ro 1.0±0.0 1.0±0.0 1.0±0.0 1.0±0.0 
157d 1.5± 0.6 1.5±0.9 1.1±0.2 0.9±0.5 
196b 1.1±0.3 0.8±0.4 0.8±0.1 0.6±0.3 
HCT116 1.2±0.3 0,8±0.4 1.0±0.0 0.7±0.2 
WRCBVA 1.2±0.7 1.7±1 .6 0.9±0.3 1.4 ±0.9 
SWif.>IJ 0.9±0.5 1.2± 0.8 0.9±0.3 1.1 ±O.S 
Figure 3.10 The mRNA levels of a range of genes in uveal melanoma cell lines compared to 
WM793 and other human control cell lines 
The mRNA levels of 18 DNA repair genes in the uveal melanoma cell lines 157d and 196b, and 
in the WM793, HCTl 16, MRC5VA and SW480 control cell lines detennined by RNase 
protection assays. The quantity of rnRNA for each gene was fif t normalised to either L32 or 
GAPDH (housekeeping genes) and then calculated a the fo ld change in the amount of mRNA 
compared to WM793 for each cell line. Data shown is the average and standard deviations of at 
least two separate experiments. Differences in mRNA levels seen with both hou ekeeping genes 
are highlighted in grey compared to WM793. 
3.8 Discussion 
Both spontaneous SCE and F ANCD2 expreSSiOn can be altered by cell cycle 
progression, however we ruled out reduced proliferation as the cause of the reduced 
spontaneous SCE phenotype. Here, we have found that there is a defect in both 
spontaneous HR (as indicated by reduced RAD51 foci fonnation) and FANCD2 gene 
expression in uveal melanoma. We postulate that these events are linked to the low 
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spontaneous SCE phenotype. F ANCD2 is an essential protein of the FA pathway and 
forms nuclear foci with BRCA2, BRCAl and RAD51 both spontaneously and in 
response to DNA damage to promote HR repair (Taniguchi et al., 2002; Wang et al., 
2004). Endogenous RAD51 foci formation was found to be decreased even though 
overall protein expression was normal. This suggests that RAD51 recruitment and 
activation, and thus HR, is reduced in response to endogenous DNA damage. F ANCD2 
and RAD51 have been shown to interact during S-phase and furthermore FANCD2 
activation is required for the activation of RAD51 following DNA damage. Thus, it is 
likely that here the lack of F ANCD2 prevents the formation of RAD51 foci at sites of 
endogenous DNA damage. In FANCDIIBRCA2 deficient cells, spontaneous and 
induced RAD51 foci formation is reduced, consistent with the known essential role of 
BRCA2 in HR (Godthelp et al., 2002). Although we have not fully ruled out a lack of 
FANCDIIBRCA2 as a possible cause of reduced spontaneous HR, in uveal melanoma 
cell lines; we observed normal levels of induced RAD51 foci formation suggesting that 
these cells have the ability to induce HR when required, but lack a response to 
endogenous DNA damage. It is unlikely then that uveal melanoma cells are deficient in 
an essential protein of HR such as FANCDIIBRCA2. Further analysis of the expression 
ofFANCDlIBRCA2 in uveal melanoma is required to assess its full involvement if any, 
in the reduced endogenous HR observed here. As SCE is a known end product of HR 
and RAD51 foci formation is a marker of HR, we propose that the lack of F ANCD2 
protein expression is responsible for the reduced spontaneous SCE. This hypothesis will 
be tested in Chapter 4. 
Uveal melanoma cell lines were found to have normal cell cycle progression suggesting 
that activation of F ANCD2 still occurs at a level sufficient enough to allow normal 
replication or that an alternative repair pathway can take over, however as spontaneous 
mutation rates and TLS levels were normal and LIGIV was decreased, we cannot find 
any evidence for this. The increased level of endogenous DNA damage, as indicated by 
spontaneous yH2A.X foci formation, is consistent with a defect in the repair of 
endogenous DNA damage and is also consistent with the lack of upregulation of other 
types of repair. 
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The underlying cause of the reduced F ANCD2 gene expression remains to r be 
elucidated. Here, we have shown that methylation may have a role in its regulation as 
genome-wide demethylation affects FANCD2 protein expression. This was true of all 
cel1lines studied however different affects were observed in each case. While it is clear 
that methylation changes effect FANCD2 protein expression, it is possible that the 
F ANCD2 promoter may not be directly affected. Demethylation of genes encoding 
regulating proteins such as transcriptional binding factors may also cause the 
differences in protein expression. Furthermore, we cannot rule out point mutations in 
the FANCD2 gene that may limit transcript stability and thus the decrease in protein 
expression. 
The E2F transcriptional binding site upstream of the CpG island in the F ANCD2 
promoter region was found to be altered in uveal melanoma cell lines compared to 
MRC5VA and S\V480 cel1lines (although not from the WM793 melanoma control). 
While it is unlikely that a single methylation change can cause an affect on protein 
expression, the alteration of the sequence of this transcriptional binding site cannot be 
ruled out as a cause for the decreased FANCD2 expression in uveal melanoma. The 
recent finding that methylation events in the surrounding areas of CpG islands may be 
more important than alterations inside the islands (Irizarry et al., 2009) suggests that 
further investigation into the surrounding areas of the F ANCD2 promoter may provide 
additional insights into its regulation by methylation. 
We have postulated that the unmethylated state of the E2F transcriptional binding site 
within the FANCD2 promoter causes the decreased FANCD2 expression in uveal 
melanoma and thus the decreased spontaneous SCE frequency. We have also shown 
that genome-wide demethylation causes a further decrease in FANCD2 protein 
expression although this does not affect SCE frequency. In MRC5VA and SW480 
control cell lines, the E2F transcriptional binding site is normally methylated and thus 
expression of F ANCD2 is normal. However, upon demethylation FANCD2 protein 
expression is increased. This therefore contradicts our hypothesis that an unmethylated 
E2F transcriptional binding site causes a decrease in F ANCD2 expression, although this 
could be cell line or melanoma specific. Alternatively, it is possible that another gene 
unrelated to this single methylation change, upstream of FANCD2 and E2F 
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transcriptional binding, is suppressed in uveal melanoma whereas in MRCSV A, it is 
activated by the loss of methylation. As there is no change in SCE frequency following 
demethylation, this suggests that this is unrelated to SCE frequency whereas the direct 
methylation change on the E2F binding site may still be related. 
Finally, we cannot rule out cytogenetic causes for the reduced F ANCD2 expression. 
Monosomy of chromosome 3 is a common, non-random chromosomal alteration in 
uveal melanoma. F ANCD2 has been mapped to chromosome 3p2S.3 and thus the 
reduced level of F ANCD2 could be due to this chromosomal loss. Both the uveal 
melanoma cell lines studied here were originally established from tumours with 
monosomy of chromosome 3, however in culture they both gained a copy of this 
chromosome. It is therefore unlikely that the lack of FANCD2 is due to the entire loss of 
chromosome 3, however partial deletions can occur. Deletion-mapping studies have 
identified 3p2S as a region that is preferentially lost (Parrella et al., 2003) and thus this 
could be a possible cause of the reduced FANCD2 protein expression in uveal 
melanoma. 
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4.1 \ Introduction 
To date, uveal melanoma is the only disease state to exhibit reduced levels of 
spontaneous SCE (Hoh, 2007 unpublished data). In Chapter 3, it was found that the 
uveal melanoma cell lines and primary tumour samples also have reduced protein 
expression of F ANCD2. As FANCD2 activation is required for normal cell cycle 
progression following exposure to MMC (Taniguchi et aI., 2002) and it is a protein that 
promotes HR (Garcia-Higuera et aI., 2001) it is a possible candidate for the reduced 
levels of spontaneous SCE in these cells. Furthermore, altered levels of both phenotypes 
have independently been associated with sporadic and hereditary cancer (Illeni et aI., 
1991; van der Groep et aI., 2008). 
Although a causal link has not been identified between F ANCD2 gene expression and 
SCE in humans, evidence suggests that there may be an association between the two. 
Firstly, it has been found that knocking out Fancd2 in chicken DT40 cell lines causes an 
increase in spontaneous SCE frequency (Yamamoto et aI., 2005). This is in contrast 
however to primary F ANCD2-1- patient cells that exhibit normal levels of spontaneous 
SCE but a reduced MMC-induced SCE frequency (Latt et aI., 1975). 
In Chapter 3, we postulated that the reduced F ANCD2 protein expression in uveal 
melanoma is associated with the reduced level of spontaneous SCE observed in these 
cells. In this chapter, using retroviral complementation, an association if any, between 
the two will be investigated. As a control for this work, the F ANCD2-1- patient cell line, 
PD20 was also studied. The PD20 cell line is a F ANCD2 deficient immortalised 
fibroblast cell line, derived from a FA patient and exhibits the hallmark of FA patient 
cell lines, i.e. a hypersensitivity to ICL-inducing agents (Timmers et aI., 2001). In 
addition, this cell line has been retrovirally complemented with FANCD2 to produce the 
functionally complemented cell line, PD20-D2 (Timmers et aI., 2001). In this Chapter, 
the same retrovirus and technique was used to complement the uveal melanoma cell 
line, 196b. The PD20 cell line has been used widely in the literature, it is therefore of 
interest to compare the effects of the decrease in, and complementation of, FANCD2 in 
uveal melanoma cell lines compared to the WM793 control melanoma cell line, the 
PD20 (absent F ANCD2) and PD20-D2 (retrovirally complemented FANCD2) cell line. 
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4.2 Generation of a uveal melanoma cell line complemented with 
pMMP-FANCD2 
Using retroviral complementation, the uveal melanoma cell line 196b was 
complemented with the retroviral pMMP-empty and pMMP-FANCD2 vectors to create 
the two stable cell lines, 196b pMMP-empty and 196b pMMP-FANCD2 (referred to as 
196b-pMMP and 196b-D2 from here in) (Figure 4.1). Retroviruses are used widely as 
an efficient method of stably complementing mammalian cells with new genetic 
material in vitro (Mulligan, 1993). Incorporating the vesicular stomatitis virus G (VSV-
G) proteins (continually expressed by packaging cell lines) into the retroviral vector, 
creates a retroviral pseudotype with enhanced efficiency of infection in human cells 
(Emi et al., 1991). Here, the retroviral vectors were first transfected into the human 
packaging cell line 293GPG. As the retroviral pseudotype becomes expressed into the 
supernatant, this was removed and added to the uveal melanoma cell line 196b in the 
presence of polybrene to enhance infection (Figure 2.5). Cultures were maintained in 3 
~lg/ml puromycin to select for cells containing the retroviral vector. 
A western blot was carried out to ensure the vectors had been incorporated into the cells 
and that FANCD2 protein expression had been restored. Figure 4.1 a) shows that 196b-
D2 cells were expressing F ANCD2 protein at a similar level to that of WM793 and 
other controls, whereas the expression of F ANCD2 remained low in the 196b and 196b-
pMMP cell lines. Also shown, is the F ANCD2 expression level in PD20 and PD20-D2 
cell lines. As reported in the literature, PD20 cells show no expression of FANCD2 
(Timmers et al., 2001), whereas the PD20-D2 cells, that are complemented using the 
same system as used here, show a similar level of F ANCD2 expression as in the 196b-
D2 cells and the other controls. 
To further confirm that the 196b-D2 and 196b-pMMP cell lines had been complemented 
with F ANCD2 and empty vector respectively, the level of endogenous FANCD2 foci 
formation in these cells was compared to 196b and WM793 (Figure 4.1 b and c). 
FANCD2 is monoubiquitinated by the FA core complex, allowing its localisation to 
chromatin foci where it interacts with other repair proteins such as BRCA2, BRCA 1 and 
RAD51 to promote DNA repair (Taniguchi et al., 2002; Wang et al., 2004). As this 
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activation is required for the normal cell cycle progression through S-phase, F ANCD2 
forms nuclear foci spontaneously (Taniguchi et al., 2002). Here, these foci were 
visualised using fluorescent microscopy with an antibody specific to the human 
F ANCD2 protein and a FITC conjugated goat anti-mouse secondary antibody. The 
nuclei were stained using DAPI to determine where the cells were located (Figure 4.1 b 
and c). 
The 196b-D2 cell line showed an average of30% of cells with greater than 10 FANCD2 
foci/cell. This is consistent with the percentage of cells with greater than 10 F ANCD2 
foci/cell observed in WM793 (25%), MRC5VA (20%) and U20S cell lines (26%) -
shown previously in Chapter 3, and consistent with published data for endogenous 
levels ofFANCD2 foci formation (Wang et al., 2004). It was also a significant increase 
from the levels observed in the parental 196b and 196b-pMMP cell lines (p = 0.004 and 
0.02 respectively). Endogenous F ANCD2 foci formation was not significantly different 
in 196b (11 %) and 196b-pMMP cell lines (16%) (Figure 4.1 b and c). The significant 
increase of FANCD2 foci formation in the 196b-D2 cell line from the levels in 196b 
suggests that endogenous F ANCD2 has been complemented in this uveal melanoma cell 
line. Together with the western blot analysis of FANCD2 protein expression, this data . 
supports the system of complementation used here as an accurate way of developing 
stable cell lines expressing pMMP-F ANCD2 and pMMP-empty vectors; in this case, to 
create the uveal melanoma cell line 196b-pMMP and 196b-D2 for use in subsequent 
studies. 
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Figure 4.1 Confirmation of the retroviral complementation of pMMP-empty and pMMP-
FANCD2 in the uveal melanoma cell line, 196b 
a) Western blot analysis for the FANCD2 protein expression in the 196b-pMMP and 196b-D2 
cell lines compared to the parental 196b cell line, PD20 and PD20-D2 cell lines, WM793 and 
other human control cell lines. ~-ACTIN is shown as a loading control where 30 Ilg of protein 
was loaded. b) Cells were fixed in 3% PFA and stained with anti-FANCD2 antibody and FITC 
goat anti-mouse antibody. On each occasion, more than 50 cells were analysed for each cell line 
and the % of cells with> 10 FANCD2 foci/cell was calculated. Data shown is the average of at 
least three experiments and error bars represent the standard deviations. Statistical significance 
was calculated using the Student's T-Test where p < 0.05 is indicated by * and p < 0.0 I is 
indicated by **. P-values were calculated between the samples as indicated by brackets, where 
no significance is indicated by ' S'. c) Representative images of endogenous FANCD2 foci 
formation (green) in all cell lines studied, nuclei stained with DAPI (blue). 
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4.3 Complementing a uveal melanoma cell line with FANCD2 
increases the spontaneous levels of SCE 
By using the complementation studies as described above, the association between 
FANCD2 protein expression and spontaneous SCE was investigated . Cells were grown 
for 72 h to ensure two rounds of replication in the presence of BrdU. As BrdU is an 
analogue of thymine, it is incorporated into the DNA during replication and allows the 
differentiation between two sister chromatids. The cells were fixed and stained using 
Hoescht 33 258 to determine regions of exchange (Figure 4.2). 
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Figure 4.2 Spontaneous SCE frequency is increased in a uveal melanoma cell line 
complemented with FANCD2 
a) Quantification of the spontaneous SCE levels in 1 96b-D2 compared to 196b, 1 96b-pMMP and 
WM793 cell lines. On each occasion, at least 30 cell were counted and the average SCE/cell 
represents three separate experiments. Error bars represent the standard deviations. Stati tical 
significance was calculated using the Student's T-te t where p < 0.01 i indicated by ...... and p < 
0.001 is indicated by .......... Significance between samples is indicated by brackets, where no 
significance is indicated by 'NS'. b) Representative image a typica l metaphase spread showing 
the number of SCE/cell in 196bD2 compared to, c) the 196b cell line using BrdU incorporation 
and Hoescht 33258 staining. Arrows indicate regions of SCE (Hoh, 2007, unpublished data) . 
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The 196b-D2 cell line was found to have a significant increase in spontaneous SCE/cell 
compared to the parental 196b and 196b-pMMP cell lines (p = 2x 10-4 and p = 0.004 
respectively) (Figure 4.2). Although the pMMP-empty caused a slight increase in the 
SCE frequency of 196b cells this was not significantly different from the parental 196b 
cell line. The average number of SCE/cell in 196b-D2 was 6.4 ± 0.24. This is consistent 
with the level of spontaneous SCE observed in MRC5VA (6.l), human primary 
fibroblasts (7.4) (Table 1.5) and also to similar levels observed in matched uveal 
melanoma patient blood samples (Table 1.6). WM793 has a higher average SCE/cell 
(10 .5) suggesting that the level of spontaneous SCE in the 196b-D2 cell line has been 
corrected to 'normal' levels, rather than to that expected for a melanoma phenotype. 
Primary FA patient cells are reported as having normal levels of spontaneous SCE. In 
contrast, data shown here suggests that reduced F ANCD2 protein expression may 
decrease SCE. To further investigate this apparent contradiction, the level of 
spontaneous SCE was examined in PD20 and PD20-D2 cell lines (Figure 4.3). 
3) 
25 
Q) 20 0 
W 
u 
C/) 15 
Q) 
Cl 
~ 
Q) 10 
> 
cl: 
5 
0 
vvtvV93 P020 P02O-D2 rvRC5VA 
Figure 4.3 Complementing the PD20 cell line with FANCD2 (PD20-D2 cell line) increase 
spontaneous SCE frequency 
Quantification of the spontaneous SCE level in PD20 and PD20-D2 cell line compared to 
MRC5V A and WM793 control cell line . On each occa ion, at lea t 30 cell were counted and 
the average SCE/cell represents three eparate experiment in the controls. PD20 and PD20-D2 
were only carried out once. Error bars represent the tandard deviation . 
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Consistent with the uveal melanoma cell lines, complementation of the PD20 cell line 
with F ANCD2 increased spontaneous SCE, supporting the hypothesis that F ANCD2 
plays a role in promoting spontaneous SCE frequency. Interestingly, compared with 
other cell lines tested here and published data (Table 1.5 and 1.6), the PD20 cell line did 
not have normal levels of SCE (Figure 4.3). This contradicts what has been reported for 
primary FA patient cells (Latt et al., 1975). 
4.4 RAD51 foci formation is increased in a uveal melanoma cell line 
complemented with FANCD2 
F ANCD2 forms nuclear foci with RAD51 during S-phase, thus promoting HR 
(Taniguchi et al., 2002). It was therefore of interest to investigate the spontaneous 
formation ofRAD51 foci in 196b-D2 compared to 196b and 196b-pMMP cel1lines by 
fluorescent microscopy. Cells were fixed and stained with an antibody specific to the 
human RAD51 protein and a CY3 goat anti rabbit secondary antibody. DAPI was used 
to stain the nuclei of the cells (Figure 4.4). 
Endogenous RAD51 foci formation was significantly increased in the uveal melanoma 
cell line complemented with F ANCD2 compared to the parental 196b cell line (p = , 
0.04) suggesting that HR increases in response to endogenous damage when FANCD2 
expression is restored (Figure 4.4). As SCE is an end product of HR, this result is 
consistent with the increase in spontaneous SCE observed in the 196b-D2 cell line, 
shown in Figure 4.2, and further suggests that the reduced FANCD2 expression is 
associated with the reduced SCE phenotype of uveal melanoma. This increase in 
endogenous RAD51 foci formation was corrected to the level observed in the control 
cell lines MRC5V A and U20S. However, it was still lower than that seen in WM793 
(Figure 4.4). 
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Figure 4.4 Endogenous RAD51 foci formation is increa ed in the uveal melanoma cell line 
196b complemented with F ANCD2 
a) Endogenous RAD5l foci formation in 196b-D2 compared to 196b-pMMP and 196b uveal 
melanoma cell lines, and WM793 , MRC5VA and U20S control cell lines. On each occasion, at 
least 50 cells were analysed and the % of cells with > 10 RAD51 foci/cell was calculated. Data 
shown is the average of at least three experiments and the error bars represent the standard 
deviations. Significance was calculated using the Student' s T-test and was calculated between 
samples as indicated by brackets where p < 0.05 is indicated by *. b) Representative images of 
endogenous RAD51 foci formation (red) in all cell lines studied, nuclei stained with DAPI (blue). 
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Of the cell lines tested in Chapter 3, the WM793 melanoma control cell line was found 
to have both the highest level of endogenous RAD51 foci formation and the highest 
spontaneous SCE frequency. Uveal melanoma cell lines had the lowest RAD51 foci 
formation and spontaneous SCE frequency while the other control cell lines, MRC5V A 
and U20S had intermediate levels of both (Table I.S and Figure 3.4). Complementation 
of the uveal melanoma cell line with FANCD2 increased spontaneous SCE frequency to 
the levels observed in the MRC5V A cell line (Table I.S and Figure 4.2). Thus, the 
similar level of increase in spontaneous RAD51 foci formation following FANCD2 
complementation in the uveal melanoma cell line~ to that observed in MRC5V A and 
U20S cell lines is consistent with the correlation seen in Chapter 3 and supports the 
hypothesis that SCE is a result of HR. 
Although FANCD2 is not essential to RAD51 foci formation (Ohashi et al., 200S), the 
data presented here supports the postulated involvement of F ANCD2 in promoting HR 
through its interactions with BRCA2, BRCAl and RADSl (Taniguchi et al., 2002; 
Wang et al., 2004). This also reflects published data where PD20 cell lines show 
defective formation of spontaneous RAD51 foci formation that is corrected in the 
PD20-D2 cell line (Wang et al., 2004). 
4.5 Complementing the uveal melanoma cell line, 196b with FANCD2 
reduces the level of endogenous DNA damage 
In Chapter 3, a significant increase in the amount of endogenous DNA damage was 
observed in the uveal melanoma cell lines compared to WM793 and MRCSV A control 
cell lines, as indicated by the increased levels of spontaneous yH2A.X foci formation 
(Figure 3.3). H2A.X is a member of the histone family and is phosphorylated upon DNA 
damage (Rogakou et al., 1998) and in response to replication stress (Ward and Chen, 
2001) forming distinct nuclear foci at sites of DNA damage. Spontaneously formed 
yH2A.X foci are representative of unrep~i~ed or aberrantly repaired spontaneous DNA 
damage. By studying the level of these foci in untreated cells, differences in the amount 
of endogenous DNA damage can be determined (Figure 4.S). 
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Figure 4.5 Complementing the uveal melanoma cell line 196b with FANCD2 decreases the 
level of endogenous yH2A.X foci formation 
a) Endogenous yH2A.X foci formation in 196b-D2 compared to I 96b-pMMP , 196b, WM793 and 
MRC5V A control cel\ lines. On each occasion, at least 50 cells were analysed and the % of cells 
with > 10 yH2A.X foci/cell was calculated. Data shown is representative of at least three separate 
experiments and the error bars represent the standard deviations. Significance was calculated 
using the Student' s T-test where p < 0.01 is indicated by ** . Significance between samples is 
indicated by brackets, where no significance is indicated by ' S'. b) Representative images of 
endogenous yH2A.X foci formation (red) in al\ cel\ lines studied, nuclei stained with DAPI 
(blue). 
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The increased amount of endogenous yH2A.X foci fonnation found in Chapter "3 is 
indicative of an increased level of endogenous DNA damage suggesting a defect in 
repair. Here, complementing the uveal melanoma cell line 196b with F ANCD2 
significantly decreased (p = 0.007) the level of endogenous yH2A.X foci formation 
(Figure 4.5) suggesting endogenous DNA damage is no longer left unrepaired. The 
empty vector control did not alter the level of yH2A.X foci formation (Figure 4.5). This 
is consistent with the restored HR activity seen in Section 4.4 .. 
4.6 Observation: Following long-term culture, uveal melanoma cell 
lines gain FANCD2 expression and exhibit increased levels of 
spontaneous SCE 
Further confinnation that there is an association between the lack of FANCD2 and 
reduced levels of spontaneous SCE in uveal melanoma came from an observation made 
whilst working with these cell lines. It was found that after the uveal melanoma cell 
lines 157d and 196b had been grown continuously for more than 20 - 30 passages, both 
cell lines started to express FANCD2 as determined by western blot analysis (Figure 4.6 
a). At th~ same time we observed a decrease in spontaneous yH2A.X foci formation, an 
increase in spontaneous RAD51 foci formation (data not shown) and interestingly, an 
increase in the level of spontaneous SCE frequency in these cells (Figure 4.6 b). 
The uveal melanoma cell line 157d at a passage between P98 ~ P120, consistently 
showed a low average SCE/cell, however once over P150, the number of SCE/cell 
significantly increased to a similar level to that found in WM793 (p = 3x 10-4). A 
similar observation was seen in 196b although at different passage numbers (p = 3.1x 
10.9) (Figure 4.6). Once this observation had been made, cells were checked every 10 
passages for an increase in F ANCD2 expression and an increase in SCE frequency. 
Once cells had 'reverted', new vials of these cell lines at a low passage were thawed and 
used for subsequent experiments. Experiments performed during the last 10 passages 
were ignored from data analysis. Studies are ongoing to identify the cause of this 
reversion that in turn may help understand the development of these genetic changes 
and turnourigenesis in uveal melanoma. 
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expression and an increase in spontaneous SCE 
a) Western blot analysis for the increa e in F ANCD2 protein expre ion in uveal melanoma cell 
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Quantification of the average number of SCE/cell showing the increa e in spontaneou CE in 
the uveal melanoma cell lines following continuou pa age. On each occa ion, at least 30 cells 
were counted and the average SCE/cell represents three eparate experiments. Error bar 
represent the standard deviations. Statistical significance was calculated u ing the Student' T-
test where p < 0.001 is indicated by ***. Significance between amples is indicated by brackets, 
where no significance is indicated by 'NS'. 
139 
Chapter 4 - Results 
4.7 Discussion 
Uveal melanoma cell lines have reduced expression of the FA protein, F ANCD2 and 
have a reduced spontaneous SCE frequency. In the FA patient derived cell line PD20, 
FANCD2 expression is absent due to a mutation in the FANCD2 gene that produces a 
severely truncated and non-ruD.ctional protein product (Timmers et al., 2001). Here, we 
have shown that the uveal melanoma cell line 196b can be successfully complemented 
with F ANCD2 using retroviral complementation confirmed by western blot analysis and 
spontaneous FANCD2 foci formation (Figure 4.1). Previously, PD20 cells have also 
been functionally complemented with F ANCD2 (PD20-D2) using the same technique 
(Timmers et al., 2001). We found that complementing the uveal melanoma cell line, 
196b or the PD20 cell line with F ANCD2 increased spontaneous SCE frequency, 
supporting an association between a loss of F ANCD2 expression and low SCE 
frequency in uveal melanoma. 
The most likely association between F ANCD2 expression and SCE frequency is 
through the HR mechanism. It has previously been shown that cells deficient in 
BRCA2IFANCDl have low RAD51 foci formation presumably as BRCA2IFANCDl is 
essential for HR (Godthelp et al., 2002). Although FANCD2 is not essential for HR, it 
has been shown to promote this pathway by promoting the chromatin loading of 
BRCA2IFANCDl (Wang et al., 2004). Consistent with this, here it was found that 
RAD51 foci formation is increased significantly in the 196b-D2 cell line compared to 
the parental 196b cell line and thus it is postulated that in uveal melanoma, increasing 
FANCD2 protein expression increases the response of HR to endogenous DNA damage 
and that this causes the increase in spontaneous SCE frequency. 
Complementing the 196b cell line with F ANCD2 also decreased the high level of 
spontaneous rH2A.X foci formation observed in the uveal melanoma cell lines. rH2A.X 
foci formation is a marker of DNA damage and thus, spontaneously formed rH2A.X 
foci are representative of unrepaired or aberrant repair of endogenous DNA damage. 
The reduction of rH2A.X foci formation therefore suggests that the defect in repair has 
been corrected by complementing the cells with F ANCD2, presumably by the 
promotion of HR. 
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Here, the association between F ANCD2 expression and SCE frequency has' been 
established, however further investigation using siRNA technology would provide 
additional evidence for a causal link between the two phenotypes. From the evidence 
discussed above, we would postulate that knocking down FANCD2 in the FANCD2 
complemented uveal melanoma cell line (196b-D2) would cause a reduction in 
spontaneous SCE to the phenotypically low level observed in these cells. As uveal 
melanoma is the only known disease state to exhibit reduced spontaneous SCE 
frequency, it would also be of interest to study the effect of knocking down FANCD2 
expression in other cancer cell types such as WM793 or HCTl16 to see if the same 
effect on SCE frequency is observed, or whether it is a phenomenon specific to uveal 
melanoma. 
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5.1 Introduction 
So far, this thesis has examined spontaneous SCE and its association with F ANCD2 
expression in uveal melanoma. However, SCE is better understood as a response to 
exogenous DNA damage, and has been extensively used as a mutagenic screen. 
Interestingly, FA patient cells are characterised by a hypersensitivity to DNA ICL-
;, \ . 
inducing agents such as MMC, such agents are potent inducers of SCE. In FA patient 
cells, less SCEs are induced by ICLs. Taken together this data suggests that the FA 
pathway functions in the repair of ICL-induced damage, which in turn results in SCE, 
most likely as an end product of HR repairing the damage. 
In mammalian cells the FA pathway is postulated to coordinate the NER, HR and TLS 
repair pathways to ensure the repair of ICL-induced . damage (Mirchandaniand 
D'Andrea, 2006). Indeed, the FA pathway been linked to all stages of ICL repair from 
the initial recognition of an ICL (Mosedale et al., 2005), to the promotion of HR in the 
repair of an ICL-generated DSB and in the bypass of the persisting ICL by TLS 
polymerases (Hinz et al., 2006; Mirchandani et al., 2008). As there is such strong 
evidence that SCEs are produced in response to DNA damage and that the FA proteins 
are particularly important in ICL repair leading to SCE, here the response of the uveal 
. . 
melanoma cell lines and F ANCD2 complemented uveal melanoma cell lines to different 
DNA damaging agents was examined. As in Chapter 4, an example of the FA patient 
phenotype, the FANCD2-1- patient cell line, PD20 and its FANCD2 complemented 
derivative (PD20-D2) has also been studied here. 
Given the extreme sensitivity of FA patient cells to ICL-induced damage, the response 
of the uveal melanoma cell lines to ICL-inducing agents was particularly important. The 
natural anti-tumour antibiotic MMC, a potent inducer of SCE, is widely used to induce 
DNA damage and thus was used here to study the uveal melanoma DNA damage 
response to ICL-inducing agents. In addition to defects in the DNA damage response, 
such as the decrease in FANCD2 expression shown here, cellular metabolism can also 
affect MMC resistance. MMC requires reductive activation by various cellular 
reductases (Iyer and Szybalski, 1963) such as cytochrome P450 reductase (CYP450R) 
and DT-Diaphorase (DTD) (also known as NQOl) before it can interact with DNA 
causing the highly toxic lesions. The CYP450R and DTD reductases therefore play a 
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major role in the anti-cancer activity of MMC, and thus chemo-resistance to ICL-
inducing agents as seen at the clinical level in uveal melanoma patients, could be the . 
result of a defect in cellular metabolism and not just a result of defects in the DNA 
repair machinery. 
5.2 Uveal melanoma cell lines have Increased resistance to thymidine 
(dT) and the ICL-inducing agents, MMC and cisplatin 
Although the FA pathway and thus F ANCD2 has an important role endogenously and in 
ICL-induced repair, it is also activated by other DNA damaging agents such as IR, UV, . 
camptothecin (CPT) and hydroxyurea (HU) (Howlett et aI., 2005) suggesting a role for 
F ANCD2 in the response to other types of damage besides ICL-inducing agents. To 
evaluate the effect that a lack of F ANCD2 expression has on the uveal melanoma . 
cellular survival following induced DNA damage, the cytotoxic response 'of the uveal 
melanoma cell lines 157d and 196b, to a wide range of DNA damaging agents was 
investigated (Table 5.1). 
Each of the DNA damaging agents used was chosen to induce different types of DNA 
lesions, repaired by the different DNA ·repair pathways. UV for example was used to 
highlight defects in the NER pathway whereas H202 was used to study BER. There was 
no difference in the survival of the uveal melanoma cell lines compared to controls to 
HU, UV irradiation, IR, CPT, MMS or H202 (Figure 5.1 a - f). The uveal melanoma 
cell lines did however, show increased survival at 8 mM dT compared to WM793, 
MRC5V A and U20S control cell lines (Figure 5.1 g). This was surprising as HR is 
required to overcome dT -induced replication stress and thus HR deficient cells have 
been shown to be sensitive to dT -induced damage (Lundin et al., 2002). In Chapter 3, 
uveal melanoma cell lines were also found to be deficient in endogenous HR as shown 
by reduced spontaneous RAD51 foci formation, thus this observed resistance may not 
be associated with the defect in repair studied here. 
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;,Cytotoxic agent Mechanism of action Dose 
:.Jt:.f \:x<~. +<. ~ , 
Camptothecin (CPT) Inhibits topoisomerase I 0 - 15 nM 
Fonns intra- and interstrand DNA 
Cisplatin (CIS) 
cross-links 
0 - 2)lM 
Hydrogen Peroxide (H202) Causes oxidative stress 0 - 10 mM (for 2 h) 
Hydroxyurea(fDU) Inhibits ribonucleotide reductase 0 - 0.6 mM 
Ionising radiation (IR) Causes double strand breaks 0 - 10 GY 
Methyl methanesulfonate Alkylating agent that Jeads to 
0-3 mM (for 30 min) 
(MMS) methylation damage 
Mitomycin C (MMC) 
Alkylating agent that forms inter-
0 - 200 nM 
strand DNA cross-links 
Thymidine (dT) Suppresses synthesis of dCTP O- SmM 
Ultraviolet irradiation (UV) Fonns intra-strand DNA cross-
0 - 100 JIM2 
I (254 mm) links 
L-
Table 5.1 The DNA damaging agents used for the sensitivity screen in uveal melanoma cell 
lines 
Each cytotoxic agent used has a different mechanism of action (as listed above) to induce the 
various DNA repair pathways. Doses shown are for the continuou exposure over a period of 15 
days, except for H20 2 and MMS where the agent wa added to the cells for the . tated period of 
time before being removed and replaced with fresh media. 
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Figure 5.1 Uveal melanoma cell lines are less sensitive to thymidine than WM793 and other 
control cell lines 
Toxicity assays for a range of DNA damaging agents in the uveal melanoma cell lines 157d and 
196b, WM793 in all cases, MRCSVA in e), f) and g), HCT116 in d) and f), U20S in d) and g), 
and fmally SW480 in e). Data shown is the average of at least three separate experiments. Error 
bars represent standard deviations and statistical significance was calculated using the Student's' 
T-test where p < 0.05 is indicated by·, p < 0.01 is indicated by·· and p < 0.001 is indicated by 
•••• 
3 
FA patient cells including the PD20 cell line used here are characterised by a 
hypersensitivity to DNA ICL-inducing agents. As the uveal melanoma cell lines also 
have a deficiency in the FA protein, F ANCD2, it was of particular interest to study the 
survival of these cells following exposure to leL-inducing agents. Figure 5.2 a) shows 
the survival of the uveal melanoma cell lines to MMC. At 200 nM MMC both uveal 
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melanoma cell lines have significantly greater survival with approximately 80 - 90% of 
cells surviving at this dose compared to all the other cell lines tested. The PD20 cell line 
was sensitive to MMC as reported in the literature and this was corrected when 
complemented with FANCD2 (Timmers et al., 2001) (Figure 5.2 b). It ~as postulated 
that the uveal melanoma cell lines would show a similar hypersensitivity to MMC as the 
PD20 cell line; the resistance observed here was therefore unexpected. The resistance is 
however, consistent with the chemo-resistant nature of uveal melanoma tumours (Albert 
et al., 1992). 
To further confirm this result and to ensure that it was not a cell line specific 
phenomenon, the survival of primary uveal melanoma tumour samples in the presence 
of MMC was studied (Figure 5.2 c). As these cells do not form colonies, the 
proliferation rates were compared using an MTT proliferation assay. Cells were grown . 
for 10 days in the presence of a range of MMC doses (0 - 50 nM) and the number of 
viable cells and thus the proliferation rate, was measured using spectrophotometry. The 
proliferation rate of the primary uveal tumour samples in MMC was significantly 
greater than in WM793 and SW480 control cell lines (for Mel533 p = 0.01 and p = 
0.005, for Mel534 p = 5x 10's and p = 4x 10,5, for Me1537 p = 5x 10,5 and p = 7x 10,6, 
and for Mel538 p = 0.007 and p = 0.001, for WM793 and SW480 respectively). This is 
consistent with the result obtained using the uveal melanoma cell lines and is consistent 
with the high chemo-resistance observed at the clinical level. 
To test whether this observed resistance was specific to MMC, the platinum-based ICL-
inducing compound cisplatin, a commonly used chemotherapeutic agent, was also 
studied. Uveal melanoma cell lines showed a similarly low level of sensitivity to 
. . . . 
cisplatin by surviving at higher doses than all other human cell lines tested (Figure 5.2 
d). This suggests that uveal melanoma cell lines are resistant to ICL-inducing agents. 
Due to the extensive use of MMC in FA studies, this agent was used for further 
experiments. 
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Figure 5.2 Uveal melanoma cell lines and primary uveal melanoma tumour samples are less 
sensitive to the ICL-inducing agents MMC and ci platin compared to control cell lines 
a) MMC toxicity assay for the uveal melanoma cell lines, 157d and 196b, in the WM793, 
HCTl16, MRC5VA, SW480 control cell line and primary human fibrobla ts. b) MMC toxicity 
assay for PD20 and PD20-D2 cell lines. c) The proliferation of the uveal melanoma primary 
tumour samples, the 157d uveal melanoma cell line, and the WM793 and W480 control cell 
lines at 50 nM MMC using an MTT assay. Absorbance (OD at 570 nm) at 50 nM MMC wa 
calculated relative to the absorbance with no treatment. d) Ci platin toxicity assay in the uveal 
melanoma cell lines, 157d and 196b, and in the WM793, HCTl16, MRC5VA, SW480 and U20S 
control cell lines. Data shown i the average of at lea t 3 experiment except for MEL524, 526 
and 530 (c) where only one repeat was pos ible. Error bar repre ent standard deviations and 
significance was calculated for survival at 50 nM MMC (a), 50 and 75 nM MMC (b) and 1 - 2 
IlM cisplatin (d). Significance for primary tumour ample and 157d were calculated compared to 
WM793 and SW480 control celllines. The Student' T-te t wa us d where p < 0.05 is indicated 
by *, p < 0.01 is indicated by ** and p < 0.001 i indicated by "'**. 
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5.3 FANCD2 is activated at a lower level in response to MMC 
treatment 
Both PD20 and uveal melanoma cell lines are deficient in F ANCD2, but whereas PD20 
cell lines are hypersensitive to MMC, here it has been shown that uveal melanoma cell 
lines are resistant. It was therefore of interest to study the expression and activation of 
F ANCD2 following ICL damage in these cells to understand the link, if any, between a 
decrease in F ANCD2 and MMC sensitivity. In response to ICL damage, the FA core 
complex is recruited to the site of damage where it monoubiquitinates F ANCD2 
allowing its formation of nuclear foci with other DNA repair proteins to promote HR. 
These foci were visualised by fluorescent microscopy following MMC treatment. Cells 
were treated with MMC for 1 h and then allowed to repair for 0, 4, 8, 24 and 48 h 
following exposure before fixing and staining. F ANCD2 foci formation was visualised 
using an antibody specific to the human F ANCD2 protein and a FITe conjugated goat 
anti-mouse antibody. The nuclei were stained using DAPI to determine where the cells 
were located (Figure 5.3). 
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Figure 5.3 FANCD2 is activated less in respon e to MMC induced damage in uveal 
melanoma cell lines compared to control cell line 
F ANCD2 foci fonnation visuali ed by fluorescent microscopy in the uveal melanoma cell lines, 
157d and 196b, and in the WM793 and MRC5VA control cell line (a and b). Cells were treated 
with MMC then allowed to repair for 0, 4, 8, 24 and 48 h, at which time the cells were fixed and 
stained. On each occasion, more than 50 cell were analy ed and the % of cell with > 10 
F ANCD2 foci/cell was calculated. Data hown i the average from at lea t 3 eparate 
experiments except for MRC5V A which wa only carried out once. Error bars repre ent the 
standard deviations and significance was calculated u ing the tudent' T-te t where p < 0.05 i 
indicated by *, p < 0.001 i indicated by ***. a) Significance wa calculated between WM793 
and 196b and for b) significance between ample is indicat d by bracket, where no ignificance 
is indicated by 'NS'. c) Western blot analy is howing the activation of FANCD2 following 
MMC and IR treatment in the uveal melanoma cell line , 157d and 196b, and in the WM793 and 
MRC5VA control cell lines. The monoubiquitinated fonn of F N D2 i hown a a hift from 
FANCD2S (155 kDa) to FANCD2L (166 kDa). Image is r pre entative of at lea t 3 separate 
experiments and ~-ACTTN is shown as a loading control where 30 flg of protein \i as added. d) 
Representative images of F ANCD2 foci fonnation (green) for each of the cell line tudied 
spontaneou ly and at 0, 8 and 48 h po t MMC treatment, nucl i tained with DAPT (blue). 
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In the WM793 and MRC5V A control cell lines, F ANCD2 foci fonnation was induced 
after 4 h of repair following exposure to MMC (Figure 5.3 a). FANCD2 foci fonnation 
reached a peak at 8 h with approximately 50% of cells containing greater than 10 
FANCD2 foci/cell. Following this, there is a small decrease in the percentage of cells 
with greater than 10 FANCD2 foci/cell at 24 h and by 48 h the percentage of cells with 
greater than 10 F ANCD2 foci/cell had returned to the levels seen at 0 h, i.e. 
immediately after MMC exposure (Figure 5.3 a and d) and those seen at endogenous 
levels (Figure 5.3 b and d). In both uveal melanoma cell lines, although the same 
, , 
response time for FANCD2 foci fonnation was observed as in the controls, the 
percentage of cells with greater than 10 FANCD2 foci/cell was significantly reduced at 
each of the time points rising from 10% of cells at 0 h post MMC treatment to only 20% 
of cells at 8 h post treatment (p = 0.009 and p = 0.01 at 0 h, and p = 0.02 and p = 0.01 at 
8 h for 157d and 196b, respectively) (Figure 5.3 a). Furthermore, there was no 
significant increase in the percentage of cells with greater than 10 F ANCD2 foci/cell at 
8 h post MMC treatment compared to those at 0 h and those seen endogenously (Figure 
5.3 b). This is in contrast to WM793 where a significant increase in the percentage of 
cells ~ith greater than 10 F ANCD2 foci/cell at 8 h compared to 0 hand endogenously 
was observed (p = 0.02 for both 0 h and endogenously). 
The activation of FANCD2 following MMC treatment was also tested using western 
blot analysis (Figure 5.3 c). In order for FANCD2 to fonn nuclear foci, it must first be 
monoubiquitinated by the FA core complex (Garcia-Higuera et al., 2001). This 
monoubiquitination was visualised as a shift on a SDS-polyacrylamide gel moving from 
the short FANCD2 isofonn (FANCD2S) at 155 kDa to the long isofonn (FANCD2L) at 
166 kDa. Using IR as a control, a clear shift from FANCD2S to FANCDL can be seen 
in the 157d uveal melanoma cell line, although at an overall lower expression level than 
in WM793 and MRC5VA cell lines (Figure 5.3 c). Following 24 h of MMC exposure, 
in 157d however, there is no increase in monoubiquitination from the untreated control 
although monoubiquitination can still clearly be seen in the control cell lines (Figure 5.3 
c). The expression ofFANCD2 in the 196b uveal melanoma cell line was too low to see 
any change at this exposure. The lack of FANCD2 activation as shown by a lack of 
monoubiquitination, suggests that at this dose ofMMC (100 ~M) there is no response to 
MMC-induced damage compared to that seen in WM793 and from that observed 
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following IR-induced damage. From this and the fluorescent microscopy experiments, it 
is clear that the uveal melanoma cell lines have the capacity to monoubiquitinate 
FANCD2 through the FA core complex and thus can still form FANCD2 foci in 
response to DNA damage. However, following MMC induced damage this activation of 
FANCD2 is at a much reduced level. As F ANCD2 activation is involved in the repair of 
ICL-induced damage this finding appears to contradict the resistance observed in uveal 
melanoma. 
5.4 HR is induced at a lower level in response to MMC treatment in 
uveal melanoma cell lines 
HR is one of the main pathways involved in the repair of ICL damage. Once the cross-
link has been excised, a DSB occurs at this site. This is then repaired by one-ended HR. 
It was therefore of interest to study the formation ofRAD51 foci, as a marker of HR, in 
response to ICL-induced DNA damage. RAD51 is an essential protein of the initial 
strand invasion step of HR and forms distinct nuclear foci upon DNA damage that can 
be visualised using fluorescent microscopy (Haaf et al., 1995). Cells were treated for 1 h 
with MMC and then allowed to repair for 0, 4, 8, 24 and 48 h before being fixed and 
stained. The nuclei of the cells were stained with DAPI so that the cells could be located 
(Figure 5.4). 
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Figure 5.4 The induction of RAD51 foci formation following MMC treatment i reduced in 
uveal melanoma cell lines 
RAD5t foci formation following MMC treatment visuali ed by fluorescent micro copy in the 
uveal melanoma cell line, t57d and 196b, and in the WM793 melanoma control cell line. a) ell 
were treated with MMC then allowed to repair for the indicated times. 0 h repre ent cell that 
were immediately fixed following treatment. b) The induction of RAD51 foci formation after 24 
h of repair compared to those at 0 h and endogenous levels. c) Induction of RAD51 foci 
formation in different cell lines. Data shown i the % cell with > 10 RAD51 foci/cell minu the 
background level ofRAD51 foci formation (pontaneou levels). In all ca es on each occasion, at 
least 50 cells were analysed and the % of cell with > 10 RAD51 foci/cell wa calculated. Data 
shown represents the average of at least 3 experiments and error bar repre ent the tandard 
deviations. Significance was calculated using the Student's T-test where p < 0.05 i indicated by 
*, p < 0.01 is indicated by ** and p < 0.001 is indicated by ***. Significance between samples is 
indicated by brackets where no significance is indicated by 'NS'. d) Repre entative image of the 
RAD5t foci formation (red) for each ofthe cell lines tudied pontaneou Iyand at 0,8 and 48 h 
post MMC treatment, nuclei stained with DAPT (blue). 
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There is a significant difference in the level of RAD51 foci formation following MMC 
treatment in the uveal melanoma cell lines compared to WM793 at 0 to 24 h post 
treatment (Figure 5.4 a and c). Immediately following MMC exposure (0 h), 
approximately 20% of WM793 cells had greater than 10 RAD51 foci/cell. This 
increased to 35% at 4 h and was maintained until 24 h, decreasing to 16% 48 h post 
treatment. At each of the time points, uveal melanoma cells have significantly reduced 
RAD5l foci formation compared to WM793 (for 0 h p = 0.02 and p = 4x 10·\ for 4 hp 
= 0.02 and p = 0.006, for 8 hp = 0.01 and p = 0.007, and for 24 hp = 9x 10-4 and p = 
0.02, for 157d and 196b respectively) (Figure 5.4 a). However despite this, at 4 h post 
treatment a small but significant increase in RAD51 foci formation was observed in 
MMC treated uveal melanoma cell lines compared to untreated uveal melanoma cell 
lines (p = 0.003 and p = 4x 10-4 for 157d and 196b respectively) and was maintained 
until 24 h post treatment. Although there was a significant induction of RAD51 foci 
formation in 196b from 0 to 24 h (p = 1.8' xl0·s) (Figure 5.4 b), this was not observed in 
157d. Both cell lines however exhibit a significant induction of RAD51 foci formation 
,. , 
following MMC damage compared to endogenous levels (p = 0.003 and p = 0.004 for 
157d and 196b respectively) (Figure 5.4 b), consistent with that observed for WM793 (p 
= 6.6 xl0-6). To ensure that only the difference in induced foci formation was compared, 
the percentage of cells with greater than 10 spontaneous RAD51 foci/cell was 
subtracted from the percentage of cells with greater than 10 RAD51 foci/cell at 24 h 
following MMC exposure (Figure 5.4 c). Significantly less RAD51 foci formation was 
observed in the uveal melanoma cell lines compared to WM793 (p = 0.001 and p = 
0.004 for 157d and 196b respectively). This data suggests that uveal melanoma cell 
lines have the ability to form RAD51 foci in response to MMC damage and thus that 
HR can be activated following MMC exposure. The reduced level of RAD51 foci 
formation compared to the WM793 melanoma control cell line suggests that MMC does 
not induce the same level of response (HR) to this type of damage in uveal melanoma 
cell lines. This is consistent with the results obtained for F ANCD2 foci formation 
induced by MMC, but again contradicts the resistance to ICL-damage in uveal 
melanoma. 
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5.5 MMC induces less DNA damage in uveal melanoma cell lines 
compared to WM793 and MRC5VA control cell lines 
A decreased sensitivity to specific DNA damaging agents, suggests that cells have an 
increased ability to deal with this type of damage. Here however, uveal melanoma cell 
lines exhibit resistance to ICL-inducing agents but appear to have a reduced repair 
response to MMC-induced damage, as measured by a lack ofFANCD2 and RAD51 foci 
induction following MMC treatment, and a reduced induction of SCE following MMC 
treatment (Hoh, 2007, unpublished data). The reduced repair response to MMC could be 
due to limited expression of F ANCD2, leading to decreased HR. However, given the 
contradiction of this result with the resistance to MMC seen in uveal melanoma cell 
lines another possibility is that the MMC induces less damage due to defects in the 
metabolism of this compound. 
To investigate the effect that MMC treatment has on uveal melanoma cell lines, yH2A.X 
foci formation was studied using fluorescent microscopy. As yH2A.X is a marker of 
DNA damage (Rogakou et at., 1998), yH2A.X foci formation should be induced 
following MMC treatment. Cells were exposed to MMC for 1 h and then immediately 
fixed and stained for human yH2A.X. DAPI was used to stain the nuclei of the cells 
(Figure 5.5). 
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Figure 5.5 MMC causes a significantly lower amount of damage in uveal melanoma cell 
lines compared to WM793 
a) yH2A.X foci formation visualised by fluorescent microscopy in the uveal melanoma cell lines 
196b and 157d, and in the WM793 and MRC5V A control cell lines. On each occasion, at least 50 
cells were analysed and the % of cells with > 1 0 yH2A.X foci/cell was calculated. Cells were 
treated with MMC for 1 h and then allowed to repair for 4 h before being fixed and stained. 
Spontaneous data is also shown for comparison. Data represents the average from at least three 
separate experiments and error bars represent standard deviations. Significance was calculated 
using the Student 's T-Test where p < 0.05 is indicated by * and p < 0.001 is indicated by ***. 
The significance between samples is indicated by brackets. c) Representative images of yH2A.X 
foci formation (red) in all cell lines studied spontaneously and at 4 h post MMC treatment, nuclei 
stained with DAPI (blue). 
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As shown in Chapter 3, uveal melanoma cel1lines have a significantly increased amount 
of spontaneous yH2A.X foci formation indicative of an increase in endogenous levels of 
DNA damage. However here, in response to MMC-induced damage, yH2A.x foci 
formation is induced to a significantly lower level in these cells compared to WM793 (p 
= 0.03 and p = 0.02, for 157d and 196b respectively) (Figure 5.5). The percentage of 
cells with greater than 10 yH2AX foci/cell significantly increases to 60% at 4 h post-
treatment in WM793 control cell line compared to spontaneous levels (15%) (p = 2.5 
x I 0-5), whereas in both uveal melanoma cell lines there is no significant induction of 
yH2A.X foci formation at 4 h post treatment compared to endogenous levels. Taken 
with the reduced repair response, this suggests that less damage is induced. 
To further investigate the effect of MMC in uveal melanoma cell lines, cell cycle status 
was investigated using PI staining and F ACS analysis. Cells were treated continually for 
24 h with MMC. MMC causes G2 arrest and thus cells accumulate in G2 phase of the 
cell cycle, the percentage of cells in G2 can therefore be compared in treated and 
untreated populations (Figure 5.6). 
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Figure 5.6 MMC does not cause G2 arrest in uveal melanoma cell lines 
The % of ceJls in G2 as indicated by PI staining in the uveal melanoma cell lines, 157d and 196b 
and in the WM793 control cell line following either non-treated or continuou ly treated with 
MMC for 24 h. Data represents the average from at least two separate experiments and error bars 
represent standard deviations. Significance between non- and MMC treated samples for each cell 
line was calculated using the Student's T-test where p < 0.05 is indicated by *. 
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Figure 5.6 shows that there is no difference in the percentage of cells in 02 in treated or 
untreated uveal melanoma cell populations. This is in contrast to WM793 where there is 
a significant increase in the percentage of cells in 02 following MMC treatment (p = 
0.04). Both the induced yH2A.X foci formation and cell cycle data are consistent with 
both the resistance to ICL-inducing agents and the decreased repair response, and 
suggests that at the same dose, less damage is induced in uveal melanoma cell lines 
compared to control cell lines. 
5.6 MMC induces fewer DNA ICLs in uveal melanoma cell lines 
To confirm that MMC was causing a lower level of ICL damage in uveal melanoma cell 
lines, ICL formation was investigated. Once the cross-link has been recognised it is 
excised creating a SSB, that collapses the replication fork forming a DSB. As the uveal 
melanoma cell lines show a reduced induction of yH2A.X foci formation following 
MMC exposure, the formation of the initial ICL was investigated using a modified 
version of the comet assay technique. 
In WM793, there is a significant reduction in TM when pre-treated with MMC (p = 5x 
10-4), suggesting that cross-links were formed, preventing the IR-induced damaged 
DNA from migrating out of the nucleus (Figure 5.7 a). However, there is no significant 
difference in TM between uveal melanoma cell lines pre-treated with MMC and those 
treated with IR alone, suggesting that the IR-induced damaged DNA was still able to 
migrate out of the nucleus during electrophoresis even in the presence of MMC. This 
suggests that at the same dose of MMC, less ICLs are formed in uveal melanoma cell 
lines compared to control cell lines. To confirm this, the MMC-induced percentage 
decrease in TM was calculated for each cell line, uveal melanoma celllines were found 
to have a significantly reduced MMC-induced percentage decrease in TM compared to .. 
WM793 (p = 0.04 and p = 0.03 for l57d and 196b respectively) further suggesting that 
the formation ofICLs was decreased in uveal melanoma cell lines (Figure 5.7 b). 
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Figure 5.7 There is a lower level of DNA ICLs formed following MMC treatment in uveal 
melanoma cells 
ICL induction by MMC in the uveal melanoma cell line 157d and 196b, and in the WM793, 
HCTl16 and SW480 control cell lines using a modified version of the comet a say. a) Cells were 
either untreated, treated with IR (10 GY) only, or pre-treated with MMC (15 lAM) for 1 h before 
being treated with JR, to induce DNA damage in each cell line. The average TM wa calculat d 
using CometScore™ software where at lea t 50 cell were analysed on each occa ion. b) The 
MMC-induced % decrea e in TM was calculated for each cellline where the decrea e i directly 
proportional to the amount of ICLs formed. Data hown i the average from at lea t two 
experiments (except SW480, which wa only done once as an extra control) and error bar 
represent standard deviations. Significance was determined u ing tbe tudent' T-test where p < 
0.05 is indicated by * and p < 0.01 is indicated by ** and calculated a) between MMC pre-treated 
and IR alone samples (as indicated by bracket) and b) compared to WM793. c) Repr entative 
comet assay images for each of the treatments, for each cellline. Images were obtained u ing the 
full spectrum function of the CometScore™ computer oftware. ells were originally tained 
with SYBR Safe™ DNA gel stain. 
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5.7 CYP450R required for MMC metabolism is reduced in uveal 
melanoma cell lines, thus causing the observed resistance to MMC 
MMC is a potent inducer of ICLs however, its interaction with DNA can only occur 
following the reductive activation of MMC by various cellular reductases (Iyer and 
Szybalski, 1963) such as CYP450R and DTD (NQOl). As the formation of ICLs was 
significantly reduced in uveal melanoma cell lines, the protein expression of these two 
reductases was investigated using western blot analysis (Figure 5.9 a). 
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Figure 5.8 Uveal melanoma cell lines and primary tumour samples have a decrea ed 
expression of CYP450R 
a) Western blot analysis to show the expres ion levels of the two reducta es CYP450R and DTD 
(NQOl) in uveal melanoma cell lines compared to WM793 , HCT116, MRC5VA and W480 
control ceUlines. b) Western blot analysis to show the expression of CYP450R in primary uveal 
melanoma tumour samples compared to WM793 , HCTl16 and SW480 control cell line . Image 
are representative of at least three separate experiments. P-ACTIN is shown a a loading control 
where 30 Ilg of protein was loaded. 
It was found that there was a decreased expression of the reductase CYP450R in uveal 
melanoma cell lines compared to WM793, HCT1l6 and SW480 control cell line 
whereas NQ01 (DTD) expression was normal (Figure 5.8 a). This reduced expression 
was also confmned in primary uveal melanoma tumour samples (Figur 5.8 b). 
Interestingly, MRC5V A also showed a reduced expression of this protein that may 
account for its lower sensitivity to MMC observed in Figure 5.2. 
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To investigate the association of the decrease in expression of CYP45QR and MMC 
resistance, the bicistronic vector pEF-P450R-IRES-P (CYP45QR) containing the human 
CYP45QR cDNA sequence (Cowen et al., 2.0.03), or an empty vector control was 
transiently expressed in 196b and WM793 cell lines using Lipofectamine™ 2.0.0.0 
reagent. A toxicity assay for MMC was performed 24 h following complementation and 
a western blot was carried out to confirm the complementation of CYP45QR. 
Transiently complementing WM793 with the CYP45QR plasmid did not affect the 
sensitivity of these cells to MMC (Figure 5.9 a). In 196b however, transient 
complementation with CYP45QR significantly increased the sensitivity of these cells to 
MMC compared to non-complemented and empty vector controls (p = .0 . .02 and p = 
.0 . .0.08, respectively) (Figure 5.9 b). It is therefore likely that the resistance to MMC in 
uveal melanoma cell lines is caused by a defect in the ability of these cells to metabolise 
MMC rather than a defect in repair. 
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Figure 5.9 Transient complementation of CYP450R in uveal melanoma cell line increa e 
sensitivity to MMC 
a) MMC toxicity assay following the transient complementation of the CYP450R pia mid into 
WM793 control cell line using lipofectamine 2000. Western blot analysis confinn the 
complementation of CYF450R. b) MMC toxicity a say and corresponding we tern blot image 
following the transient complementation of the CYP450R pIa mid in the 196b uveal melanoma 
cell line. In each case the empty vector control is also shown. Data repre ent the average of at 
least three experiments and error bars show the standard deviations. Significance wa calculated 
at 20 nM MMC for WM793 and lOO nM MMC for 196b u ing the Student' T-te t where p < 
0.05 is indicated by * and no significance is indicated by 'NS'. 
5.8 The defect in FANCD2 in uveal melanoma is not associated with 
the resistance to MMC 
To confirm that the resistance to MMC is caused by a defect in metabolism rather than a 
defect in DNA repair, the cytotoxic response to MMC was studied in the 196b uv a1 
melanoma cell line retrovirally complemented with pMMP-empty (196b-pMMP) or 
pMMP-FANCDD2 (196b-D2). The sensitivity to MMC was unchanged in the 196b-D2 
cell line compared to 196b-pMMP and parental cell line 196b (Figure 5.10) and was 
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significantly less sensitive at 50 nM MMC compared to the WM793 control cell line (p 
= 0.003). In contrast, complementation of the PD20 cell line with F ANCD2 did 
decrease sensitivity to MMC (p = 0.04) (Figure 5.10). The resistance in all 196b cell 
lines was similar to PD20-D2, again suggesting that the FANCD2 defect in uveal 
melanoma cell lines is not responsible for the resistance to MMC in these cells . 
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Figure S.10 Complementing the uveal melanoma cell line, 196b with FANCDl does not 
alter the resistance to MMC 
MMC toxicity assay in the uveal melanoma cell lines 196b. 196b-pMMP and 196b-D2. and in 
the WM793, PD20, PD20-D2, MRC5VA and SW480 control cell lines. Cells were continually 
exposed to a dose of MMC ranging from 0 - 150 nM for 15 days before being' stained and 
counted for surviving colonies. Data shown is the average of at least two experiments and error 
bars represent standard deviations. Significance was calculated between PD20 and PD20-D2 at 
75 nM MMC and between 196b-D2 and WM793 cell lines at SO oM MMC. A Student's T-test 
was performed where p < 0.05 is indicated by· and p < 0.01 is indicated by··. 
To further confirm that the resistance to MMC in uveal melanoma cell lines was due to 
a defect in metabolism rather than caused by a defect in DNA repair, MMC-induced 
FANCD2, RAD51 and yH2A.X foci formation were studied in 196b~pMMP and 196b-
D2 cell lines. Cells were treated for 1 h withMMC and' then allo~~d to rep~ir up'to 48 h 
post treatment before being fixed and stained with the appropriate antibody. Foci 
formation was visualised using fluorescent microscopy where DAPI was used to stain 
the nuclei of the cells (Figure 5.11). 
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Figure 5.11 FANCD2, RADSl and 'YH2A.X foci formation was not induced to the ame 
degree by MMC in a FANCD2 complemented uveal melanoma cell line compared to 
WM793 control cell line 
FANCD2, RAD51 and yH2A.X foci fonnation induced by MMC vi uali ed by fluore c nt 
microscopy in 196b-pMMP and 196b-D2 cell line compared to 196b and WM793 control cell 
liens. On each oeca ion, at least 50 cells were analy ed and the % of cell with > 10 foc i/cell was 
calculated. a) and b) Cells were treated for 1 h with MMC and then al lowed to repair for 0, 4, 8, 
24 and 48 h, where 0 h repre ents immediate fixing. Significance was calculated for 196b-pMMP 
and 196b-D2 compared to WM793 at each of the time points. c) Cell were treated for 1 h with 
MMC and then left to repair for 4 h po t treatment. yH2A.X foci fomlation induced at 4 h wa 
compared to spontaneou levels for each cell line. Data shown i the average of at lea t three 
separate experiments and standard deviation are repre ented by error bars. ignificance wa 
calculated using the Student' T-test where p < 0.05 i indicated by"', p < 0.01 i indicated by * ... 
and p < 0.001 is indicated by ***. Bracket indicate the significance calculated between samp! 
where no significance is indicated by 'NS'. d) Representative images of F ANCD2 (gr en) and 
RAD51 foci fonnation (red) at 0, 8 and 48 h po t treatment, and yH2A.X foci fonnation (r d) 
spontaneously and at 4 h post treatment for 196b-pMMP and 196bD2 cell line , nuclei tained 
with DAPI (blue). 
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There was no increase in MMC-induced FANCD2 foci formation in 196b-D2 compared 
to 196b-pMMP and 196b cell lines, with both cell lines showing a significant reduction 
in foci formation compared to WM793 (at 24 h, p = 0.02 and p = 1.4 x10-s, for 196b-
D2 and 196b-pMMP respectively) (Figure 5.11 a). A similar result was obtained for 
RAD51 foci formation (at 24 h, p = 6.5 xlO-7 and p = 2.4 x10-s for 196b-D2 and 196b-
pMMP respectively) (Figure 5.11 b), suggesting that HR was not being induced by 
MMC in these cells irrespective ofFANCD2 expression. 
Unlike FANCD2 and RAD51 foci formation, complementation of the uveal melanoma 
cell line 196b with FANCD2 did result in a change in the response of cells to MMC. 
While the non-complemented 196b cellline did not appear to induce yH2A.X formation 
in response to MMC, MMC induced a significant increase in yH2A.X foci formation in 
the 196b-D2 cell line compared to that seen in untreated cells (p = 0.004) (Figure 5.11 
c). The complementation of these cells with FANCD2 has been shown to decrease the 
levels of endogenous yH2A.X foci formation to that observed in WM793 and MRC5V A 
control cell lines. The increase observed here, may therefore be a reflection of the other 
types of damage induced by MMC rather than by the formation of DNA ICLs. 
In Chapter 3, it was found that the reduced F ANCD2 protein expression in uveal 
melanoma cell lines was further reduced by the addition of 5-azacytidine, a potent 
inhibitor of DNA methyl transferase that induces genome-wide demethylation (Figure 
3.8). Furthermore, a transcriptional binding site on the FANCD2 promoter that was 
. ~ -
methylated in the control cell lines, MRC5V A and SW 480, was not methylated in uveal 
melanoma cell lines (Figure 3.9). This suggests that the decrease in FANCD2 protein 
expression may be controlled by the methylation status of this transcriptional binding 
site. To finally demonstrate that resistance was not related to FANCD2 protein 
expression level, cells were treated for 5 days with 5-azacytidine before MMC toxicity 
assays were performed. Cells were grown continually in the presence of MMC for 15 
days before the survival fraction was calculated (Figure 5.12). 
Inducing genome-wide demethylation in uveal melanoma cell lines did not affect 
resistance to MMC in these cells but interestingly neither did it have an effect on 
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WM793 and MRC5V A control cell lines (Figure 5.12). These results suggest that 5-
azacytidine treatment does not affect MMC resistance in any cell line, even though 
FANCD2 protein expression is affected in all cell lines studied. This further supports 
the finding that MMC resistance in uveal melanoma cells is due to a defect in CYP450R 
required for the metabolism of the compound rather than the lack of F ANCD2 
expression that is associated with the reduced SCE phenotype in these cells. 
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Figure 5.12 Genome-wide demethylation, which affects the protein expression of FANCDl 
in uveal melanoma cell lines, has no effect on the resistance to MMC 
MMC toxicity assays for the uveal melanoma cell lines, 157d and 196b, and forthe WM793 and 
MRC5V A control cell lines following either no treatment or treatment with 2.5 mM 5-
azacytidine for 5 consecutive days. Surviving colonies were counted after IS days and the 
survival fraction calculated. Data shown represents the average from at least three experiments 
and error bars represent standard deviations. 
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5.9 Discussion 
FA patient cells (including F ANCD2-1- patient cells) are characterised by normal levels 
of spontaneous SCE but a reduced induction of SCE by MMC; this is consistent with a 
defect in repair and their hypersensitivity to ICL-inducing agents. Complementation 
studies have shown that by complementing these cells with the missing FA protein 
hypersensitivity can be restored and thus, it is postulated that the FA pathway is 
essential to ICL repair. Here, it has been found that uveal melanoma cell lines are 
resistant to the ICL-inducing agents MMC and cisplatin. This resistance was not 
expected as the cell lines have a reduction in the expression of F ANCD2 protein 
however it is consistent with the clinical phenotype of uveal melanoma (Albert et al., 
1992). 
Repair is promoted by the FA pathway, complementing the uveal melanoma cell lines 
with F ANCD2 however, does not affect ICL resistance and it was subsequently found 
~ '. ' -< 
that the resistance to MMC was due to a reduced ability to form the initial cross-link 
between the strands of the DNA duplex (Figure 5.7). The potential effect of reduced 
expression of F ANCD2 can therefore not be seen in the cellular response of uveal 
melanoma to MMC. Here, we have provided evidence to suggest that the resistance to 
ICL-inducing agents in uveal melanoma is not due to a defect in repair. 
One difference between uveal melanoma cell lines and F A-D2 patient cells (PD20 cell 
line) is that PD20 cells have a mutation in the FANCD2 gene that results in a severely 
truncated and non-functional FANCD2 protein whereas here, we postulate that the uveal 
melanoma cells have an intact FANCD2 gene, but a reduced level oftrMscription and 
'. . 
thus expression of functional F ANCD2; although it is of note that point mutations have 
not been studied here. This suggests that although uveal melanoma cell lines have a 
, 1 '. . ~ " 1 
reduced level ofFANCD2 they may still have the ability to perform ICL repair, whereas 
FA patient cells cannot. This was confirmed by the ability of the uveal melanoma cell 
lines to form F ANCD2 foci following MMC treatment. Subsequently, it ha~ been fou~d 
, > • " • 
that in the uveal melanoma cell line 196b, a dose of250 nM MMC can induce a similar 
level ofyH2A.X foci formation to those seen in WM793 and MRCSVA cell lines at 90 
nM MMC (Figure S.13). This suggests that uveal melanoma cell lines are capable ~f 
ICL repair but at any given dose have a lower response to MMC-induced damage 
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compared to control cell lines, possibly due to a lower level of ICL induction. To 
investigate this hypothesis, studying the formation of ICLs in uveal melanoma cell line 
at higher doses ofMMC is required. 
Figure 5.13 High doses of MMC increases yH2A.X foci formation in the uveal melanoma 
cell lint' 196b to similar levels observed for WM793 and MRCSVA control 
MMC-induced yH2A.X foci formation in the uveal melanoma cell line, 196b compared to 
WM793 and MRC5V A control cell line . Cell were continually treated for 24 h with either no 
treatment, 90 nM MMC, 150 nM MMC or 250 mM MMC. Spontaneou yH2A.X foci formation 
is also shown for comparison. Data shown is representative of only one experiment except for 
spontaneous data which is the average from at least three separate experiments and error bar 
represent standard deviations. On each occasion, at least 50 cells were analy ed and the % of 
cells with > 10 yH2A.X foci/cell was calculated. 
MMC is an anti-tumour antibiotic that must first be reductively activated before it an 
bind to DNA causing the highly toxic lesions. The two major cellular reductase that act 
on this compound are CYP450R and DTD (NQOl). In uveal melanoma cell line, 
CYP450R expression was found to be decreased, consistent with the reduced J L 
formation and reduced induction of DNA damage by MMC in these cells. Subsequently, 
when complemented with CYP45 OR, the uveal melanoma cell line 196b gained 
sensitivity to the ICL-inducing agent. It is postulated that CYP450R and DTD act n 
MMC in competing pathways to produce different DNA le ions. Fa t reductive 
activation of MMC by CYP450R promotes the formation of leLs, DTD activation f 
MMC however, is slower and leads to the formation of the relatively nontoxic 
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metabolite 2, 7-diaminomitosene (2, 7-DAM) (Suresh Kumar et al., 1997). Here, Oilly 
CYP450R expression is reduced, it is therefore possible that the formation of 2, 7-DAM 
by DTD (NQ01) reductive activation may be upregulated in these cells. Furthermore, 
although reductive activation is not required for cisplatin to bind to DNA directly, 
interestingly, it has been shown that in cisplatin resistant human ovarian cancer cell 
lines, DTD activity is increased and cross-resistance to MMC is also observed 
(O'Dwyer et al., 1996). This may explain the general resistance to ICL-inducing agents 
in these cells rather than specifically to MMC, although further investigation is required. 
In this study for example, only the expression of these proteins was elucidated, it is 
possible that although DTD (NQOl) expression was normal in these cells, the protein 
may have increased enzymatic activity. Further investigation into the enzymatic activity 
of these reductases may provide additional insights into the chemo-resistance of these 
cell lines and aid in the future treatment of this disease. 
The resistance to dT (Figure 5.1) was also unexpected as uveal melanoma cell1ines 
were seen in Chapter 3 to be deficient in endogenous HR, and HR is required to 
overcome dT induced replication stress (Lundin et al., 2002). dT causes nucleotide pool 
imbalance and nucleotide metabolism has been shown to be altered in many cancers (De 
Korte et al., 1986) thus, perhaps the resistance to dT seen here is also unrelated to the 
defect in repair. Studying the effects of dT in PD20 and PD20-D2 cell lines may help to 
understand this additional resistance phenotype. 
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6.1 Introduction 
Using uveal melanoma cell lines as a model system for SCE fonnation, work presented 
here suggests that there is an association between F ANCD2 expression and spontaneous 
SCE. It was initially found that uveal melanoma cells have decreased levels of 
FANCD2, which upon complementation, corrected the reduced spontaneous SCE 
phenotype suggesting an association between the two. Furthennore, spontaneous HR 
levels were decreased supporting a role for HR in spontaneous SCE fonnation, which 
we postulate is due to the role of F ANCD2. In addition, the resistance to ICL-inducing 
agents in uveal melanoma was found to be due to a lack of the cellular reductase, 
CYP450R, rather than a defect in repair. 
6.2 Decreased FANCD2 is associated with decreased spontaneous 
SCE frequency in uveal melanoma 
SCE can either occur spontaneously during S-phase or be induced by a wide range of 
mutagenic chemicals. Spontaneous SCE are considered to be a result of nonnal 
replication or repair of endogenous DNA damage, whereas induced SCE are a result of 
the DNA damage response, pre~uInably as an end product of the DNA rep~ir p~thways 
_ • • f 
(Nagasawa et al., 1983). Here, only spontaneously occurring SCEs will be discussed. 
Published data on the association between . FA proteins and SCE is conflicting.' In 
Fancc-l- and Fancd2-1- chicken DT40 cell lines an increase in spontaneous SCE has been 
observed whereas in mammalian cell lines knocking out Fancg did not affect SCE 
fonnation (Niedzwiedz et al., 2004; Yamamoto et a~., 2005). In humans, primary FA 
patient cells have also been shown to have nonnallevels of spontaneous SCE (Latt et 
al., 1975). Here, the FA patient cellline~ PD20 (deficient in FANCD2) was found to 
have decreased spontaneous SCE compared to the PD20 complemented cell line (PD20-
D2). Despite PD20 cell lines being continually used to study F ANCD2 this decrease in 
SCE has not been reported previously. It suggests an association between FANCD2 and 
spontaneous SCE and is consistent with our data obtained for the uveal melanoma cell 
lines. However, whilst the spontaneous SCE frequency in the PD20 cell line was lower 
than its F ANCD2 complemented derivative,· the overall level of SCE was high 
compared to human primary fibroblasts and other human cancer cell lines. A possible 
reason for this is that upon ilnmortalisation, the cells have adapted in culture and now 
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exhibit high SCE whereas primary FA patient cells still retain 'normal' SCE levels. 
However, there is no evidence to support this. Most importantly, the F ANCD2 
complemented PD20 cell line showed a further increase in spontaneous SCE, consistent 
with the results observed in the FAN C02 complemented uveal melanoma cell line. 
The difference in spontaneous SCE levels between cell lines highlights the importance 
of using the correct control for this work. Although the WM793 melanoma cell line is 
derived from the same precursor cells as uveal melanoma and exhibit high spontaneous 
SCE, it is possible that normal melanocytes from the uveal tract have low SCE 
irrespective of melanoma. To ensure the observed phenotypes are not specific to cells of 
the eye, it would be of interest to study the SCE frequency and FANCD2 expression in 
normal uveal melanocytes. In addition, using SiRNA technology in other cell types 
would show whether the· association between F ANCD2 and SCE is a general phenotype 
or uveal melanoma specific. 
6.3 Decreased levels of endogenous HR may be associated with 
~ ~ 
decreased spontaneous SCE through the role of FANCD21n the repair 
of endogenous damage 
Since its discovery over 50 years ago, there have been numerous theories of SCE 
formation. The most renowned was postulated by Kato (1977) and stated that SCE is a 
recombinational event involving double-stranded exchange and thus occurs during S-
phase of ~he cell cycle. This double-strand exchange is now known as HR, and SCE is a 
known end-product of HR, particularly one-ended repair that is induced by persistent 
SSBs during replication (Saleh-Gohari et al., 2005). Furthermore, defects in DNA repair 
proteins associated with HR such as Rad51 in chicken DT40 cell lines, and Brca2 in 
mouse embryonic stem cells, have been found to decrease spontaneous SCE formation 
. . ' ~ , 
(Sonoda et al., 1999; Tutt et al., 2001) although this same decrease has not been 
observed in all biological systems studied (Kim et al., 2004). Here, we have found that 
reduced. spontaneous SCE in uveal melanoma can be correlated with decreased 
-' .". , 
F ANCD2. As we also observed a decrease in spontaneous RAD51 foci formation we 
postulate that this is likely to be a result of aberrant HR repair of endogenous DNA 
damage (Figure 6.1 ). 
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During replication, persistent SSBs are converted to DSBs collapsing replication forks 
as a result of normal endogenous DNA damage (Saleh-Gohari et al., 2005). These 
lesions are a substrate for HR and, as only one-end is free for repair, result in SCE. In 
uveal melanoma cell lines, spontaneously occurring HR was reduced (as shown by 
reduced spontaneous RAD51 foci formation) suggesting that the collapsed replication 
forks arising from persistent SSBs during S-phase are not being repaired. This is 
consistent with our observation of the high levels of spontaneously formed yH2A.X foci. 
Ho~ever, decreased repair and increased persistent damage are in contrast to cellular 
survival, which we do not see decreased in uveal melanoma. How uveal melanoma cells 
continue to survive will be discussed in Section 6.8. 
The monoubiquitination of F ANCD2 is highly regulated by the cell cycle and is 
required for normal cell cycle progression. During S-phase, monoubiquitinated 
FANCD2 colocalises with BRCAl and RAD51 to fonn distinct nuclear foci (Taniguchi 
et al., 2002). It has therefore been postulated that F ANCD2 has a role in promoting 
. endogenous HR repair of collapsed replication forks. Although the exact role of 
FANCD2 in promoting HR is not known, it has been shown that fancd2 depleted 
Xenopus extracts are unable to restart collapsed replication forks whereas replication 
restart following stalled forks is unaffected (Wang et al., 2008). This implies that 
F ANCD2 has a specific role in the HR repair of collapsed replication forks during 
replication. Recently, using electrophoretic motility shift assays, it has been shown that 
FANCD2 has 3' to 5' exonuclease activity (Pace et al., 2010). A speculative rol~' for 
F ANCD2 could therefore be in the resectioning of ssDNA ends at the collapsed 
replication fork to ensure repair by HR. As we have found that uveal melanoma cell 
lines have high levels of spontaneous yH2A.X foci fonnation, indicative of high levels 
of endogenous DNA damage, reduced spontaneous FANCD2 protein expression, and 
reduced spontaneous RAD51 foci formation, our data support a role for F ANCD2 in HR 
repair of collapsed replication forks during unperturbed replication and suggests that 
this F ANCD2 function is conserved in humans. Our data are also consistent with the 
idea that endogenous lesions are collapsed forks, the repair of which by HR promotes 
SCE (Figure 6.1). 
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Figure 6.1 Proposed model for the spontaneous SCE phenotype in uveal melanoma 
a) During replication collapsed forks are repaired by HR when persi tent SSBs are converted to 
DSBs, yH2A,X foci formation can be used as a marker of t.ltis endogenous damage a they 
accumulate at the site of the DNA damage and thus the collap ed replication forks. Upon ON 
damage, F ANCD2 forms foci with BRCA2, BRCAl and RAD51 to promote it binding to the 
resected ssDNA overhang of the collapsed fork, to promote the initiation of strand inva ion. 
Collapsed replication forks leave only one-end free for repair, thu only one Holliday junction 
forms that can be resolved in a single direction producing a SCE. b) A reduction in F ANC02 
causes an increase in collapsed replication forks and thus high levels of yH2A.X foci formation. 
Reduced F ANCD2 reduces the ability of RADSl to bind to ssDNA to initiate strand inva ion, 
thus reducing endogenous HR repair. The decrease in HR repair re ult in les spontaneou C 
formation thus causing the reduced spontaneous SCE phenotype in uveal melanoma, A decrea 
in repair may also result in further collapsed replication forks and tbu further increa ed levels of 
endogenous DNA damage. 
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6.4 Types of endogenous DNA damage in uveal melanoma 
We have postulated that the increased levels of spontaneous yH2A.X foci formation is a 
result of the defect in F ANCD2 and thus HR, in the repair of endogenous DNA damage. 
One of the major sources of endogenous damage arises from aerobic metabolic 
reactions within the cell. Such products include H202, O£ and HO·, collectively known 
as ROS. ROS are highly reactive and cause oxidative damage to DNA in the form of 
base modifications, protein-DNA cross-links and SSBs. It is these SSBs that persist and 
are converted to DSBs during replication and are repaired by HR. ROS damage can 
therefore cause collapsed replication forks and thus induce endogenous HR repair. 
Besides DNA, ROS can also attack proteins and lipids within the cell. Interestingly lipid 
peroxidation, resulting from oxidative stress, can induce the formation of endogenous 
ICLs. The FA pathway and thus F ANCD2 is postulated to have a role in the repair of 
induced-ICLs due to defects in this pathway leading to ICL hypersensitivity. In addition 
to induced-ICLs, it is possible that F ANCD2 is activated in response to endogenous ICL 
lesions. Although endogenous ICLs are rare, they are highly toxic to the cell as they 
form a covalent bond between the strands of the DNA duplex preventing unwinding and 
thus replication and transcription. Once the cross-link has been excised, a SSB is left 
that, upon continued replication is converted to a DSB collapsing the replication fork. 
FANCD2 is postulated to promote HR in response to these collapsed forks and thus as 
uveal melanoma cell lines are deficient in F ANCD2 and HR, endogenous ICLs may be 
the persisting lesion causing increased collapsed forks and thus increased endogenous 
DNA damage. As ICL-inducing agents are potent inducers of SCE, the lack of repair of 
endogenous ICLs may also account for the reduced spontaneous SCE frequency and 
further supports an association between F ANCD2 and SCE formation. 
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6.5 Postulated involvement of NHEJ in the repair of endogenous DNA 
, 
damage in uveal melanoma 
Repair of endogenous DNA damage is essential to ensure efficient replication and 
transcription, thus we cannot rule out the upregulation of other repair pathways~ 
particularly NHEJ, in the repair of endogenous DNA damage in uveal melanoma, which 
would prevent cell death. This would after all account for similar survival rates. 
DSBs are· substrates for both HR and NHEJ although the exact factors that govern the 
use of each pathway are not fully understood. NHEJ is thought to primarily repair two-
ended DSBs whereas HR repairs DSBs arising from collapsed forks during replication. 
Although two-ended DSBs are rare endogenous lesions, defective HR may force the cell 
, , ,., ' 
. . 
to use NHEJ to repair persistent DSBs and ensure cell survival. Consistent with this, 
mammalian cells deficient in HR are still capable of repairing two-ended DSBs (Wang 
et aI., 2001) and are able to survive. In addition, evidence for increased NHEJ in the 
absence of FANCD2 comes from FA patient cell lines (including the PD20 cell line) 
that are characterised by increased chromosomal aberrations and radial formations 
following MMC treatment, indicative of increased end-joining by NHEJ (Timmers et . 
aI., 2001). This increase in NHEJ presumably allows their survival. More recently, a 
role for the FA pathway in the suppression ofNHEJ rather than promoting HR has been 
postulated (Adamo et aI., 2010; Pace et al., 2010). Disruption of both FANCC and 
KU70 in human and chicken DT40 cells was found to suppress sensitivity to cross-
linking agents, reduce chromosomal breaks, and reverse the defective HR (Pace et aI., 
2010). As FANCC is required for FANCD2 activation, it was further postulated that the 
role of F ANCD2 was in the protection of the DNA ends against aberrant Ku70 binding 
at the break site. Consistent with this, in the PD20 cell line, DNA-PKcs foci were found 
to be increased compared to wild-type human foreskin fibroblasts following replication 
stress (Adamo et aI., 2010). This suggests that in the absence of the FA proteins 
including F ANCD2, there is no control ov~r· initial NHEJ factors such as KU70 and 
DNA-PKcs following DNA damage and thus NHEJ is upregulated and can carry out 
illegitimate repair causing the phenotypic traits of FA patient cells. 
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It is possible then, that in uveal melanoma, repair of endogenous DNA damage is 
carried out by NHEJ, sufficient to ensure survival but deficient enough to cause 
increased yH2A.X foci formation (Figure 6.2). However, although uveal melanoma are 
characterised by gross chromosomal changes such as monosomy of chromosome 3 and 
are prone to chromosomal microdeletions, the radial formations and chromosomal 
aberrations have not been observed suggesting that NHEJ is not upregulated in uveal 
melanoma (Figure 6.2). The exact function of NHEJ in uveal melanoma is still to be 
elucidated and is the subject of a separate study. 
a) In PD20 cells: 
~ FANCD2 - t Chromosomal Aberrations and Radial Formations 
b) In uveal melanoma cells: 
- t NHEJ - Survival 
Survival? 
,,/ 
'FANCD2 -, UGIV - No Radial Formations - NHEJ - decreased? 
t VH~.X Foci Formation? 
(Endogenous Damage) 
Figure 6.2 Proposed model of NHEJ in uveal melanoma compared to PD20 cell lines 
a) PD20 cells deficient in F ANCD2 are characterised by increased chromosomal aberrations and , 
radial formations suggesting that NHEJ is upregulated in these cells, presumably accounting for 
their survival. b) Uveal melanoma cells are also deficient in F ANCD2 but show few 
chromosomal aberrations and no radial formations. We have shown that these cells are also 
deficient in UGlY suggesting that NHEJ may be decreased. Alternatively, NHEJ may be 
sufficient to ensure survival but deficient enough to cause the increased levels of yH2A.X foci 
formation that are indicative of high levels of endogenous DNA damage. 
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The reduced expression of LIGIV in uveal melanoma is again consistent with no 
< 
upregulation of NHEJ (Figure 6.2). It is more likely that repair of endogenous DNA 
damage in general is suppressed. As uveal melanoma cell lines and the PD20 cell line 
both have reduced FANCD2 expression, it would be of interest to study LIGIV 
expression in these FA patient cells. Although there is no evidence that these two 
proteins interact, it is possible that their expression is governed by the same factors (e.g. 
methylation) and that LIGIY expression is reduced to inhibit error-prone repair by 
NHEJ in the absence of HR. Furthermore, perhaps LIGIV and thus NHEJ are down-
regulated in order for these cells to survive. In this case, it is possible that uveal 
melanoma cells are able to overcome cell cycle checkpoints and progress through the 
cell cycle without the need for endogenous repair (see Section 6.8). The role of aberrant 
methylation in this situation is discussed in Section 6.7 however, the role of point 
mutations effecting protein expression remains to be elucidated. 
6.6 Resistance to ICL-inducing agents in uveal melanoma is caused 
by a lack of CYP450R 
.\ The uveal melanoma cell lines were foun,d to be resistant to the ICL-inducing agents 
MMC and cisplatin, consistent with the high level of chemo-resistance observed at the 
clinical level. MMC is a bioreductive drug that must first be reduced to an active 
metabolite before it can bind to DNA and cause the ICL lesion. One of the main 
reductases involved in this metabolism is CYP45 OR. The formation of ICLs in uveal 
melanoma cell lines was reduced and it was subsequently found that this was due to the 
<'. • ' , 
reduced expression of CYP450R. Because of this, it is not possible to study the effect 
that a defect in F ANCD2 alone has on ICL repair and thus ICL-induced SCE; whether 
this defect is a consequence or a cause of the reduced CYP405R expression remains to 
be elucidated. 
The ability to restore MMC sensitivity in uveal melanoma has therapeutic potential. 
Chemotherapy is rarely used in the treatment of uveal melanoma due to their high . 
chemo-resistance and due to difficulties in the delivery of the drug to the tumour site 
(Albert et aI., 1992). Current treatments such as plaque radiotherapy and enucleation are 
successful in treating the primary tumour, however it is the metastatic disease to the 
liver that causes mortality in over 50% of patients (Virgili et aI., 2008). This is where 
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our finding may have the greatest potential. Using targeted-gene therapy, restoring t~e 
expression of CYP450R in these metastatic cells may increase the affinity of MMC to 
bind to DNA, thus increasing the formation of ICL lesions and the effectiveness of 
cross-linking chemotherapeutics in the treatment of this disease. 
Although we have shown here that there is reduced RAD51 foci formation consistent 
with reduced HR repair of endogenous DNA damage, the lack of CYP450R suggests 
that uveal melanoma cell lines may have increased levels of endogenous DNA damage 
as a result of high levels of ROS rather than a defect in repair. The balance between the 
production and degradation of ROS maintains cellular homeostasis and thus an 
i~bal~ce of metabolic enzymes can affect this dynamic: Such metabolic enzymes 
include the P450 enzymes that have been shown to be important for ROS production 
. . . . 
(Lewis and Pratt, 1998). Here,. as CYP450R was found to be defective in uveal 
melanoma, it is possible that this defect causes an imbalance in the redox state of the 
cell producing more ROS, and thus endogenous DNA damage, as indicated by increased 
rH2A.X foci formation (Figure 6.3). Interestingly, FA patient cells exhibit high levels of 
8-oxo-G modified bases, indicative of increased oxidative stress (Degan et al., 1995). 
Furthefmore, in mammalian cells Fancc was found to interact and regulate the function 
of CYP450R (Kruyt et al., 1998), accounting for the sensitivity of the cells to H202 and 
the observed hypersensitivity to the ICL-inducing agent, MMC. Complementing the 
uveal· melanoma cell line with F ANCD2 increased HR repair and reduced 
spontaneously formed rH2A.X foci, it is likely then that a defect in repair and a defect in 
the metabolism of normal cellular processes may both contribute to the high levels of 
endogenous damage. However, the exact relationship between the two and whether the 
lack of FANCD2 is related to the reduced expression of CYP450R remains to be 
elucidated. · 
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Figure 6.3 Proposed endogenous DNA damage response in uveal melanoma 
i 
Reduced expression of CYP450R may contribute to the high levels of endogenous DNA damage 
in uveal melanoma through the accumulation of ROS. 'In addition, the reduced F ANCD2 
. expression may contribute to an accumulation of endogenous unrepaired ICLs, and thus reduced 
spontaneous SCE. Whether there is an association between reduced F ANCD2 and reduced 
CYP450R remains to be elucidated. 
The high levels of endogenous DNA damage and the reduced activation of the DNA 
repair pathways in response to this" damage suggests that there is an abnormal 
equilibrium in uveal melanoma that allows these cells to proliferate and survive. As we 
observed a normal response to induced DNA damage, it is likely that the addition of 
such DNA damaging ag~nts upsets this balance ~d th~s a~tivates the repair pathways 
resulting in a normal response to various DNA damaging agents. It may also indicate 
two separate responses to endogenous and induced DNA damage in uveal melarloma, 
possibly through differences in the lesions formed from' endogenous or exogenous 
sources. Although we have postulated that the substrate for endogenous repair is similar 
to collap~ed replication forks, these endogenously occurring lesio~s may be different~ 
and thus are not recognised as damage and do not illicit a DNA'damage response. 
We have suggested that the DNA repair pathways HR and NHEJ are suppressed in 
response to endogenous DNA damage in uveal mel~oma and that this'accounts for the 
decrease in spontaneous SCE, however the response to induced DNA damage appears 
, , 
to be normal (with the exception of ICL-induced damage) compared to WM793 
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melanoma control and other human cancer cell lines. Two-ended DSBs can be induced 
by ionising radiation and are primarily repaired by NHEJ, although they are also 
possible substrates for HR. As we have shown defects in both these repair pathways it 
was expected that uveal melanoma cell lines would be sensitive to this type of damage. 
The normal response to two-ended DSBs therefore suggests that the induced repair of 
this damage bypasses the observed defects. One possible scenario is that two-ended 
repair by HR does not require F ANCD2 and thus two-ended DSBs can be repaired. This 
would be in contrast to FA patient cells however, that have been shown to be sensitive 
to IR (Nakanishi et aI., 2002). Furthermore, this would not account for the normal 
response of uveal melanoma cell lines to camptothecin. In Xenopus extracts, fancd2 has 
been shown to be important for replication restart following the collapse of replication 
forks induced by camptothecin (Wang et al., 2008). The normal response of uveal 
melanoma cell lines to this DNA damaging agent therefore contradicts the observed 
defect in HR although it is consistent with the idea that endogenous and induced lesions 
are different substrates of repair. 
6.7 Methylation events in uveal melanoma 
Epigenetic events that alter gene expression are important in the tumourigenesis of 
many sporadic cancers. In uveal melanoma, promoter methylation has been observed 
for RASSFJa,pJ6 andpRb all of which are known tumour suppressor genes and have 
been shown to have a role in the tumour development of other human cancers (Edmunds 
et aI., 2002; Maat et aI., 2007; van der Veld en et al., 2001). The methylation events that 
may affect DNA repair genes in uveal melanoma have not been studied. Here, we found 
that FANCD2 gene expression was reduced and we postulated that this was due to the 
aberrant methylation status of a putative E2F transcriptional binding site within the 
promoter region. Aberrant methylation of F ANCD2 in human cancers has not been 
previously reported although polymorphisms in the F ANCD2 gene have been associated 
with increased sporadic breast cancer risk (Barroso et aI., 2006). 
Transcriptional regulation of FA gene expression, including FANCD2 has been 
previously found to occur through the pRblE2F pathway. This pathway is involved in 
- -
G liS cell cycle progression and is governed by the interaction between cyclin D and the 
cyclin dependent kinases, CDK4 and CDK6. When activated by cyclin D, CDK4/6 
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phosphorylates pRb leading to the activation of E2F and the subsequent expression ~f 
genes that are essential for cell cycle progression through GIIS phase (Weinberg, 1995). 
As the pRblE2F pathway regulates the expression of FANCD2, this may explain the 
required activation of F ANCD2 for normal cell cycle progression. In uveal melanoma, 
loss of p16INK4a expression through promoter hypermethylation has been observed in 
approximately half of uveal melanoma cell lines (van der Velden et aI., 2001). p16INK4a 
controls cell cycle proliferation during G 1 by inhibiting the interaction between cyclin 
D and CDK4/6, thus inhibiting the phosphorylation of pRb and the subsequent 
activation of E2F (Serrano et aI., 1993). This may therefore also contribute to the 
reduced F ANCD2 expression observed here (Figure 6.4). In addition, inducing genome-
wide demethylation in uveal melanoma caused F ANCD2 protein expression to decrease 
further. The effect of demethylation on this regulatory pathway is unknown however, in 
conjunction with, or irrespective of the single methylation change observed here, 
changes in the methylation status of p16INK4a and the pRblE2F pathway provides a 
possible explanation for the further reduction in F ANCD2 protein expression seen 
following genome-wide demethylation and highlights the difficulties in studying single 
genes in complex cell systems. 
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Figure 6.4 Possible mechanisms of inhibition of FANCD2 expression in uveal melanoma 
a) G liS cell cycle progression is governed by p 16lNK4a that controls the interaction of cyclin D 
and CDK4/6. When activated by cyclin D, CDK4/6 phosphorylates pRb leading to the activation 
of E2F. E2F then binds to the E2F transcriptional binding site of FANCD2 causing the 
subsequent expression of FA NCD2 and normal cell cycle progression. b) Aberrant methylation at 
the E2F transcriptional binding site on FANCD2 may block binding and result in reduced 
F ANCD2 expression. In this situation the upstream components of the pRblE2F pathway are 
unaffected. c) Loss of expression of p 16lNK4• through hypermethylation may inhibit the activation 
of CDK4/6 thus no phosphorylation of pRb would take place. This may lead to no activation of 
E2F, no E2F binding of FANCD2 and thus reduced FANCD2 expression. Similarly, methylation 
changes in pRb may inhibit phosphorylation by CDK4/6 and thus reducing E2F activation 
leading to reduced FANCD2 expression. 
Finally, SCE frequency was not affected by genome-wide demethylation and thus the 
reduced spontaneous SCE in uveal melanoma is unlikely to be a result of aberrant 
methylation. Given that F ANCD2 protein expression was decreased further following 
demethylation and given that we have shown an interaction between F ANCD2 
expression and SCE frequency, the lack of an effect on SCE following demethylation is 
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contradictory. One possibility is that the residual levels of spontaneous SCE observed 
here reflect those induced by BrdU during visualisation, as BrdU itself is known to 
induce SCE. In this case a further decrease in F ANCD2 would not prevent BrdU 
induction of SCE, therefore SCE would not decrease further and thus no effect would be 
observed when subjected to genome-wide demethylation. Alternatively, demethylation 
of other genes could affect HR and thus SCE formation, again highlighting the 
difficulties in studying single gene changes. The effect that demethylation has on a gene 
depends upon the methylation status of that gene prior to the induced demethylation. 
Thus, genes that are usually suppressed through methylation may gain expression and 
thus compensate for the reduced expression of F ANCD2 and result in no change in SCE 
formation. Understanding the methylation changes in F ANCD2 and other genes 
involved in HR is essential to understanding the role of methylation in SCE formation. 
6.8 How do uveal melanoma cells survive? 
From this work, we have shown that uveal melanoma cells proliferate and survive in the 
presence of high levels of endogenous DNA damage. Defects in the major repair 
pathways involved in endogenous repair have also been identified, which may explain 
these high levels of damage. In patients, the s~ppression or redundancy of the 
endogenous DNA damage response may be beneficial to uveal melanoma cell survival 
and promoting tumourigenesis (Figure 6.5). One possible explanation for this is the loss 
of tumour suppressor genes such as p16INK4a and the pRblE2F pathway as described 
above, which would promote tumour growth. p16INK4a inhibits the phosphorylation of 
pRb, controlling the progressIon of the cell from G 1 into S phase and thus proliferation. 
A loss of p 16INK4a or a methylation change as seen in approximately 50% of uveal 
melanoma tumours (van der Velden et aI., 2001) would cause hyperphosphorylation of 
pRb and uncontrolled progression of the cell cycle and. proliferation even in the 
presence of endo~enous damage that would usually induce cell cycle arrest (Figw,e 6.5). 
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Figure 6.5 Proposed model for uveal melanoma survival 
It is proposed that endogenous DNA damage is repaired by defective HR and NHEJ repair 
pathways in uveal melanoma. The reduced F ANCD2 expression causes the decreased HR repair ' 
and the reduced spontaneous SCE phenotype of these cells. In addition, LIGlY protein 
expression is reduced suggesting that NHEJ is also suppressed, although its exact role remains to 
be elucidated. We propose that the reduced HR repair (and possibly the reduced NHEJ repair) of 
endogenous damage causes an increase in persistent endogenous DNA damage as indicated by 
the high levels of yH2A.X foci formation. As both repair pathways are suppressed, we propose 
that through the loss of expression or aberrant methylation of cell cycle regulators, uveal 
melanoma cells are able to bypass cell cycle checkpoints thus overcoming high levels of 
endogenous damage to promote tumourigenesis. 
Monosomy of chromosome 3 is a common event in uveal melanoma and has been 
associated with metastatic development (Prescher et al., 1996). Partial deletions of 
chromosome 3 are also common events and thus it is thought that tumour suppressor 
genes involved in the tumourigenesis of uveal melanoma are located here. Interestingly, 
the tumour suppressor genes Von Hippel-Lindau, FHIT and RASSF 1 a are all located on 
chromosome 3p, however only RASSFla located at 3p21.3, has been associated with the 
development of metastatic disease in uveal melanoma (Maat et al., 2007). As F ANCD2 
is located at 3p2S it is possible that the loss of such tumour suppressor genes may be 
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responsible for the reduced FANCD2, deficient endogenous repair and thus the redu~ed 
SCE phenotype. Likewise, a loss of F ANCD2 may affect tumour suppressor gene 
expression. Whether the reduced expression of FANCD2 and thus reduced SCE is a 
cause or consequence of tumour development remains to be elucidated. However, 
understanding the association between tumour suppressor genes located on chromosome 
3 and F ANCD2 may provide insights into the metastatic development and 
tumourigenesis of uveal melanoma. 
191 
" 
References 
References 
Abraham, J., B. Lemmers, M.P. Hande, M.E. Moynahan, C. Chahwan, A. Ciccia, J. 
Essers, K. Hanada, R. Chahwan, A.K. Khaw, P. McPherson, A. Shehabeldin, R. 
Laister, C. Arrowsmith, R. Kanaar, S.C. West, M. Jasin, and R. Hakem. 2003. 
Erne 1 is involved in DNA damage processing and maintenance of genomic 
stability in mammalian cells. Embo J. 22:6137-47. 
Adamo, A., S.J. Collis, C.A. Adelman, N. Silva, Z. Horejsi, J.D. Ward, E. Martinez-
Perez, S.J. Boulton, and A. La Volpe. 2010. Preventing nonhomologous end 
joining suppresses DNA repair defects of Fanconi anemia. Mol Cell. 39:25-35. 
Ahmad, A., A.R. Robinson, A. Duensing, E. van Drunen, H.B. Beverloo, D.B. 
Weisberg, P. Hasty, J.H. Hoeijmakers, and L.J. Niedernhofer. 2008. ERCC1-
XPF endonuclease facilitates DNA double-strand break repair. Mol Cell Bioi. 
28:5082-92. 
Akkari, Y.M., R.L. Bateman, C.A. Reifsteck, S.B. Olson, and M. Grompe. 2000. DNA 
replication is required To elicit cellular responses to psoralen-induced DNA 
interstrand cross-links. Mol Cell Bioi. 20:8283-9. 
Albert, D.M., A.S. Niffenegger, and J.K. Willson. 1992. Treatment of metastatic uveal 
melanoma: review and recommendations. Surv Ophthalmol. 36:429-38. 
Alpi, A.F., P.E. Pace, M.M. Babu, and KJ. PateI. 2008. Mechanistic insight into site-
restricted monoubiquitination of F ANCD2 by Ube2t, FAN CL, and F ANCI. Mol 
Cell. 32:767-77. 
Andreassen, P.R., A.D. D'Andrea, and T. Taniguchi. 2004. ATR couples FANCD2 
monoubiquitination to the DNA-damage response. Genes Dev. 18:1958-63. 
Aristei, C., F. Stracci, P. Guerrieri, P. Anselmo, R. Armellini, A. Rulli, F. Barberini, P. 
Latini, and A.R. Menghini. 2009. Frequency of sister chromatid exchanges and 
micronuclei monitored over time in patients with early-stage breast cancer: 
results of an observational study. Cancer Genet Cytogenet. 192:24-9. 
Amaudeau, C., C. Lundin, and T. Helleday. 2001. DNA double-strand breaks associated 
with replication forks are predominantly repaired by homologous recombination 
involving an exchange mechanism in mammalian cells. J Mol Bioi. 307:1235-
45. 
Asami, S., H. Manabe, J. Miyake, Y. Tsurudome, T. Hirano, R. Yamaguchi, H. Itoh, 
and H. Kasai. 1997. Cigarette smoking induces an increase in oxidative DNA 
damage, 8-hydroxydeoxyguanosine, in a central site of the human. lung. 
Carcinogenesis. 18:1763-6. 
192 
References 
Audebert, M., B. Salles, and P. Calsou. 2004. Involvement of poly(ADP-ribose) 
polymerase-l and XRCCIIDNA ligase III in an alternative route for DNA 
double-strand breaks rejoining. J Bioi Chem. 279:55117-26. 
Bailly, V., J. Lamb, P. Sung, S. Prakash, and L. Prakash. 1994. Specific complex 
formation between yeast RAD6 and RAD 18 proteins: a potential mechanism for 
targeting RAD6 ubiquitin-conjugating activity to DNA damage sites. Genes 
Dev.8:811-20. 
Bailly, V., S. Prakash, and L. Prakash. 1997. Domains required for dimerization of yeast 
Rad6 ubiquitin-conjugating enzyme and Rad18 DNA binding protein. Mol Cell 
BioI. 17:4536-43. 
Baltaci, V., F. Kayikcioglu, I. Alpas, H. Zeyneloglu, and A. Haberal. 2002. Sister 
chromatid exchange rate and alkaline comet assay scores in patients with 
ovarian cancer. GynecolOncol. 84:62-6. 
Barroso, E., R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas. 
2006. FANCD2 associated with sporadic breast cancer risk. Carcinogenesis. 
27:1930-7. ' 
Baumann, P., and S.C. West. 1998. Role of the human RAD51 protein in homologous 
recombination and double-stranded-break repair. Trends Biochem Sci. 23:247-
51. 
Baumann, R.P., W.F. Hodnick, H.A. Seow, M.F. Belcourt, S. Rockwell, D.H. Sherman, 
, and A.C. Sartorelli. 2001. Reversal of mitomycin C resistance by overexpression 
ofbioreductive enzymes in Chinese hamster ovary cells. Cancer Res. 61 :7770-6. 
Baylin, S.B., M. Esteller, M.R. Rountree, K.E. Bachman, K. Schuebel, and J.G. 
Herman. 2001. Aberrant patterns of DNA methylation, chromatin formation and 
gene expression in cancer. Hum Mol Genet. 10:687-92. 
Bender, M.A., H.G. Griggs, and J.S. Bedford. 1974. Recombinational DNA repair and 
sister chromatid exchanges. Mutat Res. 24: 117-23. 
Berardini, M., P.L. Foster, and E.L. Loechler. 1999. DNA polymerase II (polB) is 
involved in a new DNA repair pathway for DNA interstrand cross-links in 
Escherichia coli. J Bacterio!' 181 :2878-82. 
; " 
Bhagwat, N., A.L. Olsen, A.T. Wang, K. Hanada, P. Stuckert, R. Kanaar, A. D'Andrea, 
L.J. Niedernhofer, and P.J. McHugh. 2009. XPF-ERCCl participates in the 
fanconi anemia pathway of cross-link repair. Mol Cell BioI. 29:6427-37. 
Bhattacharyya, N.P., A. Skandalis, A. Ganesh, J. Groden, and M. Meuth. 1994. Mutator 
phenotypes in human colorectal carcinoma celllines. Proc Natl A cad Sci USA. 
91:6319-23. 
Bird, A. 1992. The essentials of DNA methylation. Cell. 70:5-8. 
193 
,:-" 
.. 
~, ; 
[ 
.. ~ 
:\ 
c, ; 
References 
Birnboim, H.C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening 
recombinant plasmid DNA. Nucleic Acids Res. 7:1513-23. . 
Bizanek, R., B.F. McOuinness, K. Nakanishi, and M. Tomasz. 1992. Isolation and 
structure of an intrastrand cross-link adduct of mitomycin C and DNA. 
Biochemistry. 31 :3084-91. 
Blackwell, LJ., D. Martik, K.P. Bjornson, E.S. Bjornson, and P. Modrich. 1998. 
Nucleotide-promoted release of hMutSalpha from heteroduplex DNA is 
consistent with an A TP-dependent translocation mechanism. J Bioi Chem . 
. 273:32055-62. 
Bogliolo, M., A. Lyakhovich, E. Callen, M. Castella, E. Cappelli, M.J. Ramirez, A. 
Creus, R. Marcos, R. Kalb, K. Neveling, D. Schindler, and J. Surralles. 2007. 
Histone H2AX and Fanconi anemia F ANCD2 function in the same pathway to 
maintain chromosome stability. Embo J. 26:1340-51. 
Brattain, M.O., W.D. Fine, F.M. Khaled, J. Thompson, and D.E. Brattain. 1981. 
Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 
41:1751-6. 
v 
Bridges, B.A., and S.O. Sedgwick. 1974: Effect of photoreactivation on the filling of 
gaps in deoxyribonucleic acid synthesized after exposure of Escherichia coli to 
ultraviolet light. J Bacteriol. 117:1077-81. 
Broomfield, S., T. Hryciw, and W. Xiao. 2001. DNA postreplication repair and 
mutagenesis in Saccharomyces cerevisiae. Mutat Res. 486:167-84. 
Cadet, J., T. Douki, D. Gasparutto, and J.L. Ravanat. 2003. Oxidative damage to DNA: 
formation, measurement and biochemical features. Mutat Res. 531 :5-23. 
Caggana, M., and K.T. Kelsey. 1991. Sister chromatid exchange frequency in Hodgkin's 
disease patients with elevated in vivo hprt mutant frequencies. Carcinogenesis. 
12:2141-5. 
Caldecott, K., and P. Jeggo. 1991. Cross-sensitivity of gamma-ray-sensitive hamster 
mutants to cross-linking agents. Mutat Res. 255:111-21. 
Caldecott, KW., S. Aoufouchi, P. Johnson, and S. Shall. 1996. XRCCl polypeptide 
interacts with DNA polymerase beta and possibly poly (ADP-ribose) 
polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro.· 
Nucleic Acids Res. 24:4387-94. . 
Calsou, P., P. Frit, O. Humbert, C. Muller, DJ. Chen, and B. Salles. 1999. The DNA-
dependent protein kinase catalytic activity regulates DNA end processing by 
means ofKu entry into DNA. J BioI Chem. 274:7848-56. 
Carney, J.P., R.S. Maser, H.: Olivares, E.M. Davis, M. Le Beau, J.R. Yates, 3rd, L. 
Hays, W.F. Morgan, and J.H. Petrini. 1998. The hMrelllhRadSO protein 
194 
References 
complex and Nijmegen breakage syndrome: linkage of double-strand break 
repair to the cellular DNA damage response. Cell. 93:477-86. ' 
Carrano, A.V., L.H. Thompson, P.A. Lindl, and J.L. Minkler. 1978. Sister chromatid 
exchange as an indicator of mutagenesis. Nature. 271 :551-3. 
Chaganti, R.S., S. Schonberg, and J. German. 1974. A manyfold increase in sister 
chromatid exchanges in Bloom's syndrome lymphocytes. Proc Natl Acad Sci U 
SA. 71:4508-12. 
Chen, P.L., C.F. Chen, Y. Chen, J. Xiao, Z.D. Sharp, and W.H. Lee. 1998. The BRC 
repeats in BRCA2 are critical for RAD51 binding and resistance to methyl 
methanesulfonate treatment. Proc Natl Acad Sci USA. 95:5287-92. 
Ciccia, A., A. Constantinou, and S.C. West. 2003. Identification and characterization of· 
the human mus81-eme1 endonuclease. J Bioi Chem. 278:25172-8. 
Ciccia, A., C. Ling, R. Coulthard, Z. Van, Y. Xue, A.R. Meetei, H. Laghmani el, H. 
Joenje, N. McDonald, J.P. de Winter, W. Wang, and S.C. West. 2007. 
Identification of F AAP24, a Fanconi anemia core complex protein that interacts 
with FANCM. Mol Cell. 25:331-43. 
Cole, R.S. 1973. Repair of DNA containing interstrand crosslinks in Escherichia coli: 
sequential excision and recombination. Proc Natl A cad Sci USA. 70: 1 064-8. 
Collins, N.B., J.B. Wilson, T. Bush, A. Thomashevski, K.J. Roberts, NJ. Jones, and 
G.M. Kupfer. 2009. ATR-dependent phosphorylation ofFANCA on serine 1449 
after DNA damage is important for FA pathway function. Blood. 113:2181-90. 
Cortes-Gutierrez, E.I., R.M. Cerda-Flores, and C.H. Leal-Garza. 2000. Sister chromatid 
exchanges in peripherallymphocytes from women with carcinoma of the uterine 
cervix. Cancer Genet Cytogenet. 122:121-3. 
Costantini, S., L. Woodbine, L. Andreoli, P.A. Jeggo, and A. Vindigni. 2007. 
Interaction of the Ku heterodimer with the DNA ligase IVIXrcc4 complex and 
its regulation by DNA-PK. DNA Repair (Amst). 6:712-22. 
Cowen, R.L., A.V. Patterson, B.A. Telfer, R.E. Airley, S. Hobbs, R.M. Phillips, M. 
, Jaffar, IJ. Stratford, and K.J. Williams. 2003. Viral delivery of P450 reductase 
recapitulates the ability of constitutive overexpression of reductase enzymes to 
potentiate the activity of mitomycin C in human breast cancer xenografts. Mol 
Cancer Ther. 2:901-9. 
Cross, N.A., A. Ganesh, M. Parpia, A.K. Murray, 1.0. Rennie, and K. Sisley. 2006. 
Multiple locations on chromosome 3 are the targets of specific deletions in uveal 
melanoma. Eye (Lond). 20:476-81. 
195 
References 
Cross, N.A., 1.0. Rennie, A.K. Murray, and K. Sisley. 2005. The identification of 
chromosome abnormalities associated with the invasive phenotype of uveal 
melanoma in vitro. Clin Exp Metastasis. 22:107-13. 
Cunningham, RP. 1997. DNA glycosylases. Mutat Res. 383:189-96. 
Davies, A.A., J.Y. Masson, M.J. McIlwraith, A.Z. Stasiak, A. Stasiak, A.R. 
Venkitaraman, and S.C. West. 2001. Role ofBRCA2 in control of the RAD51 
recombination and DNA repair protein. Mol Cell. 7:273-82. 
De Korte, D., W.A. Haverkort, D. Roos, H. Behrendt, and A.H. van Oennip. 1986. 
Imbalance in the ribonucleotide pools of lymphoid cells from· acute 
lymphoblastic leukemia patients. Leuk Res. 10:389-96. 
de Laat, W.L., E. Appeldoom, K. Sugasawa, E. Weterings, N.O. Jaspers, and J.H. 
Hoeijmakers. 1998. DNA-binding polarity of human replication protein A 
positions nucleases in nucleotide excision repair. Genes Dev. 12:2598-609 .. 
de Laat, W.L., N.G. Jaspers, and J.H. Hoeijmakers. 1999. Molecular mechanism of 
nucleotide excision repair. Genes Dev. 13:768-85. 
de Murcia, J.M., C. Niedergang, C. Trucco, M. Ricoul, B. Dutrillaux, M. Mark, FJ .. 
Oliver, M. Masson, A. Dierich, M. LeMeur, C. Walztinger, P. Chambon, and O. 
de Murcia. 1997. Requirement of poly(ADP-ribose) polymerase in recovery 
from DNA damage in mice and in cells. Proc Natl A cad Sci USA. 94:7303·7. 
De Silva, I.U., PJ. McHugh, P.H. Clingen, and J.A. Hartley. 2000. Defining the roles of 
nucleotide excision repair and recombination in the repair of DNA interstrand 
cross-links in mammalian cells. Mol Cell Bioi. 20:7980-90. 
Degan, P., S. Bonassi, M. De Caterina, L.O. Korkina, L. Pinto, F. Scopacasa, A. 
Zatterale, R Calzone, and G. Pagano.1995. In vivo accumulation of 8-hydroxy-
2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in 
Fanconi's anaemia families. Carcinogenesis. 16:735-41. 
Degrassi, F., R. De Salvia, C. Tanzarella, and F. Palitti. 1989. Induction of 
chromosomal aberrations and SCE by camptothecin, an inhibitor of mammalian 
topoisomerase I. Mutat Res. 211:125-30. 
Dillehay, L.E., D. Jacobson-Kram, and J.R. Williams. 1989. DNA topoisomerases and 
models of sister-chromatid exchange. Mutat Res. 215:15-23. 
Dominguez, I., N. Pastor, S. Mateos, and F. Cortes. 2001. Testing the SCE mechanism 
with non-poisoning topoisomerase 11 inhibitors. Mutat Res. 497:71-9. 
Dronkert, M.L., H.B. Beverloo, R.D. Johnson, J.H. Hoeijmakers, M. Jasin, and R. 
Kanaar. 2000. Mouse RAD54 affects DNA double-strand break repair and sister 
chromatid exchange. Mol Cell Bioi. 20:3147-56. 
196 
References 
Dnunmond, J.T., G.M. Li, M.J. Longley, and P. Modrich. 1995. Isolation ofan hMSH2-
p160 heterodimer that restores DNA mismatch repair to tumor cells. Science. 
268:1909-12 .. 
Edmunds, S.C., D.P. Kelsell, I.L. Hungerford, and I.A. Cree. 2002. Mutational analysis 
of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal 
melanoma. Invest Ophthalmol Vis Sci. 43 :2845-51. 
Ellis, N.A., J. Groden, T.Z. Ye, J. Straughen, D.J. Lennon, S. Ciocci, M. Proytcheva, 
and J. German. 1995. The Bloom's syndrome gene product is homologous to 
RecQ helicases. Cell. 83 :655-66. ; . 
Emi, N., T. Friedmann, and J.K. Yee. 1991. Pseudotype formation of murine leukemia 
virus with the G protein of vesicular stomatitis virus. J Virol. 65:1202-7. 
Evans, E., J.G. Moggs, J.R. Hwang, J.M. Egly, and R.D. Wood. 1997. Mechanism of 
open complex and dual incision formation by human nucleotide excision repair 
factors. Embo J. 16:6559-73. 
Fan, J., P.F. Wilson, H.K. Wong, S.S. Urbin, L.H. Thompson, and D.M. Wilson, 3rd . 
. 2007. XRCCl down-regulation hi human cells leads to DNA-damaging agent 
hypersensitivity, elevated sister chromatid exchange, and reduced survival of 
BRCA2 mutant cells. Environ Mol Mutagen. 48:491-500. 
Fichtinger-Schepman, A.M., J.L. van der Veer, I.H. den Hartog, P.H. Lohman, and I. 
Reedijk. 1985. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) 
with DNA: formation, identification, and quantitation. Biochemistry. 24:707-13. 
Fisher, L.A., M. Bessho, and T. Bessho. 2008. Processing of a psoralen DNA 
interstrand cross-link by XPF-ERCC1 complex in vitro. J Bioi Chem. 283:1275-
81. 
Fortini, P., E. Parlanti, O.M. Sidorkina, J. Laval, and E. Dogliotti. 1999. The type of 
DNA glycosylase determines the base excision repair pathway in mammalian 
cells. J Bioi Chem. 274:15230-6. 
Friedberg, T., M.A. Grassow, and F. Oesch. 1990. Selective detection of mRNA forms 
encoding the major phenobarbital inducible cytochromes P450 and other 
members of the P450IIB family by the RNAse A protection assay. Arch 
Biochem Biophys. 279:167-73. 
Fuller, L.F., and R.B. Painter. 1988. A Chinese hamster ovary cell line hypersensitive to 
ionizing radiation and deficient in repair replication. Mutat Res. 193:109-21. 
Gan, Y., Y. Mo, J.E. Kalns, J. Lu, K. Danenberg, P. Danenberg, M.G. Wientjes, and 
J.L. Au. 2001. Expression of DT-diaphorase and cytochrome P450 reductase 
correlates with mitomycin C activity in human bladder tumors. Clin Cancer Res. 
7:1313-9. 
197 
References 
Garcia-Higuera, I., T. Taniguchi, S. Ganesan, M.S. Meyn, C. Timmers, J. Hejna, M. 
Grompe, and A.D. D'Andrea. 2001. Interaction of the Fanconi anemia proteins 
and BRCAl in a common pathway. Mol Cell. 7:249-62. 
Genschel, J., and P. Modrich. 2003. Mechanism of 5'-directed excision in human 
mismatch repair. Mol Cell. 12:1077-86. 
Godthelp, B.C.~ F. Artwert, H. Joenje, and M.Z. Zdzienicka. 2002. Impaired DNA 
damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi 
anemia group D 1. Oncogene. 21 :5002-5. 
Godthelp, B.C., W.W. Wiegant, A. van Duijn-Goedhart, O.D. Scharer, P.P. van Buul, 
R. Kanaar, and M.Z. Zdzienicka. 2002. Mammalian Rad51 C contributes to DNA 
cross-link resistance, sister chromatid cohesion and genomic stability. Nucleic 
Acids Res. 30:2172-82. 
Goyanes, V., J.L. Fernandez, S. Pereira, A. Campos, E. Rodriguez, M. Gonzalez, M. 
Rodriguez, O. Espido, and M. Garcia. 1994. Frequency of sister chromatid 
exchanges in humans at 14-16 week foetal stage and at birth. Cytobios. 77:67-
72. . 
Gradia, S., D. Subramanian, T. Wilson, S. Acharya, A. Makhov, J. Griffith, and R. 
Fishel. 1999. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on 
mismatched DNA. Mol Cell. 3:255-61 .. 
Gragoudas, E.S., K.M. Egan, J.M. Seddon, RJ. Glynn, S.M. Walsh, S.M. Finn, J.E. 
Munzenrider, and M.D. Spar. 1991. Survival of patients with metastases from 
uveal melanoma. Ophthalmology. 98:383-9; discussion 390. 
Graham, F.L., J. Smiley, W.C. Russell, and R. Nairn. 1977. Characteristics of a human 
cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 
36:59-74. 
Grawunder, U., M. Wilm, X. Wu, P. Kulesza, T.E. Wilson, M. Mann, and M.R. Lieber. 
1997. Activity of DNA ligase IV stimulated by complex formation with XRCC4 . 
protein in mammalian cells. Nature. 388:492-5. 
Gu, L., Y. Hong, S. McCulloch, H. Watanabe, and G.M. Li. 1998. ATP-dependent 
interaction of human mismatch repair proteins and dual role of PCNA in 
mismatch repair. Nucleic Acids Res. 26: 1173-8. 
Gupta, R., S. Sharma, J.A. Sommers, Z. Jin, S.B. Cantor, and R.M. Brosh, Jr. 2005. 
Analysis of the DNA substrate specificity of the human BACH! helicase 
associated with breast cancer. J Bioi Chem. 280:25450-60. 
Gupta, R., S. Sharma, J.A. Sommers, M.K. Kenny, S.B. Cantor, and R.M. Brosh, Jr. 
2007. FANCJ (BACH1) helicase forms DNA damage inducible foci with 
replication protein A and interacts physically and functionally with the single-
stranded DNA-binding protein. Blood. 110:2390-8. 
198 
References 
Haaf, T., E.I. Golub, G. Reddy, C.M. Radding, and D.C. Ward. 1995. Nuclear foci of 
mammalian Rad51 recombination protein in somatic cells after DNA damage 
and its localization in synaptonemal complexes. Proc Natl Acad Sci USA. 
92:2298-302. 
Hanada, K., M. Budzowska, M. Modesti, A. Maas, C. Wyman, J. Essers, and R. Kanaar. 
2006. The structure-specific endonuclease Mus81-Emel promotes conversion of 
interstrand DNA crosslinks into double-strands breaks. Embo J. 25:4921-32 .. 
Hazra, T.K., T. lzumi, L. Maidt, R.A. Floyd, and S. Mitra. 1998. The presence of two 
distinct 8-oxoguanine repair enzymes' in human' cells: their potential 
complementary roles in preventing mutation. Nucleic Acids Res. 26:5116-22. 
Heid, C.A., L Stevens, KJ. Livak, and P.M. Williams. 1996. Real time quantitative 
peR. Genome Res. 6:986-94. 
Hell eday, T. 2003. Pathways for mitotic homologous recombination in mammalian 
cells. Mutat Res. 532:103-15. ' 
Hinz, J.M., P.B. Nham, E.P. Salazar, and L.H. Thompson. 2006. The Fanconi anemia 
pathway limits the severity of mutagenesis. DNA Repair (Amst). 5:875-84. 
Hobbs, M.V., W.O. Weigle, DJ. Noonan, B.E. Torbett, RJ. McEvilly, RJ. Koch, G.J. 
Cardenas, and D.N. Emst. 1993. Patterns of cytokine gene expression by CD4+ 
T cells from young and old mice. J Immunol. 150:3602-14. ' 
Hoege, C., B. Pfander, G.L. Moldovan, G. Pyrowolakis, and S. Jentsch. 2002. RAD6-
, dependent DNA repair is linked to modification of PCNA by ubiquitin and 
SUMO. Nature. 419:135-41. 
Hoeijmakers, lH.J. 2001. Genome maintenance mechanisms for preventing cancer. 
Nature. 411:366-374. 
Hoh, L. 2007. unpublished data. 
Hoskins, E.E., R.W. Gunawardena, K.B. Habash, T.M. Wise-Draper, M. Jansen, E.S. 
Knudsen, and S.I. Wells. 2008. Coordinate regulation of Fanconi anemia gene 
expression occurs through the RblE2F pathway. Oncogene. 27:4798-808. ' 
Houghtaling, S., C. Timmers, M. NoIl, MJ. Finegold, S.N. Jones, M.S. Meyn, and M. 
Grompe. 2003. Epithelial cancer in Fanconi anemia complementation group D2 
(Fancd2) knockout mice. Genes Dev. 17:2021-35. 
Howlett, N.G., J.A. Hamey, M.A. Rego, F.W.t. Kolling, and T.W. Glover. 2009. 
Functional interaction between the Fanconi Anemia D2 protein and proliferating 
cell nuclear antigen (PCNA) via a conserved putative PCNA interaction motif. J 
Bioi Chem. 284:28935-42. 
199 
References 
Howlett, N.G., T. Taniguchi, S.G. Durkin, A.D. D'Andrea, and T.W. Glover. 2005. The 
Fanconi anemia pathway is required for the DNA replication stress response arid 
for the regulation of common fragile site stability. Hum Mol Genet. 14:693-701. 
Hsu, M.Y., Elder, D. E., Herlyn, M. 1999. Melanoma: The Wistar Institute (WM) cell 
lines. Kluwer Academic Publishers, Great Britain. 259 - 274 pp. 
Hussain, S., I.B. Wilson, A.L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J.Y. 
Masson, R. Moses, S.C. West, J.P. de Winter, A. Ashworth, N.J. Jones, and C.G. 
Mathew. 2004. Direct interaction of FANCD2 with BRCA2 in DNA damage 
response pathways. Hum Mol Genet. 13:1241-8. 
Illeni, M.T., D. Rovini, C. Grassi, C. Lombardo, M. Placucci, P. Squicciarini, N. 
Cascinelli, and A. Ghidoni. 1991. Sister chromatid exchange analysis in familial 
groups of malignant melanoma patients. Cancer Genet Cytogenet. 53:237-46. 
lp, S.C., U. Rass, M.G. Blanco, H.R. Flynn, J.M. Skehel, and S.C. West. 2008. 
Identification of Holliday junction resolvases from humans and yeast. Nature. 
456:357-61. 
Irizarry, R.A., C. Ladd-Acosta, B. Wen, Z. Wu, C. Montano, P. Onyango, H. Cui, K. 
Gabo, M. Rongione, M. Webster, H. Ji, J .B. Potash, S. Sabunciyan, and A.P. 
Feinberg. 2009. The human colon cancer methylome shows similar hypo- and 
hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 
41:178-86. ' 
Ishiai, M., H. Kitao, A. Smogorzewska, J. Tomida, A. Kinomura, E. Uchida, A. Saberi, 
,E. Kinoshita, E. Kinoshita-Kikuta, T. Koike, S. Tashiro, S.J. Elledge, and M. 
Takata. 2008. F ANCI phosphorylation functions as a molecular switch to turn 
on the Fanconi anemia pathway. Nat Struct Mol Bioi. 15:1138-46. 
lshii, Y., and M.A. Bender. 1980. Effects of inhibitors of DNA synthesis on 
spontaneous and ultraviolet light-induced sister-chromatid exchanges in Chinese 
hamster cells. Mutat Res. 79:19-32. 
Iyer, V.N., and W. Szybalski. 1963. A Molecular Mechanism of Mitomycin Action: 
Linking of Complementary DNA Strands. Proc Natl A cad Sci USA. 50:355-62. 
Jachymczyk, W.J., R.C. von Borstel, M.R. Mowat, and P.J. Hastings. 1981. Repair of 
interstrand cross-links in DNA of Saccharomyces cerevisiae requires two 
systems for DNA repair: the RAD3 system and the RAD51 system. Mol Gen 
Genet. 182:196-205. 
Jacobs, lP., C.M. Jones, and I.P. BailIe. 1970. Characteristics of a human diploid cell 
designated MRC-5. Nature. 227:168-70. 
Jansen, lG., A. Tsaalbi-Shtylik, P. Langerak, F. Calleja, C.M. Meijers, H. Jacobs, and 
N. de Wind. 2005. The BRCT domain of mammalian Revl is involved in 
regulating DNA translesion synthesis. Nucleic Acids Res. 33:356-65. 
, 200 
References 
Jenner, TJ., C.M. deLara, P. O'Neill, and D.L. Stevens. 1993. Induction and rejoining 
of DNA double-strand breaks in V79-4 mammalian cells following gamma- and 
alpha-irradiation. Int J Radiat BioI. 64:265-73. 
Jung, E.O., E. Bohnert, and H. Boonen. 1986. Dysplastic nevus syndrome: ultraviolet 
hypennutability confinned in vitro by elevated sister chromatid exchanges. 
Dermatologica. 173:297-300. 
Kannouche, P.L., and A.R. Lehmann. 2004. Ubiquitination of PCNA and the 
polymerase switch in human cells. Cell Cycle. 3:1011-3. 
Karow, J.K., A. Constantinou, J.L. Li, S.C. West, and LD. Hickson. 2000. The Bloom's 
syndrome gene product promotes branch migration of holliday junctions. Proc 
Natl Acad Sci USA. 97:6504-8. 
Kato, H. 1973. Induction of sister chromatid exchanges by UV light and its inhibition 
by caffeine. Exp Cell Res. 82:383-90. 
Kato, H. 1974. Possible role of DNA synthesis in fonnation of sister chromatid 
exchanges. Nature. 252:739-41. 
Kato, H. 1977. Spontaneous and induced sister chromatid exchanges as revealed by the 
BUdR-Iabeling method. Int Rev Cytol. 49:55-97. 
Kato, H., and H.F. Stich. 1976. Sister chromatid exchanges in ageing and repair-
. deficient human fibroblasts. Nature. 260:447-8. 
Kee, Y., J.M. Kim, and A.D. D'Andrea. 2009. Regulated degradation ofFANCM in the 
Fanconi anemia pathway during mitosis. Genes Dev. 23:555-60. 
Kim, J.M., Y. Kee, A. Ourtan, and A.D. D'Andrea. 2008. Cell cycle-dependent 
chromatin loading of the Fanconi anemia core complex by FANCMIF AAP24. 
Blood. 111 :5215-22. 
Kim, M.K., S. Zitzmann, F. Westennann, K. Arnold, S. Brouwers, M. Schwab, and L. 
Savelyeva. 2004. Increased rates of spontaneous sister chromatid exchange in 
lymphocytes of BRCA2+/- carriers of familial breast cancer clusters.' Cancer 
Lett. 210:85-94. 
Knees-Matzen, S., M. Roser, U. Reimers, U. Ehlert, M. Weichenthal, E.W. Breitbart, 
and H.W. Rudiger. 1991. Increased UV-induced sister-chromatid exchange in 
cultured fibroblasts of first-degree relatives of melanoma patients. Cancer Genet 
Cytogenet. 53 :265-70. 
Kok, K., S.L. Naylor, and C.H. Buys. 1997. Deletions of the short arm of chromosome 
3 in solid turnors and the search for suppressor genes. Adv Cancer Res. 71 :27-
92. 
201 
References 
Kokoska, RJ., L. Stefanovic, A.B. Buenneyer, RM. Liskay, and T.D. Petes. 1999. A 
mutation of the yeast gene encoding PCNA destabilizes both micro satellite and 
minisatellite DNA sequences. Genetics. 151:511-9. 
Kolodner, RD., and G.T. Marsischky. 1999. Eukaryotic DNA mismatch repair. Curr 
Opin Genet Dev. 9:89-96. 
Korenberg, J.R, and E.F. Freedlender. 1974. Giemsa technique for the detection of 
sister chromatid exchanges. Chromosoma. 48:355-60. 
Kruyt, F.A., T. Hoshino, J.M. Liu, P. Joseph, A.K. Jaiswal, and H. Youssoufian. 1998. 
Abnonnal microsomal detoxification implicated in Fanconi anemia group C by 
interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 
92:3050-6. 
Kuluncsics, Z., D. Perdiz, E. Brulay, B. Mue1, and E. Sage. 1999. Wavelength 
dependence of ultraviolet-induced DNA damage distribution: involvement of 
direct or indirect mechanisms and possible artefacts. J Photochem Photobiol B. 
49:71-80. 
Kumaresan, K.R., M. Hwang, M.P. Thelen, and M.W. Lambert. 2002. Contribution of 
XPF functional domains to the 5' and 3' incisions produced at the site of a 
psoralen interstrand cross-link. Biochemistry. 41 :890-6. . 
Latt, S.A. 1973. Microfluorometric detection of deoxyribonucleic acid replication in 
human metaphase chromosomes. Proc Natl Acad Sci USA. 70:3395-9. 
Latt, S.A., and R.R. Schreck. 1980. Sister chromatid exchange analysis. Am J Hum 
Genet. 32:297-313. 
Latt, S.A., G. Stetten, L.A. Juergens, G.R Buchanan, and P.S. Gerald. 1975. Induction 
by alkylating agents of sister chromatid exchanges and chromatid breaks in 
Fanconi's anemia. Proc Natl Acad Sci USA. 72:4066-70. 
Le Page, F., E.E. Kwoh, A. Avrutskaya, A. Gentil, S.A. Leadon, A. Sarasin, and P.K. 
Cooper. 2000. Transcription-coupled repair of 8-oxoguanine: requirement for 
XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell. 101:159-
.71. .. 
Lee, J.W., L. Blanco, T. Zhou, M. Garcia-Diaz, K. Bebenek, T.A. Kunkel, Z. Wang, 
and L.F. Povirk. 2004. Implication of DNA polymerase lambda in alignment-
based gap filling for nonhomologous DNA end joining in human nuclear 
extracts. J Bioi Chem. 279:805-11 .. 
Lewis, D.F., and J.M. Pratt. 1998. The P450 catalytic cycle and oxygenation 
mechanism. Drug Metab Rev. 30:739-86. 
202 
References 
Liang, F., M. Han, PJ. Romanienko, and M. Jasin. 1998. Homology-directed repair is a 
major double-strand break repair pathway in mammalian cells. Proc Natl Acad 
Sci USA. 95:5172-7. 
Lindahl, T. 1979. DNA glycosylases, endonuc1eases for apurinic/apyrimidinic sites, and 
base excision-repair. Prog Nucleic Acid Res Mol Bioi. 22:135-92. 
Lindahl, T. 1993. Instability and decay of the primary structure of DNA. Nature. 
362:709-15. 
Lindahl-Kiessling, K., I. Karlberg, and A.M. Olofsson. 1989. Induction of sister-
chromatid exchanges by direct and indirect mutagens in human lymphocytes, 
co-cultured with intact rat liver cells. Effect of enzyme induction and 
preservation of the liver cells by freezing in liquid nitrogen. Mutat Res. 211 :77-
87. 
Ling, C., M. Ishiai, A.M. Ali, A.L. Medhurst, K. Neveling, R. Kalb, Z. Van, Y. Xue, 
A.B. Oostra, A.D. Auerbach, M.E. Hoatlin, D. S chindl er, H. Joenje, J.P. de 
Winter, M. Takata, A.R. Meetei, and W. Wang. 2007. FAAP100 is essential for 
activation of the Fanconi anemia-associated DNA damage response pathway. 
Embo J. 26:2104-14. ' 
Liu, L.F., T.C. Rowe, L. Yang, K.M. Tewey, and G.L~ Chen. 1983. Cleavage of DNA 
by mammalian DNA topoisomerase 11. J Bioi Chem. 258: 15365-70. . 
Livak, KJ., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2(-Delta Delta C(T» Method. Methods. 
25:402-8. 
Lundin, C., K. Erixon, C. Amaudeau, N. Schultz, D. Jenssen, M. Meuth, and T. 
Helleday. 2002. Different roles for nonhomologous end joining and homologous 
recombination following replication arrest in mammalian cells. Mol Cell Bioi. 
22:5869-78. 
Luria, S.E., and M. Delbruck. 1943. Mutations of Bacteria from Virus Sensitivity to 
Virus Resistance. Genetics. 28:491-511. ' 
Ma, Y., U. Pannicke, K. Schwarz, and M.R.' Lieber. 2002. Hairpin opening and 
overhang processing by an ArtemislDNA-dependent protein kinase complex in 
nonhomologous end joining and V(D)J recombination. Cell. 108:781-94. 
Maat, W., P.A. van der Veld en, C. Out-Luiting, M. Plug, A. Dirks-Mulder, MJ. Jager, 
and N.A. Gruis. 2007. Epigenetic inactivation of RASSFla 'in uveal melanoma. 
Invest Ophthalmol Vis Sci. 48:486-90. 
Machida, Y.J., Y. Machida, Y. Chen, A.M. Gurtan, G.M. Kupfer, A.D. D'Andrea, and 
A. Dutta. 2006. UBE2T is the E2 in the Fanconi anemia pathway and undergoes 
negative autoregulation. Mol Cell. 23:589-96. 
203 
\ 
References 
Mahajan, K.N., L. Gangi-Peterson, D.H. Sorscher, J. Wang, K.N. Gathy, N.P. Mahajan, 
W.H. Reeves, and RS. Mitchell. 1999. Association oftenninal deoxynucleotidyl 
transferase with Ku. Proc Natl Acad Sci USA. 96:13926-31. 
Mahajan, K.N., S.A Nick McElhinny, B.S. Mitchell, and D.A. Ramsden. 2002. 
Association of DNA polymerase mu (po1 mu) with Ku and ligase IV: role for pol 
mu in end-joining double-strand break repair. Mol Cell Bioi. 22:5194-202. 
Mari, P.O., RI. Florea, S.P. Persengiev, N.S. Verkaik, H.T. Bruggenwirth, M. Modesti, 
G. Giglia-Mari, K. Bezstarosti, J.A. Demmers, T.M. Luider, A.B. Houtsmuller, 
and D.C. van Gent. 2006. Dynamic assembly of end-joining complexes requires 
interaction between Ku70/S0 and XRCC4. Proc Natl Acad Sci U' S A. 
103:18597-602. 
McCabe, K.M., A. HemphilI, Y. Akkari, P.M. Jakobs, D. Pauw, S.B. Olson, RE. 
Moses, and M. Grompe. 2008. ERCC1 is required for F ANCD2 focus 
fonnation. Mol Genet Metab. 95:66-73. 
McLean, I.W., W.D. Foster, and L.E. Zimmennan.' 1982. Uveal melanoma: location, 
size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 13:123-
32. " . . 
McPherson, J.P., B. Lemmers, R. Chahwan, A. Pamidi, E. Migon, E. Matysiak-
Zablocki, M.E. Moynahan, J. Essers, K. Hanada, A. Poonepalli, O. Sanchez-
. "Sweatman, R Khokha, R. Kanaar, M. Jasin, M.P. Hande, and R Hakem. 2004. 
Involvement of mammalian Mus81 in genome integrity and tumor suppression. 
Science. 304:1822-6. ' 
Medhurst, A.L., H. Laghmani el, J. Steltenpool, M. Ferrer, C. Fontaine, J. de Groot, 
M.A. Rooimans, RJ. Scheper, A.R. Meetei, W. Wang, H. Joenje, and J.P. de 
Winter. 2006. Evidence for sub complexes in the Fanconi anemia pathway. 
Blood. 108:2072-80. 
Meek, K., P. Douglas,' X .. Cui, Q.', Ding, and S.P. Lees-Miller. 2007.· trans 
Autophosphorylation , at . DNA-dependent· protein kinase's two major 
autophosphorylation site clusters facilitates end processing but not end joining. 
Mol Cell Bioi. 27:3881-90. : . i 
Meetei, AR., lP. de Winter, AL. Medhurst, M. Wallisch, Q. Waisfisz, H.J. van de 
Vrugt, A.B. Oostra, Z. Yan, C. Ling, C.E. Bishop, M.E. Hoatlin, H. Joenje, and 
W. Wang. 2003. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat 
Genet.35:165-70. . ' 
Meetei, A.R., A.L. Medhurst, C. Ling, Y. Xue, T.R. Singh, P. Bier, J. Steltenpoo1, S. 
Stone, 1. Dokal, C.G. Mathew, M. Hoatlin, H. Joenje, J.P. de Winter,' and W. 
Wang. 2005. A human ortholog ofarchaea1 DNA repair protein Hefis defective 
in Fanconi anemia complementation group M. Nat Genet. 37:958-63. 
204 
References 
Mello Filho, A.C., and R Meneghini. 1984. In vivo fonnation of single-strand breaks in 
DNA by hydrogen peroxide is mediated by the Haber-Weiss reaction. Biochim 
Biophys Acta. 781:56-63. 
Meschini, R., R Bastianelli, and F. Palitti. 1996. The diplochromosome of 
endoreduplicated cells: a new approach to highlight the mechanism of sister 
chromatid exchange. Chromosoma. 105:50-4. 
Mimitou, E.P., and L.S. Symington. 2009. DNA end resection: many nucleases make 
light work. DNA Repair (Amst). 8:983-95 .. 
Mimori, T., and J.A. Hardin. 1986. Mechanism of interaction between Ku protein and 
DNA. J Bioi Chem. 261:10375-9. 
Miranda, M., C. Ligas, F. Amicarelli, E. D'Alessandro, F. Brisdelli, O. Zarivi, and A. 
Poma. 1997. Sister chromatid exchange (SCE) rates in human melanoma cells as 
an index of mutagenesis. Mutagenesis. 12:233-6. 
Mirchandani, K.D., and A.D. D'Andrea. 2006. The Fanconi anemialBRCA pathway: a 
coordinator of cross-link repair. Exp Cell Res. 312:2647-53. 
Mirchandani, K.D., RM. McCaffrey, and A.D. D'Andrea. 2008. The Fanconi anemia 
core complex is required for efficient point mutagenesis and Revl foci 
assembly. DNA Repair (Amst). 7:902-11. 
Mitchell, D.L., C.A. Haipek, and J.M. Clarkson. 1985. (6-4)Photoproducts are removed 
from the DNA of UV-irradiated' mammalian cells more efficiently than 
cyclobutane pyrimidine dimers. Mutat Res. 143:109-12. 
Modesti, M., J.E. Hesse, and M. GelIert. 1999. DNA binding of Xrcc4 protein is 
associated with V(D)J recombination but not with stimulation of DNA ligase IV 
activity. Embo J. 18:2008-18. 
Mohindra, A., L.E. Hays, E.N. Phillips, B.D. Preston, T. Helleday, and M. Meuth. 2002. 
Defects in homologous recombination repair In mismatch-repair-deficient 
tumour cell lines. Hum Mol Genet. 11 :2189-200. 
Moldovan, G.L., and A.D. D'Andrea. 2009. How the Fanconi Anemia Pathway Guards 
the Genome. Annu Rev Genet. . 
Moldovan, G.L.', M.V. Madhavan, K.D. Mirchandani, R.M. McCaffrey, P. Vinciguerra, 
and A.D. D'Andrea. 2010. DNA polymerase POLN participates in cross-link 
repair and homologous recombination. Mol Cell Bioi. 30: 1 088-96. 
Mosedale, G., W. Niedzwiedz, A. Alpi, F. Perrina, J.B. Pereira-Leal, M. Johnson, F. 
Langevin, P. Pace, and K.J. Patel. 2005. The vertebrate Hef ortholog is a 
component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol 
Bioi. 12:763-71. 
205 
References 
Moser, J.; H. Kool, I. Giakzidis, K. Caldecott, L.H. Mullenders, and M.I. Fousteri. 
2007. Sealing of chromosomal DNA nicks during nucleotide excision repair 
requires XRCCl and DNA ligase III alpha in a cell-cycle-specific manner. Mol 
Cell. 27:311-23. 
Mulligan, R.C. 1993. The basic science of gene therapy. Science. 260:926-32. 
Nagasawa, H., D. Fomace, and J.B. Little. 1983. Induction of sister-chromatid 
exchanges by DNA-damaging agents and 12-0-tetradecanoyl-phorbol-13-
acetate (TPA) in synchronous Chinese hamster ovary (CHO) cells. Mutat Res. 
107:315-27. 
Nair, V., C.S. Cooper, D.E. Vietti, and G.A. Turner.' 1986. The chemistry of lipid 
peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids. 
21:6-10. 
Nakanishi, K., T. Taniguchi, V. Ranganathan, H.V. New, L.A. Moreau, M. Stotsky, 
C.G. Mathew, M.B. Kastan, D.T. Weaver, and A.D. D'Andrea. 2002. Interaction 
ofFANCD2 and NBSl in the DNA damage response. Nat Cell Bioi. 4:913-20. 
Niedernhofer, L,J., J.S. Daniels, C.A. Rouzer, R.E. Greene, and L,J. Marnett. 2003. 
Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J 
Bioi Chem. 278:31426-33. 
Niedzwiedz, W., G. Mosedale, M. Johnson, C.Y. Ong, P. Pace, and K.J. Pate!. 2004. 
. . The Fanconi anaemia gene F ANCC promotes homologous recombination and 
error-prone DNA repair. Alol Cell. 15:607-20. 
Nijman, S.M., T.T. Huang, A.M. Dirac, T.R. Brummelkamp, R.M. Kerkhoven, A.D. 
D'Afldrea, and R. Bemards. 2005. The deubiquitinating enzyme USPl regulates 
the Fanconi anemia pathway. Mol Cell. 17:331-9. 
Nimonkar, A.V., R.A. Sica, and S.C. Kowalczykowski. 2009. Rad52 promotes second-
end DNA capture in double-stranded break repair to form complement-stabilized 
joint molecules. Proc Natl A cad Sci USA. 106:3077-82. 
Norppa, H., S. Bonassi, I.L. Hansteen, L. Hagmar, U. Stromberg, P. Rossner, P. 
Boffetta, C. Lindholm, S. Gundy, J. Lazutka, A. Cebulska-Wasilewska, E. 
Fabianova, R.J. Sram, L.E. Knudsen, R. Barale,' and A.' Fucic. 2006. 
Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res .. 
600:37-45. 
O'Dwyer, P.J., R.P. Perez, K.S. Yao, A.K. Godwin, and T.C. Hamilton. 1996. Increased 
DT -diaphorase expression and cross-resistance to mitomycin C in a series of 
cisplatin-resistant human ovarian cancer cell lines. Biochem Pharmacol. 52:21-
7. 
Ohashi, A., M.Z. Zdzienicka, J. Chen, and F,J. Couch. 2005. Fanconi anemia 
complementation group 02 (FANC02) functions independently of BRCA2- and 
206 
References 
RAD51-associated homologous recombination in response to DNA damage. J 
BioI Chem. 280:14877-83. ' 
Okada, T., E. Sonoda, M. Yoshimura, Y. Kawano, H. Saya, M. Kohzaki, and S. Takeda. 
2005. Multiple roles of vertebrate REV genes in DNA repair and recombination. 
Mol Cell BioI. 25:6103-11. 
." 
Olive, P.L., I.P. Banath, and R.E. Durand. 1990. Heterogeneity in radiation-induced 
DNA damage and repair in tumor and normal cells measured using the "comet" 
assay. Radiat Res. 122:86-94 .. 
Onken, M.D., I.P. Ehlers, L.A. Worley, I. Makita, Y. Yokota, and I.W. Harbour. 2006. 
Functional gene expression analysis uncovers phenotypic switch in aggressive 
uveal melanomas. Cancer Res. 66:4602-9. 
Ory, D.S., B.A. Neugeboren, and R.C. Mulligan. 1996. A stable human-derived 
packaging cell line for production of high titer retrovirus/vesicular stomatitis 
virus G pseudotypes. Proc Natl Acad Sci USA. 93:11400-6. 
Ostling, 0., and KJ. Iohanson. 1984. Microelectrophoretic study of radiation-induced 
, DNA damages in individual mammalian cells. Biochem Biophys Res Commun. 
123:291-8. 
Pace, P., G. Mosedale, M.R. Hodskinson, I.V. Rosado, M. Sivasubramaniam, and KJ. 
Pate!. 2010. Ku70 corrupts DNA repair in the absence of the Fanconi anemia 
pathway. Science. 329:219-23. 
Painter, R.B. 1980. A replication model for sister-chromatid exchange. Mutat Res. 
70:337-41. 
Palombo, F., I. Iaccarino, E. Nakajima, M. Ikejima, T. Shimada, and I. Iiricny. 1996. 
hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion 
loops in DNA. Curr Bioi. 6: 1181-4. 
Parrella, P., V.M. Fazio, A.P. Gallo, D. Sidransky, and S.L. Merbs. 2003. Fine mapping 
of chromosome 3 in uveal melanoma: identification of a minimal region of 
deletion on chromosomal arm 3p25.1-p25.2. Cancer Res. 63:8507-10. 
Paull, T.T., and M. Gellert. 1998. The 3' to 5' exonuclease activity ofMre 11 facilitates 
repair of DNA double-strand breaks. Mol Cell. 1:969-79. 
Paull, T.T., and I.H. Lee. 2005. The Mrel1IRad50lNbsl complex and its role as a DNA 
double-strand break sensor for AIM. Cell Cycle. 4:737-40.' 
Perry, P., and H.I. Evans. 1975. Cytological detection of mutagen-carcinogen exposure 
by sister chromatid exchange. Nature. 258:121-5. . " 
. . 
Perry, P., and S. Wolff. 1974. New Giemsa method for the differential staining of sister 
chromatids. Nature. 251:156-8. 
207 
References 
Perticone, P., R. Cozzi, and B. Gustavino. 1987. Sister chromatid exchanges induced by 
DNA demethylating agents persist through several cell cycles in mammallan 
cells. Carcinogenesis. 8:1059-63. 
Petukhova, G., S. Stratton, and P. Sung. 1998. Catalysis of homologous DNA pairing by 
yeast Rad51 and Rad54 proteins. Nature. 393:91-4. 
Pichierri, P., D. Averbeck, and F. Rosselli. 2002. DNA cross-link-dependent 
RAD50IMREI1INBS 1 subnuclear assembly requires the Fanconi anemia C 
protein. Hum Mol Genet. 11 :2531-46. 
Pichierri, P., and F. Rosselli. 2004. The DNA crosslink-induced S-phase checkpoint 
depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EmboJ. 23:1178-
87. 
Pommier, Y., L.A. Zwelling, C.S. Kao-Shan, J. Whang-Peng, and M.O. Bradley. 1985. 
Correlations between intercalator-induced DNA strand breaks and sister 
chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. 
Cancer Res. 45:3143-9. 
Ponten, J., and E. Saksela. 1967. Two established in vitro cell lines from human 
mesenchymal tumours. Int J Cancer. 2:434-47 .. 
Prescher, d., N. Bomfeld, H. Hirche, B. Horsthemke, K.H. Jockel, and R. Becher. 1996. 
Prognostic implications of mono so my 3 in uveal melanoma. Lancet. 347:1222-5. 
Prescher, G., N. Bomfeld, B. Horsthemke, and R. Becher. 1992. Chromosomal 
aberrations defining uveal melanoma of poor prognosis. Lancet. 339:691-2 .. 
Puebla-Osorio, N., D.B. Lacey, F.W. Alt, and C. Zhu. 2006. Early embryonic lethality 
due to targeted inactivation of DNA ligase Ill. Mol Cell Bioi. 26:3935-41. 
Qiao, F., J. Mi, IB. Wilson, a. Zhi, N.R. Bucheimer, NJ. Jones, and a.M. Kupfer . 
. 2004. Phosphorylation of fanconi anemia (FA) complementation group G 
protein, F ANCG, at serine 7 is important for function of the FA pathway. J Bioi 
Chem. 279:46035-45. 
Radman, M. 1975. SOS repair hypothesis: phenomenology of an inducible DNA repair 
which is accompanied by mutagenesis. Basic Life Sci. 5A:355-67. 
Ralf, C., I.D. Hickson, and L. Wu. 2006. The Bloom's syndrome helicase can promote 
the regression of a model replication fork. J Bioi Chem. 281 :22839-46. 
Ramilo, C., L. Gu, S. Guo, X. Zhang, S.M. Patrick, J.J. Turchi, and G.M. Li. 2002. 
Partial reconstitution of human DNA mismatch repair in vitro: characterization 
of the role of human replication protein A. Mol Cell Bioi. 22:2037-46. 
208 
References 
Raschle, M., P. Knipscheer, M. Enoiu, T. Angelov, J. Sun, J.D. Griffith, T.E. 
Ellenberger, O.D. Scharer, and J.C. WaIter. 2008. Mechanism of replication-
coupled DNA interstrand crosslink repair. Cell. 134:969-80. 
Richardson, C., and M. Jasin. 2000. Coupled homologous and nonhomologous repair of 
a double-strand break preserves genomic integrity in mammalian cells. Mol Cell 
Bioi. 20:9068-75. 
Robertson, K.D. 2002. DNA methylation and chromatin - unraveling the tangled web. 
Oncogene.21:5361-79. 
Rogakou, E.P.~ D.R. Pitch, A.H. Orr, V.S. Ivanova, and W.M. Bonner. 1998. DNA 
double-stranded breaks induce histone H2AX phosphorylation on serine 139. J 
Bioi Chem. 273:5858-68. 
Roy, S.K., A.H. Trivedi, S.R. Bakshi, R.K. Pate1, P.H. Shukla, S.J. Patel, J.M. 
Bhatavdekar, D.D. Patel, and P.M. Shah. 2000. Spontaneous chromosomal 
instability in breast cancer families. Cancer Genet Cytogenet. 118:52-6. 
Rudland, P.S., A.M. Platt-Higgins, L.M. Davies, S. de Silva Rudland, J.B. Wilson, A. 
Aladwani, J.H. Winstanley, D.L. Barraclough, R. Barrac1ough, C.R. West, and 
N.J. Jones. 2010. Significance of the FanconiAnemia FANCD2 Protein in 
Sporadic and Metastatic Human Breast Cancer. Am J Path 01. 176. 
Saiki, R.K., S. Scharf, F. Faloona, K.B. Mullis, G.T. Horn, H.A. Erlich, and N. 
Arnheim. 1985. Enzymatic amplification of beta-globin genomic sequences and 
restriction site analysis for diagnosis of sickle cell anemia. Science. 230:1350-4. 
Saleh-Gohari, N., H.E. Bryant, N. Schultz, K.M. Parker, T.N. Cassel, and T. Helleday. 
2005. Spontaneous homologous recombination is induced by collapsed 
replication forks that are caused by endogenous DNA single-strand breaks. Mol 
Cell Bioi. 25:7158-69. 
Sancar, A., and J.E. Hearst. 1993. Molecular matchmakers. Science. 259:1415-20. 
Sargent, R.G., M.A. Brenneman, and J.H. Wilson.1997. Repair of site-specffic double-
strand breaks in a mammalian chromosome by homologous and illegitimate 
recombination. }r/ol Cell Bioi. 17:267-77. 
Scotto, J., J.F. Fraumeni, Jr., and J.A. Lee. 1976. Melanomas of the eye and other 
noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 56:489-91. 
Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle 
control causing specific inhibition of cyclin D/CDK4. Nature. 366:704-7. 
Shafer, D.A. 1977. Replication bypass model of sister chromatid exchanges and 
implications for Bloom's syndrome and Fanconi's anemia. Hum Genet. 39: 177-
9Q .
209 
References 
Shen, H.M., C.Y. Shi, Y. Shen, and C.N. Ong. 1996. Detection of elevated reactive 
oxygen species level in cultured rat hepatocytes treated with aflatoxin B 1. Free 
Radic Bioi Med. 21:139-46. 
Shields, C.L., J.A. Shields, M. Materin, E. Gershenbaum, A.D. Singh, and A: Smith. 
2001. Iris melanoma: risk factors for metastasis in 169 consecutive patients. 
Ophthalmology. 108:172-8. 
Shields, J.A., C.L. Shields, and L.A. Donoso. 1991. Management of posterior uveal 
melanoma. Surv Ophthalmol. 36:161-95. 
Siegel, D., H. BeaU, C. Senekowitsch, M. Kasai, H. Arai, N.W. Gibson, and D. Ross. 
1992. Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry. 
31 :7879-85. 
Siegel, D., N.W. Gibson, P.C. Preusch, and D. Ross. 1990. Metabolism of mitomycin C 
by DT -diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity 
in human colon carcinoma cells. Cancer Res. 50:7483-9. 
S iehl er, S.Y., M. Schrauder, U. Gerischer, S. Cantor, G. Marra, and L. Wiesmuller. 
2009. Human MutL-complexes monitor homologous recombination 
independently of mismatch repair. DNA Repair (Amst). 8:242-52. 
Simpson, L.J., and J.E. Sale. 2003. Revl is essential for DNA damage tolerance and 
non-templated immunoglobulin gene mutation in a vertebrate cell line. Embo J. 
22:1654-64. 
Singh, A.D., and A. Topham. 2003. Incidence of uveal melanoma in the United States: 
1973-1997. Ophthalmology. 110:956-61. 
Singh, A.D., and A. Topham. 2003. Survival rates with uveal melanoma in the United 
States: 1973-1997. Ophthalmology. 110:962-5. 
Singh, N.P., M.T. McCoy, R.R. Tice, and E.L. Schneider. 1988. A simple technique for 
quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 
175:184-91. 
Singleton, M.R., L.M. Wentzell, Y. Liu, S.C. West, and D.B. Wigley. 2002. Structure of 
the single-strand annealing domain of human RAD52 protein. Proc Natl Acad 
Sci USA. 99:13492-7. 
Sisley, K. 1996. unpublished data. 
Sisley, K., M.A. Parsons, J. Garnham, A.M. Potter, D. Curtis, R.C. Rees, and 1.0. 
Rennie. 2000. Association of specific chromosome alterations with tumour 
phenotype in posterior uveal melanoma. Br J Cancer. 82:330-8. 
210 
References 
Sisley, K., I.G. Rennie, D.W. Cottam, A.M. Potter, C.W. Potter, and RC. Rees. 19?0. 
Cytogenetic findings in six posterior uveal melanomas: involvement of 
chromosomes 3, 6, and 8. Genes Chromosomes Cancer. 2:205-9. 
Sisley, K., LG. Rennie, M.A. Parsons, R. Jacques, D.W. Hammond, S.M. Bell, A.M. 
Potter, and RC. Rees. 1997. Abnormalities of chromosomes 3 and 8 in posterior 
uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 19:22-
8. 
Smiraldo, P.G., A.M. Gruver, J.C. Osbom, and D.L. Pittman. 2005. Extensive 
chromosomal instability in Rad51d-deficient mouse cells. Cancer Res. 65:2089-
96. 
Smogorzewska, A., S. Matsuoka, P. Vinciguerra, E.R McDonald, 3rd, K.E. Hurov, J. 
Luo, B.A. Ballif, S.P. Gygi, K. Hofmann, A.D. D'Andrea, and S.J. Elledge. 
2007. Identification of the F ANCI protein,' a monoubiquitinated F ANCD2 
paralog required for DNA repair. Cell. 129:289-301. .. 
Sobol, RW., J.K. Horton, R. Kuhn, H. Gu, R.K. Singhal, R Prasad, K. Rajewsky, and 
S.H. Wilson. 1996. Requirement of mammalian DNA polymerase-beta in base-
excision repair. Nature. 379:183-6: 
Sonoda, E., M.S. Sasaki, C. Morrison, Y. Yamaguchi-Iwai, M. Takata, and S. Takeda. 
1999. Sister chromatid exchanges are mediated by homologous recombination in 
vertebrate cells. Afol Cell BioI. 19:5166-9. 
Stetka, D.G., Jr. 1979. Further analysis of the replication bypass model for sister 
chromatid exchange. Hum Genet. 49:63-9. . 
Strathdee, C.A, H. Gavish, W.R Shannon, and M. Buchwald. 1992. Cloning ofcDNAs 
for Fanconi's anaemia by functional complementation. Nature. 356:763-7. 
Sugasawa, K., T. Okamoto, Y. Shimizu, C. Masutani, S. Iwai, and F. Hanaoka. 2001. A 
multistep damage recognition mechanism for global genomic' nucleotide 
excision repair. Genes Del'. 15:507-21. 
Sugiyama, T., J.H. New, and S.C. Kowalczykowski. 1998. DNA annealing by RAD52 
protein is stimulated by specific interaction with the complex of replication 
protein A and single-stranded DNA Proc Natl Acad Sci USA. 95:6049-54. 
- ',"' 
Suresh Kumar, G., R Lipman, J. Cummings, and M. Tomasz. 1997. Mitomycin C-ONA 
adducts generated by DT -diaphorase. Revised mechanism of the enzymatic 
reductive activation of mitomycin C. Biochemistry. 36:14128-36. 
. ,~ 
Surtees, J.A, J.L Argueso, and E. Alani. 2004. Mismatch repair proteins:. key 
regulators of genetic recombination. Cytogenet Genome Res. 107:146-59. ,. 
Takata, M., M.S. Sasaki, S. Tachiiri, T. Fukushima, E. Sonoda, O. Schild, L.H. 
Thompson, and S. Takeda. 2001. Chromosome instability and· defective 
211 
References 
recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell 
BioI. 21 :2858-66. . 
Taniguchi, T., I. Garcia-Higuera, P.R Andreassen, RC. Gregory, M. Grompe, and A.D. 
D'Andrea. 2002. S-phase-specific interaction of the Fanconi anemia protein, 
FANCD2, with BRCAl and RAD51. Blood. 100:2414-20. 
Tateishi, S., H. Niwa, I. Miyazaki, S. Fujimoto, H. !noue, and M. Yamaizumi. 2003. 
Enhanced genomic instability and defective postreplication repair in RAD 18 
knockout mouse embryonic stem cells. Mol Cell Bioi. 23:474-81. 
Taylor, I.H. 1958. Sister Chromatid Exchanges in Tritium-Labeled Chromosomes. 
Genetics. 43:515-29. 
J. 
Tebbs, RS., I.M. Hinz, N.A. Yamada, I.B. Wilson, E.P. Salazar, C.B. Thomas, I.M. 
Iones, N.I. lones, and L.H. Thompson. 2005. New insights into the Fanconi 
anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 
(Amst). 4: 11-22 .. 
Thompson, L.H. 2005. Unraveling the Fanconi anemia-DNA repair connection. Nat 
Genet.37:921-2. . 
Thompson, L.H., K.W. Brookman, L.E. Dillehay, A.V. Carrano, I.A. Mazrimas, C.L. 
Mooney, and I.L. Minkler. 1982. A CHO-cell strain having hypersensitivity to 
mutagens, a defect in DNA strand-break repair, and an extraordinary baseline 
frequency of sister-chromatid exchange. Mutat Res. 95:427-40. 
Timmers, C., T. Taniguchi, I. Hejna, C. Reifsteck, L. Lucas, D. Bruun, M. Thayer, B. 
Cox, S. Olson, A.D. D'Andrea, R. Moses, and M. Grompe. 2001. Positional 
cloning of a novel Fanconi anemia gene, F ANCD2. Mol Cell. 7:241-8 .. 
Tomasz, M., D. Chowdary, R. Lipman, S. Shimotakahara, D. Veiro, V. Walker, and 
G.L. Verdine. 1986. Reaction of DNA with· chemically or enzymatically 
activated mitomycin C: isolation and structure of the major covalent adduct. 
Proc Natl Acad Sci USA. 83 :6702-6. 
Tomasz, M., and R Lipman. 1981. Reductive metabolism and alkylating activity of 
mitomycin C induced by rat liver microsomes. Biochemistry. 20:5056-61. 
0,', 
Tomasz, M., R. Lipman, D. Chowdary, I. Pawlak, G.L. Verdine, and K. Nakanishi. 
1987. Isolation and structure of a covalent cross-link adduct between mitomycin 
C and DNA. Science. 235:1204-8. 
Tschentscher, F., G. Prescher, D.E. Horsman, V.A. White, H. Rieder, G. Anastassiou, 
H. Schilling, N. Bomfeld, K.U. Bartz-Schmidt, B. Horsthemke, D.R. Lohmann, 
and M. Zeschnigk. 2001. Partial deletions of the long and short arm of 
chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer 
Res. 61:3439-42. 
212 
References 
Tutt, A., D. Bertwistle, J. Valentine, A. Gabriel, S. Swift, G. Ross, C. Griffin, J. 
Thacker, and A. Ashworth. 2001. Mutation in Brca2 stimulates error-prone 
homology-directed repair of DNA double-strand breaks occurring between 
repeated sequences. Embo J. 20:4704-16. 
Urtishak, K.A., K.D. Smith, R.A. Chanoux, R.A. Greenberg, F.B. Johnson, and EJ. 
Brown. 2009. Timeless Maintains Genomic Stability and Suppresses Sister 
Chromatid Exchange during Unperturbed DNA Replication. J Bioi Chem. 
284:8777-85. 
van der Groep, P., M. Hoelzel, H. Buerger, H. Joenje, J.P. de Winter, and P.J. van Diest. 
2008. Loss of expression of F ANCD2 protein in sporadic and hereditary breast 
cancer. Breast Cancer Res Treat. 107:41-7. 
van der Velden, P.A., J.A. Metzelaar-Blok, W. Bergman, H. Monique, H. Hurks, R.R. 
Frants, N.A. Gruis, and M.J. Jager. 2001. Promoter hypermethylation: a 
common cause of reduced p 16(INK4a) expression in uveal melanoma. Cancer 
Res. 61 :5303-6. 
van Hoffen, A., J. Venema, R. Meschini, A.A. van Zeeland, and L.H. Mullenders. 1995. 
Transcription-coupled repair removes both cyc10butane pyrimidine dimers and 
6-4 photoproducts with equal efficiency and in a sequential way from 
transcribed DNA in xeroderma pigmentosum group C fibroblasts. Embo J. 
14:360-7. 
Virgili, G., G. Gatta, L. Ciccolallo, R. Capocaccia, A. Biggeri, E. Crocetti, J.M. Lutz, 
and E. Paci. 2008. Survival in patients with uveal melanoma in Europe. Arch 
. Ophthalmol. 126:1413-8. 
Walker, J.R., R.A. Corpina, and J. Goldberg. 2001. Structure of the Ku heterodimer 
bound to DNA and its implications for double-strand break repair. Nature. 
412:607-14. " 
Wang, H., Z.C. Zeng, T.A. Bui, E. Sonoda, M. Takata, S. Takeda, and G. Iliakis. 2001. 
Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate 
cells deficient in genes of the RAD52 epistasis group. Oncogene. 20:2212-24. 
Wang, L.C., S. Stone, M.E. Hoatlin, and J. Gautier. 2008. Fanconi anemia proteins 
stabilize replication forks. DNA Repair (Amst). 7:1973-81. 
Wang, M., A. Mahrenholz, and S.H. Lee. 2000. RPA stabilizes the XPA-damaged DNA 
complex through protein-protein interaction. Biochemistry. 39:6433-9. 0 
Wang, RY., K.C. Kuo, C.W. Gehrke, L.H. Huang, and M. Ehrlich. 1982. Heat- and 
alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA: 
Biochim Biophys Acta. 697:371-7. 
Wang, W. 2008. A major switch for the Fanconi anemia DNA damage-response 
. pathway. Nat Struct Mol Bioi. 15:1128-30. 
213 
References 
Wang, X., P.R. Andreassen, and A.D. D'Andrea. 2004. Functional interaction of 
monoubiquitinated FANCD2 and BRCA2IFANCDI in chromatin. Mol Cell 
Bioi. 24:5850-62. 
Wang, X., R.D. Kennedy, K. Ray, P. Stuckert, T. Ellenberger, and A.D. D'Andrea. 
2007. Chkl-mediated phosphorylation of FANCE is required for the Fanconi 
anemialBRCA pathway. Mol Cell Bioi. 27:3098-108. 
Ward, I.M., and J. Chen. 200LHistone H2AX is phosphorylated in an ATR-dependent 
manner in response to replicational stress. J Bioi Chem. 276:47759-62. 
Watanabe, K., S. Tateishi, M. Kawasuji, T. Tsurimoto, H. Inoue, and M. Yamaizumi. 
2004. Rad18 guides poleta to replication. stalling sites through physical 
interaction and PCNA monoubiquitination. Embo J. 23:3886-96. 
Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-
30. 
Weinfe1d, M., M.A. Chaudhry, D. D'Amours, J.D. Pelletier, G.G. Poirier, L.F. Povirk, 
and S.P. Lees-Miller. 1997. Interaction of DNA-dependent protein kinase and 
poly(ADP-ribose) polymerase with radiation-induced DNA strand breaks. 
Radiat Res. 148:22-8. 
Weterings, E., and D.J. Chen. 2008. The endless tale of non-homologous end-joining. 
. Cell Res. 18:114-24. . 
Weterings, E., N.S. Verkaik, H.T. Bruggenwirth, J.H. Hoeijmakers, and D.C. van Gent. 
2003. The role of DNA dependent protein kinase in synapsis of DNA ends. 
Nucleic Acids Res. 31 :7238-46. 
Willers, H., L.A. Kachnic, C.M. Luo, L; Li, M. Purschke, K. Borgmann, K.D. Held, and 
S.N. Powell. 2008. Biomarkers and mechanisms ofFANCD2 function. J Biomed 
Biotechnol.2008:821529. 
Winer, J., C.K. Jlmg, I. Shackel, and P.M. Williams. 1999. Development and validation 
of real-time quantitative reverse transcriptase-polymerase chain reaction for 
monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 270:41-
, 9. 
Wojcik, A., E. Bruckmann, and G. Obe. 2004. Insights into the mechanisms of sister 
chromatid exchange formation. Cytogenet Genome Res. 104:304-9. 
Wolff, S., J. Bodycote, G.H. Thomas, and J.E. Cleaver. 1975. Sister chromatid 
exchange in xeroderma pigmentosum cells that are defective in DNA excision 
repair or post-replication repair. Genetics. 81 :349-55. 
Woodward, J.K., C.E. Nichols, I.G. Rennie, M.A. Parsons, A.K. Murray, and K. Sisley. 
2002. An in vitro assay to assess uveal melanoma invasion across endothelial 
and basement membrane barriers. Invest Ophthalmol Vis Sci. 43: 1708-14. 
214 
References 
Wu, L., and I.D. Hickson. 2003. The Bloom's syndrome helicase suppresses crossing 
over during homologous recombination. Nature. 426:870-4. 
Xia, B., Q. Sheng, K. Nakanishi, A. Ohashi, J. Wu, N. Christ, X. Liu, M. Jasin, F.J. 
Couch, and D.M. Livingston. 2006. Control of BRCA2 cellular and clinical 
functions by a nuclear partner, PALB2. Mol Cell. 22:719-29. 
Yamamoto, K., S. Hirano, M. Ishiai, K. Morishima, H. Kitao, K. Namikoshi, M. 
Kimura, N. Matsushita, H. Arakawa, J.M. Buerstedde, K. Komatsu, L.H. 
Thompson, and M. Takata. 2005. Fanconi anemia protein FANCD2 promotes 
immunoglobulin gene conversion and DNA repair through a mechanism related 
to homologous recombination. Mol Cell Bioi. 25:34-43. 
Yamashita, Y.M., T. Okada, T. Matsusaka, E. Sonoda, G.Y. Zhao, K. Araki, S. Tateishi, . 
M. Yamaizumi, and S. Takeda. 2002. RAD18 and RAD54 cooperatively 
contribute to maintenance of genomic stability. in vertebrate cells. Embo J. 
21 :5558-66. . 
. \ 
Yang, H., P.D. Jeffrey, J. Miller, E. Kinnucan, Y. Sun, N.H. Thoma, N. Zheng, P.L. 
Chen, W.H. Lee, and N.P. Pavletich. 2002. BRCA2 function in DNA binding 
and recombination from a BRCA2-DSSl-ssDNA structure. Science. 297:1837-
48. 
Yonetani, Y., H. Hochegger, E. Sonoda, S. Shinya, H. Yoshikawa, S. Takeda, and M. 
Yamazoe. 2005. Differential and collaborative actions ofRad51 paralog proteins 
in cellular response to DNA damage. Nucleic Acids Res. 33:4544-52. 
Yu, X., and J. Chen. 2004. DNA damage-induced cell cycle checkpoint control requires 
CtIP, a phosphorylation-dependent binding partner of BRCAl C-tenninal 
domains. Mol Cell Bioi. 24:9478-86. 
Yun, M.H., and K. Hiom. 2009.· CtIP-BRCAI modulates the choice of DNA double-
strand-break repair pathway throughout the cell cycle. Nature. 459:460-3. 
Zander, L., and M. Bemark. 2004. Immortalized mouse cell lines that lack a functional 
Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment. DNA 
> Repair (Amst). 3:743-52. 
215 
Appendix 1 
• Clinco-pathological details of the patients with primary uveal melanoma 
from which primary short-term cultures were obtained (Hoh, 2007, 
unpublished data). 
Case Patient sexa Tumour Cell typeC Mean 
Number locationb tumour 
diameter 
(mm) 
SOM 494 F C M 14.85 
SOM 520 F CB S -
SOM 521 F C E 18.6 
SOM 524 F CB M 13.1 
SOM 526 F CB M 8.3 
SOM 537 M CB/C S 13.8 
SOM 538 M C M 
-
SOM 543 M C M 9.3 
SOM 544 M C S 10.3 
SOM 545 F C E 
-
SOM 546 F C S 14.25 
SOM 547 F C S 12.67 
SOM 548 F C M 15.4 
SOM 551 M C M 15.3 
• Patient sex indicates male (M) or female (F) 
b Tumour type indicates choroid (C) or ciliary body (CB) 
e Cell type indicates spindle (S), epithelioid (E) or mixed (M) 
,. 
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Appendix 2 
• The pMMP-f2-FANCD2 vector with the human FANCD2 cDNA sequence cloned 
into the multiple cloning site (MCS). A kind gift from Dr. Alan D' Andrea at the 
Dana-Farber Cancer Institute, in Boston, Massachusetts. 
• The pMMP-f2-empty (PMMP-f2) vector was also a kind gift from Dr. Alan 
D' Andrea at the Dana-Farber Cancer Institute, in Boston, Massachusetts. 
M13F IJ (2 0) 
Lacl alpha ___ - .... ~ ( 
~U3 R 
pMMP-f2 
CoIE1ori 
LBoD f 
13 Rev 
us 
~U5 
"'--SO 
~Bgm(::~9) 
SA 
BamHl (:.q -) 
MCS - mUltiple cloning site, unique restriction sites are indicated 
M13 F - M13 forward primer site 
M13 Rev - M13 reverse primer site 
ColE 1 ori - ColE I-type bacterial origin of replication 
R - R viral promoter (part ofLTR) 
US - US viral promoter (part ofLTR) 
U3 - U3 viral promoter (part of L TR) 
SD - splice donor site 
SA - splice acceptor site 
LacZ alpha - LacZ alpha fragment 
AmpR - ampicillin resistance gene 
LacO - LacO bacterial operon fragment 
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Appendix 3 
• The pEF-P450R-IRES-P vector with the human CYP450R cDNA sequence cloned 
into the multiple cloning site (MCS). A kind gift from Dr. Kaye Williams at the 
School of Pharmacy and Pharmaceutical Sciences, University of Manchester, 
Manchester. 
BglII 
Hindlll 
Pstl 
Pstl Nhel 
AmpR INTRON XhOl 
EcoRI EFIRES-P MCS CJ---~ Mlul 
P IRES Xbal 
Notl Hind III 
, , 
BamHI 
pEF-la - human elongation factor la promoter 
pCMV - cytomegalovirus immediate early enhancer/promoter 
INTRON - chimaeric intron 
MCS - multiple cloning site, unique restriction sites are indicated 
IRES - EMC internal ribosome entry site from pCITE-l 
pac - modified pac gene encoding puromycin N-acetyl transferase 
SV40 PA - SV40 terminator/poly(A) signal 
fl - phage fl origin 
AmpR - bla ampicillin resistance gene 
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Appendix 4 
• Apoptosis levels were no different in the uveal melanoma cell lines 
compared to the WM793 control as determined by Annexin-V staining. 
Annexin-V is an anticoagulant that binds to phosphatidylserine, a plasma-
membrane phospholipid that gets flipped-out and exposed on the external 
side of the lipid bilayer during apoptosis. Annexin-V conjugated to FITC 
allows the identification of this change in the lipid bilayer and thus when 
co-stained with PI, the percentage of apoptotic cells can be determined 
using FACS. 
Figure 1 The percentage of apoptotic cells was no different in uveal melanoma 
cell lines compared to the WM793 cutaneous control. 
Annexin-V and PI staining to detennine the percentage of apoptotic cells in the uv al 
melanoma cell lines 157d and 196b compared to the control cell line WM93. Cells 
were stained with Annexin-V and PI before being analysed using F ACS. The 
percentage of apoptotic cells was calculated as the percentage of cell that wer 
positive for Annexin-V staining but negative for PI (not actively cycling). Data 
represents the average from at least 3 separate experiments and error bars represent 
standard deviations. Significance between samples as shown by brackets was 
calculated using the Student's T-Test where 'NS' represents no significance. 
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